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Abstract
In order to examine the role of partial intercalation in double-stranded (ds) DNA
cleavage mediated by a single bleomycin (BLM), a bulky group (-cyclodextrin) was
chemically attached to the polyamine tail of BLM AS to prevent the intercalation of the
bithiazole tail. The ability of this analog (CD-BLM) to effect ds-DNA cleavage was
quantitatively analyzed using the internally [32P]-labeled hairpin DNA technology and the
supercoilded DNA relaxation assay. CD-BLM can mediate both ss and ds-DNA cleavage,
although 5-fold less efficient than BLM AS. Analysis of DNA cleavage by CD-BLM with
competitive BLM-Co(III)-OOH indicates that the ds-DNA cleavage is mediated by two
CD-BLM molecules, suggesting that the partial intercalation is essential for one BLM
molecule to mediate ds-DNA cleavage.
A "hot spot" for blunt-ended ds-cleavage by BLM (5'-GTCA-3'/3'-CAGT-5') has been
identified in an effort to obtain structural insights into the mechanism of the blunt-ended
ds-DNA cleavage. A 3'-phosphoglycolate/5'-phosphate (3'PG/5'P) gapped lesion in this
"hot spot" has been synthesized to probe the structural basis for re-organization of BLM to
the second cleavage site. This lesion was titrated with BLM-Co(III)-OOH. The resulting
mixture of complexes was in fast exchange on the NMR time scale, which precluded
further structural characterization.
In order to understand the mechanism(s) of recognition and repair of DNA lesions
generated by BLM, a duplex DNA containing a 4'-oxidized abasic site (X) in
d(CCAAAGXACCGGG)-d(CCCGGTACTTTGG) (1) was synthesized and characterized
by 2D NMR spectroscopy and molecular modeling. The results indicate that the 4'-
oxidized abasic site adopts an intrahelical conformation, in contrast to a normal abasic site
in the same sequence context, which is partially extrahelical.
A systematic structural characterization was performed using 2D NMR methods and
molecular modeling on an oligonucleotide containing a normal abasic site (Y) with four
different bases (A, G, T, or C) opposite the lesion in d(CCAAAGYACCGGG). The results
suggest that the conformation in the abasic site region is more perturbed with a pyrimidine
opposite the abasic site. This study provides the first structural insight into the dynamics
of abasic sites that are intrinsically modulated by the opposite and neighboring bases.
Thesis Supervisor: JoAnne Stubbe
Title: Novartis Professor of Chemistry and Biology
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Preface
Figure 1.7 in Chapter 1 is reproduced with permission from Figure 5 and Figure 6 in"
Chemical and structural characterization of the interaction of bleomycin A2 with
d(CGCGAATTCGCG)2. Efficient, double-strand DNA cleavage accessible without
structural reorganization. Keck, M.V.; Manderville, R.A.; Hecht, S.M.; J. Am. Chem. Soc.;
2001, 123 (36), 8690-8700. Copyright (2001) American Chemical Society.
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Chapter 1. Introduction
1.1 Overview
The bleomycins (BLMs, Figure 1.1) are a family of natural glycopeptides isolated
from Streptomyces verticillus by Umezawa et al. in 1966(1). The BLMs have been an
essential component in combination chemotherapy against head and neck cancer, and
certain types of lymphomas(2). BLM is also part of a regiment involving etoposide and
cisplatin (BEP Regiment) that is 90% curative for testicular cancer(3). The clinically
administered form of the drug, Bleonoxane (Bristol-Myers Squibb), is composed of
-60% BLM A2, 30% BLM B2 (Figure 1.1) and additional minor components(2).
The BLM's cytotoxicity against cancer cells is proposed to be related to their ability
to cause both single-stranded (ss) and double-stranded (ds) DNA damage, which requires
cofactors including a reduced transition metal, 02, and a one-electron reductant(4-6). Ss-
cleavage occurs predominantly at pyrimidines 3' to a guanine (5'-GC-3' 5'-GT-3' >>
5'-GA-3', _ denotes cleavage site)(7). Ds-DNA cleavage is a rare event compared to ss-
cleavage. The average ratios of ss to ds cleavage by BLMs are reported to range from 6:1
to 20:1 measured by several groups using the supercoil DNA relaxation assay(8-12). Ds-
cleavage is thought to play a major role in BLMs-induced cell death due to its severe
intracellular consequences(13, 14).
BLMs are attractive therapeutics because of their unique low myelo-suppressive(15)
and low immuno-suppressive(16) properties compared to other chemotherapy agents.
However, the therapeutic efficacy of the BLMs is limited by drug resistance and dose-
dependent development of pneumonitis that can lead to fatal pulmonary fibrosis( 7).
Our group has recently been interested in understanding the mechanism of BLM-
mediated dsDNA cleavage, determining the structures of DNA lesions generated by
20
~ R1 = ~NHyNH2
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BLMs, and understanding the mechanism(s) of BLM uptake. This thesis is focused on the
first two problems. The long-range goal of our research is to make a more effective, less
toxic BLM.
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Figure 1.1 Structures of BLMs. The proposed equatorialligands for metal binding are in
red and the proposed axialligands are in green. A consensus has not been reached on the
identity of the axialligands.
1.2 Structures of metallo- BLMs
The BLM family members share the same core structure but differ in their positively
charged tails (Figure 1.1). The BLM molecule can be divided into four functional
domains- the metal-binding domain, the disaccharide moiety, the bithiazole tail, and the
linker region connecting the bithiazole tail with the metal-binding domain. Synthetic
methods have been used extensively by the Boger(18-24) group and the Hecht group(25-
32) to dissect the function of each domain. The role of the sugars is least well
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understood. In vitro and in vivo studies have shown that deglycoBLM, which lacks the
disaccharide moiety, has reduced affinity for DNA and is much less effective at
mediating ds-DNA cleavage, suggesting that the disaccharide moiety is involved in DNA
binding(33, 34). Furthermore, studies on monosaccharide BLM analogs by Boger and
Hecht et al. suggest that the nature of the first carbohydrate (L-gulose) is important for
efficient ss and ds-DNA cleavage(24, 31). The sugar moiety has also been speculated to
be involved in the drug uptake by interacting with cell surface receptors(35). However,
recent genetic studies in yeast suggest that the positively charged tail might be
responsible for the uptake of BLM into the cell (See the discussion below) (36, 37).
The metal-binding domain is the warhead and contains the ligands involved in
octahedral complex formation with the transition metals (Figure 1.1, the proposed
equatorial ligands are in red and the proposed axial ligands are in green). The
organization of the ligands around the metal center has important implications for the
recognition of the DNA binding site. As discussed in Section 1.3, the cleavage chemistry
requires activation of 02 in the presence of a transition metal. The ligand geometry
around the metal center has been studied with iron, copper, cobalt, or zinc-BLM
complexes (reviewed by Claussen and Long (38)). A consensus has been reached
regarding the equatorial ligands, which include the secondary amine of the 3-
aminoalanine, the pyrimidine nitrogen, the deprotonated histidine amide, and the
imidazole of the histidine (colored in red, Figure 1.1). However, the identity of the axial
ligand(s) (colored in green, Figure 1.1) and consequently, the screw sense of the complex
remain controversial. Based on the DNA cleavage chemistry as discussed in Section 1.3,
one axial ligand is provided by exogenous 02. The other axial ligand has been proposed
22
to be either the primary amine of the 1-aminoalanine or the carbamoyl group on the
mannose. A model structure of BLM-Co(III)-OOH (an "activated BLM" analog, Section
1.3) determined by 2D NMR methods by our group suggests that the primary amine of 3-
aminoalanine is the axial ligand and is on the same face as the disaccharide moiety with
OOH as the second axial ligand (Figure 1.2 A)(39). Recent X-ray structural studies on
BLM-Cu(II) in a complex with BLM-binding protein from the BLM-producing strain (S.
verticillus) also suggests the same ligand geometry and screw sense (Figure 1.2 B) with
the exogenous axial ligand as Cl- (colored in cyan, Figure 1.2 B)(40). However, studies
on BLM-Zn(II) suggest a different ligand geometry. In the model structure of BLM-
Zn(II), both the primary amine of the 1-aminoalanine and the carbamoyl group on the
mannose are axial ligands to the metal center(41-43). Other studies (Petering) suggest
that the ligands in BLM-Zn(II) are in rapid exchange on the NMR time scale. In no case
has the screw sense isomer of the BLM-Zn(II) complex been established. The binding of
BLM to DNA and the chemistry of BLM-mediated cleavage (which is initiated by 4'-H
atom abstraction as discussed in Section 1.3) suggest that the screw sense observed for
BLM-Co(III)-OOH site is sufficient for the close proximity between the exogenous
ligand and the 4'-H atom of DNA(44). Since we don't have a model for BLM-Zn(II)
binding, we don't know if it is consistent with 4'-H atom abstraction.
In addition to providing ligands to coordinate metal ions, the metal binding domain
has also been proposed to play a key role in the sequence specific binding of DNA by
BLM. The 2D NMR structure of BLM A2-Co(III)-OOH bound to several duplexes of
DNA containing a single binding site (5'-GGCC-3', 5'-GTAC-3', _ denotes the cleavage
site) reveals that the N3 and 4-amino groups of the pyrimidine within the metal binding
23
domain form two H-bonds with the N3 and 2-amino group of the guanine 5' to the
pyrimidine cleavage site(45) (see the discussion in Section 1.5).
c
Figure 1.2 Ligand geometries of BLM-Co(III)-OOH and BLM-Cu(II) A: The solution
structure of BLM-Co(III)-OOH determined by 20 NMR methods (39). B: The 30
structure of BLM-Cu(II) bound to the active site of a "resistant protein" from the host
organism (S. verticillus) determined by X-ray crystallography (POB No. InF)(40). In A
and B, the atoms are colored as follows: N, blue; 0, red; C, green; Co(III) or Cu(II) ion,
magenta sphere; chloride ion, cyan sphere. The bithiazole tail is omitted for clarity. C:
The superimposition of the metal binding domains of Cu(II)-BLM (in green) and the
BLM-Co(III)-OOH (in gray).
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The bithiazole tail is also in part responsible for DNA binding. The binding can
occur either by partial intercalation(46) or by interactions with the minor groove(47, 48).
In support of the intercalative mode of binding, Povirk et al. have studied relaxation of
supercoiled DNA and reversal of supercoiling in the presence of BLM at pH 5.5 using
sedimentation methods(46). No metal ions were used in those studies due to the lack of
knowledge of the metal ion requirement at that time and the low pH was utilized to avoid
nicking of supercoiled DNA. The DNA unwinding angle caused by BLM binding was
determined to be 12° per BLM(46). In addition, Povirk et al. also measured the
lengthening of linear DNA molecules by BLM binding by determining the characteristic
time (s) for rod-like DNA to orient in an electric field monitored by linear
dichroism(46). The observed lengthening effect caused by BLM was measured to be 3.1
A /BLM, which is within the range of other intercalators (1.8-4.5 A). However, other
studies have supported binding of the bithiazole tail to DNA by interaction with the
minor groove. Chien et al. measured the lengthening of DNA by BLM using viscometric
methods. In contrast to the expected increase in viscosity for an intercalator, no change in
viscosity was observed for BLM(48). In addition, Huang et al. showed that binding to
DNA caused two types of quenching of the fluorescence signal of the bithiazole
moiety(49). One type was sensitive to the ionic strength of the solution and the other type
was not. Huang et al. proposed that the ionic-sensitive type was associated with binding
of the bithiazole in the minor groove by electrostatic interaction with DNA backbone and
that the ionic-insensitive type was associated with binding by intercalation. Thus,
previous studies suggest that there are multiple binding modes for the bithiazole tail of
BLM to DNA.
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The key question is which binding mode is responsible for efficient ss and ds DNA
cleavage in vivo. As will discussed in Section 1.5, based on biochemical and structural
studies, our group proposes that the partial intercalation of the bithiazole tail is essential
for BLM-mediated ds-cleavage(50, 51).
The positively charged C-terminal tail of BLMs has also been proposed to contribute
to DNA binding by electrostatic interactions with negatively charged DNA backbones.
Members of the BLM family that differ in this tail demonstrate similar DNA cleavage
efficiencies and sequence specificities. Recent studies from the Ramotar's group also
suggest that the positively charged group might be involved in drug uptake(36, 37).
Using genome-wide screening in yeast, Ramotar et al. identified BLM-resistant strains
using a fluorescently labeled BLM that appear to have altered drug-uptake (37). One
mutant gene, Agp2, encodes a known L-carnitine transporter and two other mutant genes,
Ptk2 and Sky2, are involved in polyamine transport. These results suggest that the
positively charged group on the tail might be responsible for BLM's uptake into the cell.
The linker region, which contains a methylvalerate-threonine dipeptide fragment,
connects the metal binding domain and the bithiazole tail (Figure 1.1). Studies from the
Boger group in collaboration with our group have demonstrated the essential role of the
linker region in ds-DNA cleavage events(21, 22). The Boger lab synthesized a number of
BLM analogs with variations in the linker region. The efficiency of the ds-DNA cleavage
by these analogs was examined quantitatively using the supercoiled DNA relaxation
assay and the internal 132 P-hairpin DNA assay. The results show that tinkering with any
position within the linker significantly lowers ds cleavage efficiency. The linker in the
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BLM appears to have been optimized to pre-organize the BLM for efficient ss and,
especially, ds cleavage.
1.3 Chemistry of DNA cleavage by activated BLM.
The BLMs require a redox-active transition metal, 02, and a reductant to mediate
oxidative DNA damage(4). In vitro, both Fe(II)-BLM and Cu(I)-BLM can mediate DNA
cleavage. The "active species" of Cu(I)-BLM that initiates DNA cleavage has never been
identified and its efficiency to mediate DNA cleavage is still controversial(52, 53). Most
of the studies have been focused on Fe(II)-BLM, which has long been believed to be the
active form inside the cell. In the presence of Fe(II), 02 and a one electron reductant, an
"activated" BLM (BLM-Fe(III)-OOH) is generated (Figure 1.3)(54, 55). Formation of
activated BLM is fast (k = 0.1 s') and the rate of its decomposition is slow (tl 2~2min at
4°C)(55). The identity of this activated species as BLM-Fe(III)-OOH was established by
rapid freeze-quench (RFQ) M6ssbauer spectroscopy, RFQ-EPR spectroscopy, and ESI
mass spectrometry(55). This species is the last intermediate detected spectroscopically
prior to the DNA cleavage event.
The "activated" BLM mediates both ss and ds cleavage, directly or indirectly, by first
abstracting the 4'-hydrogen atom from C4' of the deoxyribose moiety of a pyrimidine 3'
to a guanine (Figure 1.3A)(56). The identity of the BLM species that actually generates
the putative 4'-nucleotide radical remains unclear. It has been proposed based on model
inorganic complexes, that BLM-Fe(III)-OOH can undergo either heterolytic O-O bond
cleavage to generate BLM-Fe(V)=O (and OH-) or homolytic O-O bond cleavage to
generate BLM-Fe(IV)=O and HO(57, 58) (Figure 1.3 A). The latter scenario seems
27
unlikely for BLM-Fe(III)-OOH because the hydroxyl radical generated concomitant with
BLM-Fe(IV)=O would result in non-specific cleavage patterns on analysis by SDS-
PAGE of DNA cleavage products that are not experimentally observed. Recently, the
Solomon group proposed a third mechanism in which the peroxide is the activated BLM
resulting in the cleavage of the O-O bond of the BLM-Fe(III)-OOH concerted with 4'-
hydrogen atom abstraction (59)(Figure 1.3 A). Further experimental evidence is required
to distinguish between those mechanistic options.
Depending on the availability of 02, the 4'-nucleotide radical intermediate can
partition between two pathways (Pathway A and B, Figure 1.3B). In the presence of
oxygen (Pathway A), the 4'-radical intermediate reacts with 02 to form a 4'-peroxy
radical(60, 6]). The resulting 4'-peroxy radical intermediate may then be reduced to the
4'-hydroperoxide, which undergoes a series of chemical transformations, ultimately
generating a gapped DNA with a 3'-phosphoglycolate/5' phosphate (3'-PG/5'-P) ends and
a pyrimidine propenal(60). Under oxygen-limited conditions (Pathway B), the 4'-radical
intermediate is proposed to be oxidized to a 4'-carbocation to which H20 adds, generating
a 4'-oxidized abasic site and a free nucleic acid base(62). In Pathway B, no direct strand
cleavage occurs.
In addition to initiating chemical and sequence specific cleavage of DNA, the
"activated" BLM (BLM-Fe(III)-OOH) can destroy itself(55), oxidize lipids(63),
hydrolyze amide bonds of proteins(64), cleave RNA(65), as well as decompose to
hydroxyl radicals that react rapidly and non-specifically with any molecule they
encounter. Results from extensive in vitro and in vivo studies have demonstrated that
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DNA cleavage is responsible for the observed cytotoxicity induced by BLM (recently
reviewed by Chen and Stubbe(l4».
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BlM + Fe(lI) + O2r H+, e-
BLM-Fe(III)-OOH
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Figure 1.3 DNA cleavage pathways by ~~activated"BLM. A: Activation of BLM and
three proposed mechanisms for 4' -H atom abstraction. B: DNA cleavage pathways by
"activated" BLM. Two types of DNA lesions result from the common 4' -radical
intermediate: Pathway A9a direct strand break generates a 3'-phosphoglycolate/5'-
phosphate (3'PG/5'P) gap and a base propenal; Pathway B9an oxidized abasic site with
an intact backbone. Ds-cleavage is proposed to occur through Pathway A.
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1.4 BLM-mediated dsDNA cleavage
Povirk and other researchers have demonstrated that BLM causes both ss- and ds-
DNA cleavages using the supercoiled plasmid relaxation assay(8-12). By quantitating the
amounts of ss and ds cleavage products (nicked and linear plasmids, respectively), Povirk
and other group measured the average ss to ds ratios for BLM to be 6.0-20 to 1,
depending on the assay conditions(8-12). Thus, ds cleavage by BLM is a rare event
compared to ss cleavage. In addition, in his seminal studies, Povirk also noted that the
apparent ss to ds ratio (6.0 to 1) did not change over a wide range (20 folds) of BLM
concentrations under the single-hit condition, which led Povirk to propose that the ds-
cleavage is not due to two random ss-cleavage events(8).
Povirk et al. have also studied the chemistry and the sequence selectivity of dsDNA
cleavage using native and denaturing DNA gel electrophoresis(66, 67). Their studies
revealed that termini of both strands in the ds cleavage product possess 3'PG/5'P ends,
indicating that cleavage on both strands involves 4'-H atom abstraction(66). In addition,
Povirk et al. also observed that some ds cleavage sites contain a 3'-PG/5'-P gap with
oxidized abasic sites on the opposite strand. No lesions with abasic sites on both strands
were observed. These results led Povirk to a model in which the 3'-PG/5'-P lesion or its
precursor is required for all ds-DNA cleavage events.
Based on examination of 30 ds-cleavage sites in a limited sequence space, Povirk et al.
proposed a set of rules for prediction of ds-cleavage sites (Figure 1.4) (66). The rules for
ds-cleavage specificity that result from these studies are that the initial cleavage site is a
good ss cleavage site (5'-G-Py-3' site). If the base 3' to the PFy is a purine, the second
cleavage site on the opposite strand is 5'-staggered to the cleavage site on the first strand;
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if the base 3' to the Py is a pyrimidine, then the cleavage site on the second strand is
directly opposite the first cleavage site, resulting a blunt-ended cleavage (Figure 1.4).
I 1 °0 1 °
5'-G-Py-Pu-Pu-3' 5'-G-Py-Pu-Py-3'
3'-C-Pu-Py-Py-5' 3'-C-Pu-Py-Pu-5'
t 2° t 2°
Staggered-ended cleavage
5'-G-Py-Py-Pu-3' 5'-G-Py-Py-Py-3'
3'-C-Pu-Pu-Py-5' 3'-C-Pu-Pu-Pu-5'
t 2 2°
Blunt-ended cleavage
Figure 1.4 Proposed sequence specificity for BLM mediated ds-DNA cleavage. The
primary cleavage site (10, in bold) is a good ss cleavage site and is indicated by large
arrows. The secondary (2°) cleavage site is governed by the residue (purines versus
pyrimidines) 3' to the pyrimidine in the primary cleavage site and is indicated by small
arrows. (Py, pyrimidine; Pu, purine)
The chemistry and sequence-selectivity of BLM-mediated ds-cleavage led Povirk et
al. to propose that a single BLM molecule is responsible for the cleavage at both strands
of DNA(66). In this model, BLM is reactivated after the first cleavage event and "without
dissociating from DNA, undergoes a rearrangement in binding and effects a secondary
attack in the complementary strand, at a site whose position is determined primarily by
the position of the first break"(66).
An alternative model of ds-cleavage by BLM was proposed by Keller and
Oppenheimer, in which the DNA lesion formed at the first cleavage site potentiates
binding of a second molecule of BLM to the second cleavage site(68). Keller and
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Oppenheimer showed that a one-base gap with 3'-P/5'P termini (which mimics the 3'-
PG/5'P lesion) increased the extent of the cleavage directly opposite the gap(68).
Although the second cleavage site in this study is not consistent with the sequence-
selectivity rules observed for BLM, these results raise the possibility that ds-cleavage
could be effected by cooperative binding of a second BLM. This cooperative binding
model also explains the concentration-independent ss to ds cleavage ratio.
Our group has taken a different approach to study BLM-mediated ds cleavage.
Absalon developed internal 132 Pl-hairpin DNA technology that allows quantitation of ss
and ds cleavage site-specifically(69, 70). Our studies have been focused on a "hot spot"
for ds-cleavage, 5'-GTAC-3'/3'-CATG-5', which was identified by examining 17 ds
cleavage sites in a 120-bp DNA fragment using native DNA gel electrophoresis(69). The
ss to ds cleavage ratio for the 5'-GTAC-3' site using this technology was measured to be
3.4 to 1(69). In addition, the ss to ds ratio for the 5'-GTAC-3' sequence appeared to
remain constant with 50 fold changes in BLM concentration(69). Finally, Absalon et al.
also have demonstrated that ds DNA cleavage by BLM is never observed under
anaerobic conditions(69). This observation is consistent with Porvirk's previous studies
showing that a 3'-PG end is present at the primary cleavage site in all ds cleavage
products.
The internal [32Pl-hairpin DNA technology also enabled the study of sequence-
specific isotope effects at the 5'-GTAC-3' site(70). Isotope effects on ds-cleavage were
observed when the C-4' hydrogen at either cleavage site (5'-GTAC-3'/3'-CATG-5') was
substituted with deuterium, consistent with Porvirk's studies indicating that C-4'
chemistry is involved in both cleavage events(70). The size of the isotope effects (6 to 8)
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for ss and ds cleavage events were indistinguishable, suggesting that pathways leading to
both cleavage events partition from a common intermediate subsequent to the 4'-H atom
abstraction at the first cleavage site(70).
In order to distinguish between the single-BLM model proposed by Povirk et al. and
the cooperative binding model proposed by Keller and Oppenheimer, Absalon et al.
showed that the presence of a chemically unreactive BLM-Co(III)-OOH suppressed both
ss- and ds-DNA cleavage to approximately the same extent, indicating that BLM-Co(III)-
OOH did not compete for binding at the second cleavage site. These results are
inconsistent with the prediction based on the cooperative binding model(70). Therefore,
these results and the observation that the ss:ds cleavage ratio remains unchanged over a
broad concentration range support the model that a single BLM molecule is responsible
for ds-DNA cleavage.
In order for one BLM molecule to mediate two cleavage events, the BLM molecule
must be reactivated after the initial 4'-H atom abstraction. A mechanism for the
reactivation of BLM has been proposed(70). The reactivated BLM then has to re-position
itself to the second cleavage site that is 15-18 A away from the first cleavage site based
on the observed sequence selectivity rule assuming B-form DNA structure. The relative
rate of BLM dissociation versus reorganization after the first cleavage event is proposed
to dictate the observed ss:ds cleavage ratio. A model to explain the large re-organization
of the BLM molecule has been proposed by our group(50) and is discussed in the next
section.
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1.5 Models of BLM-mediated dsDNA cleavage
A structural model has been proposed by our group to explain how a single molecule
of BLM can cause ds-cleavage without dissociation from the DNA(50). This model is
based on the solution structure of the 1:1 complex of BLM-Co(III)-OOH (a diamagnetic
analog for the activated BLM, BLM-Fe(III)-OOH) and duplex DNA containing a single
BLM cleavage site (5'-GTAC-3' or 5'-GGCC-3') (Figure 1.5)(51). The structure of the
BLMoDNA complex reveals that the metal-binding domain is located in the minor
groove of DNA (Figure 1.5A). The pyrimidine moiety of BLM forms two H-bonds with
guanine 5' to the cleavage site (indicated by two yellow lines in Figure 1.5A and red
dashed lines in Figure 1.5B). The dipeptide linker folds under the HOO ligand and the
disaccharide moiety is on the opposite face of the linker. The bithiazole tail is inserted 3'
to the cleavage site in a partial intercalative mode of binding (Figure 1.5C). This binding
mode positions the OOH ligand about 4 A from the 4'-H of the pyrimidine to be cleaved
(Figure 1.5A, grey line). The solution structure of BLM-Co(III)-OOH°DNA and a
number of additional complexes(71-73) solved independently of our work offer a
structural basis for the site specific cleavage and the chemistry of 4'-H abstraction.
We have proposed a model for BLM-mediated ds-DNA cleavage based on the
structures of BLM5'-GTAC-3' and BLMo5'-GGCC-3' (Figure 1.6A)(50). This model
requires the partial intercalative mode of binding of the bithiazole tail of BLM, rotation
of 180° around the C-C bond connecting the two thiazolium rings once the damage is
effected on the first stand, and further rotation of 117° around the axis perpendicular to
the plane of the bithiazole rings (Figure 1.6B). The BLM at the first cleavage site has two
options. It can dissociate from the duplex DNA or it can re-organize to the second strand.
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The relative rates of these two processions are the key to identifying and understanding
hot spots for ds-cleavage in this model.
A
(Figure 1.5 To be continued)
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cFigure 1.5 Solution structure of BLM-Co(III)-OOH bound to a "hot spot" (5' -GIAC-3')
for ds-cleavage. A: The overall structure of the complex. The metal-binding domain is
located in the minor groove with the bithiazole tail adopting a partial intercalative
conformation. The yellow lines indicate two H-bonds between the 4-NH2 and N3 groups
of BLM and N3 and 2-NH2 of guanine 5' to the cleavage site. The sugar moieties are
disordered with no defined interactions with the DNA. The gray line indicates the
proximity of the OOH ligand to the 4' -H atom to be abstracted. B: H-bond interactions
between the pyrimidine residue of BLM and G indicated by the red dashed lines. C:
Partial intercalative conformation of the bithiazole moiety (colored in CPK) between
neighboring base pairs (in gray).
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Figure 1.6 Model of BLM-mediated ds-DNA cleavage. A: The re-organization of BLM
from the frrst cleavage site (yellow) to the second cleavage site (red). The white arrows
indicate the 4' -H to be abstracted on each strand, the yellow arrows indicate the HOO
moiety and the red arrow indicates the bithiazole tail partially intercalated. B: A cartoon
rendition of the re-organization, which is effected by rotation of 1800around the C-C
bond connecting the thiazolium rings and rotation of 1170 perpendicular to the plane of
these rings. The metal-binding domain is depicted as a gray oval. Note the protons (in
red) with the bithiazole tail change from a trans to a cis conformation during this process.
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The structural element that triggers BLM to reorganize from the first cleavage site to
second is not understood. We have postulated that it involves the 3'-PG/5'-P lesion or a
precursor to this lesion(74). The lesion on the first strand could increase the flexibility of
the DNA at the lesion site and thus facilitates the reorganization process. However,
studies by Burger et al. suggest that formation of the 3'-PG/5'-P lesion (tl 2: 6.7 + 0.3 min
at 4 C) is too slow to account for the observed rate of ds-DNA cleavage(75, 76), which
led Povirk to propose that a precursor to the 3'PG/5'P is involved in the
reorganization(77). However, the methods used by Burger et al. to measure rate of base
propenal release/3'-PG/5'-P formation (3 1 p and H NMR) are insensitive and not site
specific. Therefore, the question is raised as to whether there are certain sites that effect
this transformation much more rapidly. In addition, the intermediates that precede the 3'-
PG/3'-P lesion are chemically labile and could never be recapitulated in a stable DNA
duplex that could be examined by NMR. Therefore, our group has focused on the stable
3'-PG/5'-P lesion and its effect to trigger the re-organization of BLM to the other strand.
Using 2D NMR spectroscopy, our group has shown that the 3'-PG/5'-P gapped lesion in
the 5'-G_AC-3'/3'-CATG-5' sequence is sufficient to direct BLM to the second
strand(74) (see the discussion in Section 1.6).
Recently, the Hecht group reported a ds cleavage site (5'-CGCGA-3'/3'-GCGCT-5')
in the Dickerson-Drew dodecamer. This site is distinct from any previously reported ds-
cleavage sites and does not conform to Povirk's rules(78). The observed secondary
cleavage site is staggered in the 3' direction (Figure 1.7A) and is two base pairs removed
from the first cleavage site. NMR structural studies of a BLM-Zn(II) bound to the
Dickerson-Drew dodecamer were interpreted to suggest that the metal binding domain of
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BLM-Zn(II) is located halfway between the two cleavage sites with the bithiazole tail in
the minor groove (Figure 1.7 B and C). The coordination of the Zu(II) atom is octahedral
with all 6 ligands provided by BLM and with no binding site for the exogenous 02. The
organization of the ligands around the Zn(II) atom and thus, the structure of the BLM-
Zn(II) complex has never been defined. Additional problems associated with the
structural determination result from the BLM-Zn(II)/DNA complex being in a fast
exchange on the NMR time scale and inability to assign the chemical shifts of the
bithiazole protons (H5 and H5', Figure 1.1). The scarcity of the NOE interactions (12
NOEs) between BLM-Zn(II) and the Dickerson dodecamer (Figure 1.7 A) has prevented
accurate modeling of a single conformation of the bithiazole tail (compared to 60 NOEs
between BLM-Co(III)-OOH and d(CCAGTACTGG) 2 (51)). Our attempt to reproduce the
ds-cleavage pattern on the Dickerson-Drew dodecamer using the hairpin DNA
technology has been unsuccessful. Therefore, the relevance of this unusual ds-cleavage
site and the model structure proposed by Hecht et al. is called into question.
Several studies using BLM analogs have demonstrated that alternative binding modes
to partial intercalation of the bithiazole tail can also lead to ss-DNA cleavage. Studies on
a BLM analog with a chlorinated bithiazole (the H5 and H5' of the bithiazole were
substituted with chlorine atoms) showed that this analog could mediate a sequence-
selective DNA cleavage, similar to nature BLMs. Furthermore, the chlorinated bithiazole
tail was bound to DNA in the minor groove, demonstrated by the light-mediated cleavage
pattern of DNA by the chlorinated bithiazole group(79).
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Figure 1.7 Structural model of BLM-Zn bound to Dickerson-Drew dodecamer*. A:
Sequence of the Dickerson-Drew dodecamer with the observed intermolecular NOE
interactions with Zn-BLM by arrows. Two proposed cleavage sites (A5 ad ell) are in
boxes. B: Model structure of BLM-Zn(II)eDNA viewed along the minor groove. The two
4'-H atoms to be abstracted are colored in yellow and purple. C: Side view of the
structure. The two 4'-H atoms are indicated by two orange arrows. In Band C, the Zn-
BLM molecule is in red and the Zn atom is shown as a white sphere. The DNA is colored
in green. (* Figure 5 and 6 from Keck et al., l.Am.Chem.Soc. 2001(123) 8690-8700.
Because a structural file has not been deposited in POB, we are not able to present a
clearer picture depicting the detailed interaction between BLM-Zn and DNA.)
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The Hecht group has studied the DNA cleavage by BLM A5 tethered to either
controlled pore glass beads or a dendrimer at the polyamine tail(80-82). These
modifications have been proposed to be sufficiently large to prevent binding of the
bithiazole tail by partial intercalation. DNA cleavage was examined with these analogs
and both the efficiency and sequence selectivity was shown to be similar to untethered
BLMs. These results suggest that a non-intercalative mode of binding can also lead to
DNA cleavage. Although dsDNA cleavage was observed for the both dendrimer and
CPG-tethered BLM using supercoiled plasmid relaxation assays, the ss to ds cleavage
ratios were not reported. In addition, with the CPG-tethered BLM, the structure of BLM
and the effective concentration in solid support is hard to quantitate. Therefore, it is not
clear whether the observed ds cleavage resulted from a single tethered BLM or two
tethered BLMs.
In order to re-examine the role of partial intercalation of the bithiazole tail in the ds
DNA cleavage process and building on the approach used by Hecht and coworkers, we
synthesized a BLM A5 analog with a 3-cyclodextrin group chemically attached to the
polyamine tail of BLM A5. This analog (CD-BLM) has been well characterized
spectroscopically. The ability of this CD-BLM-Fe to effect ss and ds cleavage was
examined quantitatively using the hairpin DNA technology and the supercoiled DNA
relaxation assay. The mechanistic studies on the CD-BLM are the focus of Chapter 2.
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1.6 Synthesis and structures of DNA lesions: Implications for the mechanism of ds-
DNA cleavage by a single BLM
Our efforts to examine the structural basis for ds-cleavage require the synthesis and
structural characterization of the 3'-PG/5'-P gapped lesion and the 4'-oxidized abasic
lesion generated by BLM. This structural information and its interaction with BLM-
Co(III)-OOH is requisite to understand the mechanism of dsDNA cleavage by a single
BLM molecule.
As discussed in Section 1.5, based on our studies and Povirk's studies, we focused on
the 3'PG/5'P lesion as the trigger to initiate structural re-organization of BLM to the
second cleavage site. Our group synthesized a 3'PG/5'P lesion in a duplex DNA suitable
for 2D NMR studies(83). The synthetic procedure involved two oxidation steps in a one-
pot reaction to convert a precursor, 3'-glycerol, to a 3'-PG end(84). Two
hexaethyleneglycol linkers were incorporated at each end of duplex by solid-phase
synthesis in order to increase the thermostability of the gaped DNA(83). The
incorporation of the 3'PG/5'P lesion was confirmed by complete enzymatic digestion of
the duplex DNA followed by quantitation of individual nucleotides(83).
The ability to generate the 3'PG/5'P lesion allowed us to test the hypothesis that the
3'PG/5'P lesion could trigger the re-organization of BLM to the second cleavage strand.
A 3'PG/5'P gap was introduced into a 13mer duplex DNA containing a hot spot for ds
cleavage, 5'-G_AC-3' (_ denotes the 3'PG/5'P gap, Figure 1.8A). Interaction between the
5'-G_AC-3' duplex and BLM-Co(III)-OOH was studied by titrating the 5'-GAC-3'
duplex with BLM-Co(III)-OOH monitored by 1D NMR(74). The titration led to a 1:1
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complex formation, indicating a high affinity between the 3'PG/5'P lesion in the 5'-
G_AC-3' sequence and BLM. The structure of the 1:1 complex was solved by 2D
NMR(74). The structural model revealed that BLM binds to minor groove of the gapped
lesion with its bithiazole tail partially intercalated between base pairs 3' to the cleavage
site and its metal binding domain (reactive center) H-bonded to G18 in the second
cleavage site and its OOH group poised close to the H4' atom to be abstracted in T19
(Figure 1.8B). ROESY 2D NMR experiments also indicated that the trans and cis
conformations of the bithiazole rings were rapidly interconverting, but that the trans
conformation dominated in solution(74). These results provide strong support for the
reorganization model in which BLM reorganization could be triggered by the lesion on
the first strand, to move to the second cleavage site.
Our reorganization model further predicts that 4'-oxidized abasic lesion would not
lead to sequence specific binding of BLM to the second cleavage site. Using a normal
abasic site as a structural analog for the 4'-oxidized abasic site, Silvia et al. synthesized
the lesion in the same sequence context and titrated with BLM-Co(III)-OOH, monitoring
the complex formation by 1ID NMR spectroscopy(85). The results indicated the presence
of multiple conformations in rapid exchange on the NMR time scale, consistent with our
model.
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Figure 1.8 Structure of BLM-Co(III)-OOH bound to a 3'PG/S'P-containing duplex DNA
determined by 2D NMR methods. A: Sequence of the 13mer duplex DNA containing a
3'PG/S'P gap and tethered ends. Our model predicts that BLM would bind to the second
cleavage site (T 19) with two H-bonding interactions with G 18 and the bithiazole moiety
would intercalate between T19 and A20. B: the structure of the complex. The H-bond
interactions between BLM and G18 are indicated by the red dashed lines. The black
dashed line indicates the close proximity of the OOH group to the 4'-H atom ofT19
(white sphere) to be abstracted.
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The success with the 3'PG/5'P DNA lesion to study the structural basis for the
reorganization in the staggered-end ds cleavage site (5'-GTAC-3'/3'-CATG-5') has
prompted us to apply this methodology in an effort to identify a similar structural
transformation in a blunt end cleavage site. Chapter 3 describes our studies to identify a
hot spot (5'-GTCA-3') for blunt-ended ds cleavage from 5 sequence candidates generated
using Povirk's specificity rules. We determined the ss to ds cleavage ratios using the
internally labeled hairpin DNA method. Based on these results, duplex DNA containing
an intact 5'-GTCA-3' sequence or 5'-G_CA-3' (_ denotes a 3'PG/5'P lesion) was
synthesized and its interaction with BLM-Co(III)-OOH was studied by D and 2D NMR
spectroscopy (Chapter 3).
In contrast to our efforts to obtain the structure of the 3'G/5'P lesion, efforts to gain
structural insight into the 4'-oxidized abasic site lesion (Figure 1.3) have been hindered
by the synthetic challenges to make this chemical labile species. Recently, we have
developed a convenient method to generate the 4'-oxidized abasic site(86). The detailed
synthesis of this lesion in any sequence context and its characterization using 2D NMR
methods is reported in Chapter 4. In Chapter 5, we report the first structural study on a
duplex DNA containing a 4'-oxidized abasic site at the ds cleavage hot spot (5'-GXAC-
3') and compare this structure to a normal abasic site in the same sequence context.
1.7 Repair of DNA lesions generated by BLMs
Our ability to synthesize DNA lesions generated by BLM and characterize these
lesions structurally offers the opportunity to study the mechanism of repair of these
lesions in vitro and potentially, in vivo. At present, it is not clear why certain tumors are
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more susceptible to BLM treatment than other tumors or normal tissues. Besides the
potential differences in drug uptake and metabolism, another possible factor governing
effectiveness could be the repair of BLM-induced DNA damage. Many tumor cells have
mutated signal transducers and effectors that can alter the efficiency of DNA repair or the
signals that lead to cell death or apoptosis. Thus, it is likely that understanding the DNA
repair pathways in normal cells and identifying which of BLM-induced DNA lesions are
most difficult to repair, could provide insight into how BLM's cytoxicity is enhanced in
specific tumor cells. As noted in Figure 1.3, the BLMs cause both ss- and ds-DNA
damage. Recent studies are beginning to provide insight into the proteins involved in ss
break repair and their similarities and differences from the proteins involved in the ds-
break repair pathways.
ss-DNA Damage Repair The ss-DNA lesions generated by BLM, as noted above, are
either an oxidized abasic site or a 3'-PG/5'-P gapped DNA (Figure 1.3). The ss-lesions
are thought to be repaired by the base-excision repair (BER) pathway using Apel and
DNA polymerase a (pol3) (Figure 1.9)(87). Demple and coworkers by studying a single
site have suggested that repair of the 4'-oxidized abasic site by Apel occurs with a
similar rate to normal abasic sites by generating an oxidized abasic site using BLM-
Fe(88). Repair of a 3'-PG site by Apel (which possesses a weak 3'-exonuclease activity),
however, occurs at 1/400 the rate of the 4'-oxidized abasic site in the same sequence
context(89, 90). The slow rate of repair suggested that other intracellular nucleases might
be responsible for the removal of the 3'-PG lesion. Studies by Povirk et al. have shown
that human tyrosine-DNA phosphatase (hTDP1) can remove the 3'-PG lesion in
vitro(91). More recent studies suggest that in HeLa cell extracts, Apel is the major
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nuclease involved in repairing the 3'-PG lesion(92). Thus, the role of Apel in vivo in the
removal of the 3'-PG end and also the oxidized abasic site requires further analysis. The
repair of both of these ss-lesions is template-driven and should lead to accurate
restoration of genetic information. However, base substitution mutations can occur due to
the lack of the proofreading function of pol3(93).
The proposed role of Apel in repairing BLM-induced ssDNA lesions has been
demonstrated in several cell culture studies. In one study, elevated levels of Ape 1 in
germ cell lines have been shown to correlate with BLM resistance(94). In addition, HeLa
cells and primary fibroblasts treated with BLM showed an adaptive response in which
Apel levels were up-regulated and Apel was translocated into the nucleus(95).
Transforming Apnl (the S. cerevisiae Apel homolog) into lung epithelial cells made
them more BLM resistant(96).
ds-DNA Damage Repair As discussed in Section 1.4, BLMs also generate ds-lesions
containing 5'-staggered and blunt ends (Figure 1.4). In mammalian cells, two pathways
exist to repair ds DNA breaks, non-homologous end joining (NHEJ) and homologous
recombination repair (HRR)(97). To repair BLM-generated ds-breaks, exonucleases like
Apel or TDPI are required to remove 3'-PG ends. In the staggered ends, a polymerase
can be used for formation of a phosphodiester bond using the information on the opposite
strand. Once the appropriate nucleotide is incorporated, ligation can occur. With blunt-
ended lesions, however, the information on the opposite strand has been lost. Thus, the
fidelity of the repair becomes challenging. The NHEJ pathway for repair is thus of
special interests with respect to BLM-induced ds-breaks because of its error-prone
nature(98).
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Figure 1.9 Proposed base-excision repair pathway for repairing ss-DNA lesions
generated by BLM. The repair pathway is initiated by Apel, which catalyzes the
hydrolysis of the phosphodiesterase bond 5' to the oxidized abasic site or the 3'-PG site to
generate a 3'-OH. In the case of the oxidized abasic site, the remaining 5'-deoxyribose is
removed by the lyase activity of polymerase 3 (pol 3) that then also fills in the gap with
the appropriate nucleotide (Short patch pathway). The final ligation is catalyzed by
XRCC1 and Ligase III. The one-nucleotide-gap intermediate can also be repaired by the
long patch pathway without the involvement of po1 . In this pathway, PCNA, RFC, and
pol /r work together to catalyze strand-displacing DNA synthesis 3' to the gap. The
resulting flapping DNA is cleaved by FENI and the nicked DNA is ligated by Ligase I.
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1.8 Structures of DNA containing abasic sites and their interaction with Apel.
Because of the importance of DNA repair in understanding BLM-induced
cytotoxicity in vivo, our group has been interested in using the structural information
obtained about the DNA lesions generated by BLMs to gain insight into the recognition
elements required by DNA repair enzymes. We have focused our attention on the
interaction between DNA lesions and Ape 1 because of Ape l's essential role in repair
BLM-induced DNA lesions as well as normal abasic DNAs.
The X-ray structure of Apel has been solved by the Tainer group in a complex with
duplex DNA containing an abasic site analog (tetrahydrofuran, or THF)(99) and provides
a paradigm to think about structural basis for lesion recognition by Apel. In this
structure, Apel interacts with the abasic site (THF) using residues from a flexible loop
and a helix-turn-helix motif, which bind the DNA from both major and minor grooves
(Figure 1. 10A). The duplex DNA is bent 35 at the site of the lesion. The most striking
feature of the structure is that the THF moiety is flipped out of the phosphodiester
backbone into a binding pocket formed by protein side chains that exclude intact bases
(Figure 1.1 OB). It remains unclear whether Apel recognizes complete or partially
flipped-out abasic sites or Apel actively flips the abasic site into the binding pocket.
The flexibility of the abasic site has been proposed to be exploited by the repair
enzymes for the recognition and repair of the abasic lesions. The conformational
dynamics of duplex DNA around the abasic site have been studied using time-resolved
fluorescence spectroscopy on THF-containing DNAs with fluorescent base analogs
incorporated opposite to or on either side of THF site(100-102). The fluorescence
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relaxation times ranging from 50 ps to IOns have been detected in these studies.
However, it is still largely speculative as to whether the fluorescent relaxation times
correlate with specific conformational changes in the abasic site region. Recently, the
Berg group has measured the time-dependent Stokes-shift of coumarin-labeled THF
DNA in a complex with Apel and compared it to the free DNA(103). No significant
differences were observed for the Stokes-shift between free THF DNA and its complex
with Ape I, suggesting that the fluorescent probe is insensitive to conformational changes
due to the interaction with Ape I.
THF
Figure 1.10 The structure of human Ape I bound to a duplex DNA containing a THF
site. A: Ape I binds the THF site by clamping it from the major groove (front) using a
helix-tum-helix motif (residue 175-185, in magenta) and from the minor (back) groove
using a coil region (residue 266-280, in orange). B: The front helix-turn-helix motif is
removed to show the extrahelical conformation of the THF moiety in the complex
(indicated by the arrow).
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Given the technical challenges to study the structure and dynamics of abasic DNAs
on a fast time scale, we(85) and Bolton's group(104-106) have been using 2D NMR
spectroscopy to study the averaged structures of abasic DNA lesions in solution. As with
fluorescence studies, There are several limitations for 2D NMR structural studies. First,
information obtained from 2D NMR spectroscopy reflects the averaged structures in
solution and can only be deconvoluted if multiple conformations are in slow exchange.
Second, NMR experiments are not sensitive to minor conformations in the ensemble of
solution structures that are often mechanistically relevant. Third, the accuracy of the final
structural modeling relies on the richness of the NOE interactions and coupling constants
around the abasic site, which thus far have been very limited due to the flexible nature of
the lesion. Despite the above limitations, 2D NMR spectroscopy remains a major tool to
obtain structural insight into the flexability of the lesions and the neighboring base pairs.
Hoehn et al. have determined the solution structures of a piece of duplex DNA
containing the 5'-GXAC-3'/3'-CATG-5' sequence (X denotes an abasic site) (85). Four
NOE interactions involving the abasic site and nearby residues were used to define the
extrahelical conformation of the abasic site. The Bolton group has also studied
oligonucleotides containing an abasic sites in a defined sequence context using 2D
NMR(104-106). The consensus for the abasic DNA structures studied by our group and
by Bolton's group is that the abasic site does not perturb the overall B-form structure of
duplex DNA and that the base opposite to the abasic site stacks well between neighboring
base pairs. However, sequence-dependent variations have been observed for the
conformation of the deoxyribose at the abasic site. In the structure of 5'-GAXAC-3' with
an adenine opposite to the abasic site, the abasic site is extrahelical for the cc anomer and
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intrahelical for the f3 anomer (105). Surprisingly, in the same sequence (5'-GAXAC-3')
with a cytosine opposite to the abasic site, the structural modeling showed that the abasic
site existed only as the 1i anomer in two distinct conformations attributed to two different
hydration states(104). The observation that the base opposite the lesion could alter its
anomerization state is contradictory to early studies that showed that two anomers existed
in abasic sites with all four opposite bases(107, 108). However, in these early studies, the
ambiguity of the chemical shift assignments and the lack of any NOE information
between the abasic site and the adjacent residues require that the model structures are
solely the results of molecular modeling.
In addition to studies on normal abasic sites discussed above, most researchers have
focused on THF analogs of the abasic sites due to their chemical stability(109-112).
There are several studies on solution structures of the THF-containing duplex DNA. A
consensus has been reached from these studies that the THF does not change the overall
B-form structure, similar to model structures determined for normal abasic sites.
However, the conformations of the THF moiety (sugar pucker and intra- versus
extrahelicity) and of the bases opposite to the lesion remain controversial. In most
studies, the THF moiety is intrahelical and the opposite base stacks well between
neighboring base pairs. In one study, however, both the THF and the pyrimidine opposite
to this lesion are proposed to be extrahelical (110). However, no final structures were
determined in that study due to the lack of molecular modeling techniques at that time. It
has been proposed that the conformations of THF and/or the opposite base could be
sequence-dependent. However, no systematic studies have been performed to analyze the
role of neighboring bases in determining the local conformation and no generalized rules
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have been postulated to predict the influence on abasic site conformations by sequence
contexts. Furthermore, because there is no structural comparison of abasic-site and THF-
containing duplex DNA in the same sequence context, it remains unclear whether the
THF represents a good structural model for the abasic site.
Structural studies on normal abasic sites and THF analogs summarized above raise
two interesting questions: how does the sequence context (including opposite and
neighboring bases) affect the abasic site conformation and how does local conformation
affect the interaction of abasic sites with DNA repair enzymes. As a first step to address
the modulation of abasic site conformation in different sequence contexts, we studied
solution structures of duplex DNA containing a normal abasic site in the 5'-GXAC-3'/3'-
CNTG-5' sequence (N= A, T, G, or C) by 2D NMR methods. These studies, presented in
Chapter 6, provide insight into structural variations at the abasic site caused by the
identity of the opposite base, which could be exploited by DNA repair enzymes for
sequence-specific recognition of abasic sites.
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Chapter 2. Mechanistic studies of BLM-mediated dsDNA cleavage using CD-BLM
2.1 Introduction
The bleomycins (BLMs, Figure 2.1) are a group of natural glycopeptides produced by
Steptomyces verticillus that have potent antitumor activity against lymphomas, head and
neck cancers, and testicular cancer(1, 2). The BLMs' therapeutic efficacy is proposed to
be related to their ability to cause both single-stranded (ss) and double-stranded (ds)
DNA damage in the presence of the required cofactors (Fe(II), 02, and a one-electron
reductant) (3-8). Figure 2.2 shows the pathways proposed for BLM-mediated DNA
damage. The ds-DNA cleavage events have long been believed to be the major source of
BLMs' cytotoxicity(8, 9). This chapter will focus on the mechanism of BLM-mediated
dsDNA cleavage.
A model in which a single BLM molecule, which has a single site that can be
activated for cleavage, can effect two cleavage events without dissociation from DNA
has been proposed by Povirk et al.(10). This model was initially proposed based on the
analysis of the ss to ds cleavage ratios using the supercoiled DNA relaxation assay(I),
which revealed a constant ss:ds cleavage ratio (6:1) over a 20-fold range of BLM
concentrations. Povirk et al. also studied the chemistry and sequence selectivity of the ds
DNA cleavage by analyzing 30 ds-cleavage sites using native DNA gel
electrophoresis(10, 12). These studies led to a set of sequence selectivity rules for BLM-
mediated ds cleavage (Figure 1.4, Chapter 1), which could not be explained by two
random ss cleavage events(10). Using the internally 132 Pl-labeled hairpin DNA
technology(13, 14), Abaslon in our group has determined the ss to ds cleavage ratios at a
hot spot for ds cleavage (5'-GTAC-3', _ indicates the cleavage site). The results indicated
that the ss to ds cleavage ratio remained constant over a 70-fold range of the BLM
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concentration(13). In addition, the ratio was not perturbed by the competitive binding of a
chemically unreactive BLM-Co(III)-OOH, which supported the model of a single BLM
molecule to effect dsDNA cleavage.
Structural models of BLM-Co(III)-OOH bound to several oligonucleotides containing
a single BLM-binding site have been determined using 2D NMR studies by our group(15,
16), which provided a working model to explain the mechanism by which a single BLM
molecule can effect ds-cleavage without dissociation from the DNA. This model requires
binding of the bithiazole tail of BLM by partial intercalation at the first cleavage site
(Figure 1.5, Chapter 1). Subsequent to damage initiation on the first stand, the BLM
molecule is repositioned to the second strand by rotation of 180° around the C-C bond
connecting the two thiazolium rings and by further rotation of 117° around the axis
perpendicular to the bithiazole ring (Figure 1.6, Chapter 1). The mechanism of triggering
the re-organization to the second cleavage site and the relative rate of this process versus
dissociation from the DNA play a key role in identifying which sites are hot spots for ds-
cleavage.
Several studies using BLM analogs have demonstrated that alternative binding modes
to the partial intercalation can lead to ss-DNA cleavage. A BLM analog with a
chlorinated bithiazole (the H5 and H5' of the bithiazole were substituted with chlorine
atoms) was shown to mediate a sequence-selective DNA cleavage similar to BLM(17,
18). The chlorinated bithiazole tail was shown to be located in the minor groove of DNA
by light-mediated DNA cleavage(18). The Hecht group has shown that BLM AS tethered
through the polyamine tail to either controlled pore glass (CPG) beads(19, 20) or a
dendrimer(21) can also cleave DNA. These attachments were designed be sufficiently
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large to prevent binding of the bithiazole tail by partial intercalation. The efficiency and
sequence selectivity of cleavage by these tethered BLMs has been reported to be similar
to that observed with the untethered BLM, demonstrating that non-intercalative modes of
binding can also lead to DNA cleavage(19-21). Unfortunately, the relationship of the
alternative binding mode to the ds-DNA cleavage was not quantitatively investigated in
these studies(19, 21).
In this chapter, we extend Hecht's approach to directly test the significance of the
partial intercalation in the model of one BLM molecule to effect ds-cleavage. A bulky
BLM analog with a -cyclodextrin attached to the terminal amine of BLM A5 was
synthesized(Figure 2.1). This modification is sufficiently large to prevent the binding of
BLM by partial intercalation of the bithiazole tail. This -cyclodextrin-tethered BLM
analog (CD-BLM) has been thoroughly characterized. CD-BLM's ability to effect
dsDNA cleavage is reported using the internally [32PI labeled hairpin DNA method(13)
and the supercoiled plasmid relaxation assay. The results indicate that CD-BLM can
mediate both ss and ds-DNA cleavage in the same sequence-selective fashion as BLM
A5, although 5 fold less efficient. Competition assays of the CD-BLM-mediated ds-
DNA cleavage in the presence of chemically unreactive BLM-Co(III)-OOH indicate that
the ds DNA cleavage is mediated by two CD-BLM molecules. The current study suggests
that the partial intercalation is essential for one BLM molecule to mediate ds cleavage.
Minor groove binding of the bithiazole tail can also lead to dsDNA cleavage, however, it
requires cooperative binding of a second BLM molecule.
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2.2 Experimental Section
Material The oligonucleotides (full-length GT-2 and GT-2 self-primer, Figure 2.3), were
synthesized by Invitrogen Inc. on a 1-/mol scale. BLM A2 and A5 were purchased from
CalBiochem in a metal-free form. BLM-Co(III)-OOH was prepared and purified as
previously described. BLM CD-BLM was synthesized by Dr. Manas K. Ghorai of our
group. The detailed synthesis and characterization of CD-BLM is reported in Appendix
A. The concentration of CD-BLM was determined by the extinction coefficient at 292 nm
(14,500 Mcm-'), assumed to be identical to BLM A5. DNA-sequencing gel solutions
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were purchased from National Diagnostics Co. E. coli DNA polymerase I-Klenow
fragment (Klenow Fragment) was purchased from New England Biolabs (Catalogue No.
M0210S, 1 U is defined as the amount of enzyme required to convert 10 nmol dNTPs
into an acid-insoluble form in 30 min at 37 C). T4 Polynucleotide Kinase (T4 PNK) was
purchased from New England Biolabs (Catalogue No. M0201S, 1 U is defined as the
amount of enzyme to incorporate 1 nmol acid-insoluble 132p] in 30 min at 37 °C). [_y-32P]
Adenosine triphosphate (ATP) (Catalogue No.BLU502H, 3000 Ci/mmol) and lc- 32PI
deoxyguanosine triphosphate (dGTP) (Catalogue No.BLU514H, 3000 Ci/mmol) were
purchased from Perkin Elmer Life Sciences. Other chemicals were purchased from
Sigma-Alrich Co.
10 13
1 A A
5'-CGAATTCTGCT GTAC ACTTTCCC A
3'-GCTTAAGACGA CATG TGAAAGGG A 
43 38 36 32
GT-2
Cleavage site Predicted length 5'-End 3'-End Observed length
C 10lss 41 Phosphate OH 42-43
C43ss 42 OH Phosphoglycolate 42-43
(PG)
T 13 38 Phosphate OH 39
T36 15 Phosphate OH 16
T38 37 OH PG 37-38
A32 19 Phosphate OH 20
_ T 13+T38ds 24 phosphate PG 24
Figure 2.3 Sequence of GT-2 and the distribution of the cleavage products. The predicted
ss-cleavage sites of GT-2 are numbered. The G in bold denotes the internal [32p] labeling
site. The GT-2 self-primer contains the first 36 nucleotides of the full-length GT-2 (5'-
CGA ATT CTG CTG TAC ACT TTC CCA AAA AGG GAA AGT-3').
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Purification of the GT-2 primer by polyacrylamide gel electrophoresis (PAGE) The
PAGE experiments to purify oligonucleotides were carried out on a Bio-Rad Protean Xi
II Cell apparatus with the gel dimensions of 14 cm x 15.5 cm x 1.5mm. Each gel
contained 40 mL 20% acrylamide/bis-acrylamide (19:1 cross-linking) in TBE buffer (89
mM Tris, 89 mM Boric acid and 2 mM EDTA pH 8.3) with 8 M urea. Crude GT-2
primer (200 nmol) from solid phase synthesis was dissolved in 500 tL loading buffer
containing 8 M urea in TBE buffer with bromophol blue (0.01%) and Xylene FF (0.01%)
as the indicator dyes (under these conditions, bromophol blue and Xylen FF co-migrated
with 22-mer and 6-mer ss-DNA, respectively). The PAGE gel was run under a constant
voltage of 290V for 2 h with circulating 50°C water. The apparatus was then dissembled
and the gel was removed from the glass plates and wrapped with plastic film
(SaranWrap). To visualize the region containing the GT-2 primer, the gel was laid on top
of a Kodak Intensifying plate that had a fluorescent surface. A handheld UV light was
used to detect the shadow on the Kodak Intensifying plate, which corresponded to the
DNA bands in the gel. The regions of gel containing the DNA bands were excised
soaked in the TBE buffer (5 mL) at 4 °C for 16 h. The purified GT-2 primer was then
precipitated from the extraction buffer by mixing with 2 mL 3 M sodium acetate (pH 5.3)
and 13 mL ethanol. The mixture was incubated at -80°C for 1 h and was centrifuged for
30 min at 13,000 rpm at 4 °C. The supernatant was discarded and the precipitate was
washed once by mixing with 1 mL 75% ethanol and centrifuging for 30 min at 13,000
rpm at 4 °C. The supernatant was discarded and the precipitate was dried in vacuum. The
yield of the GT-2 primer was 110 nmol (55%).
5'[ 32P] labeling offull length GT-2. The 5'-[32P] labeling reaction was carried out in a 50
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~tL reaction mixture containing 5 tM full length GT-2, 5 tM [y-32 IATP (250 ~tCi) and
30 U T4 PNK in T4 PNK buffer (50mM Tris-HCI, 10mM MgCI2, 5mM DTT, pH 7.6).
The reaction mixture was incubated at 37 °C for 1 h. T4 PNK was deactivated by heating
the reaction mixture at 75 °C for 5 min. The reaction mixture was then ethanol-
precipitated by adding 20 tL 3 M sodium acetate (pH 5.3) and 120 tL ethanol. The
ethanol precipitation mixture was kept at -80°C for 1 h and was centrifuged at 13,000
rpm for 30 min at 4°C. The supernatant was discarded and the precipitate was washed
once by re-suspending the pellet with 1 mL 75% ethanol and centrifuging for 30 min at
13,000 rpm at 4 °C. The supernatant was discarded and the precipitate was dried in
vacuum. The labeling product was further purified by PAGE as described above. This
labeling procedure yielded approximately 120 pmol 5'-[32P] GT-2 (2.1 x 106 cpm/tmol).
Maxam-Gilbert sequencing of 5'-[ 3 2P] GT-2 The "G+A" reaction of the Maxam-Gilbert
sequencing method was performed according to the published method(22) with slight
modification. The reaction mixture of 30 ]tL contained 50, 000 cpm 5'-[32PI GT-2, 3 tg
calf thymus DNA, and 6 [tL 98% formic acid. The reaction mixture was incubated at 37
°C for 9 min. The reaction was quenched by adding 10 ~tL 1 mg/mL calf thymus DNA
and was dried in vacuum. The DNA pellet was then re-dissolved in 100 [tL piperidine
and the mixture was incubated at 95 °C for 30 min. The piperidine was removed by
evaporating the reaction mixture in vacuum in a SpeedVac concentrator (Savant Co.).
The final sample was dissolved in 50 L DNA loading buffer containing 8 M urea in the
TBE buffer.
Internal [3 2 P]-labeling of GT-2 The internal labeling procedure was carried out in two
steps in a one-pot reaction: incorporation of [32 P]-dGMP followed by further extension of
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the primer-template(13). For the incorporation of 32P1-dGMP, the reaction mixture (50
tL) contained 2 tM GT-2 self-primer (Figure 2.3), 2 tM [c- 32 P]-dGTP (84.5 1tCi), and
10 U Klenow Fragment in Klenow reaction buffer (10mM Tris-HCl, 5mM MgCl 2, and
7.5mM DTT, pH 7.5). Before adding [cL- 32 P1-dGTP and Klenow Fragment, the mixture
was heated to 95 C for 2 min in a heating block and was cooled slowly to 25 °C for 1 h.
The reaction mixture was incubated at 25 °C for 15 min before the dNTP mixture and an
additional 10 U of Klenow Fragment were added. The final primer extension reaction
contained 1.5 FM partially extended GT-2 primer, 400 itM dNTP and 20 units Klenow
Fragments in 75 tL Klenow buffer. The reaction mixture was incubated at 25 °C for 20
min and was quenched by adding 30 tL of 3 M sodium acetate (pH 5.3) and 220 tL
ethanol. The ethanol precipitation mixture was kept at -80°C for 1 h and was centrifuged
at 13,000 rpm for 30 min at 4°C. The supernatant was discarded and the precipitate was
re-suspended in 1 mL 75% ethanol. The mixture was centrifuged for 30 min at 13,000
rpm at 4 °C. The supernatant was discarded and the precipitate was dried in vacuum. The
labeling product was further purified by PAGE as described above. The final yield of
internal-[ 32P! GT-2 was approximately 60 pmol (2 x 107 cpm/tmol).
Cleavage of internal [32P]-GT-2 by BLMs The reaction mixture of 80 tL contained
internal [32P1-GT-2 (100,000 cpm), 0.6 tg/ltL calf thymus DNA, 50 mM NaCI, and 50
mM HEPES pH 7.5. Before adding BLM, the mixture was heated to 95 °C for 2 min in a
heating block and was cooled to 4 °C over 1 h. BLM A5 or CD-BLM was activated ex
situ by mixing 500 tM BLM with equal concentration and volume of iron(II) (
(NH4)2 Fe(SO4)2) for 60 ±+ 2 s at 4 °C(13). For the reactions with low BLM
concentrations (2.5 to 10 tM), the activation mixture was diluted 10-fold with deionized
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water to make a 25 tM solution. For the reactions with high BLM concentrations (10 to
50 tM), the activation mixture was used without further dilution. An appropriate aliquot
of the activation mixture (250 tM or the 25 ~tM after dilution) was added to the reaction
mixture to achieve the desired final concentration. The reaction mixture was incubated at
4 °C for 10 min and was quenched by adding 50 [tL 3 M NH4OAc (pH 5.2) and 370 [tL
ethanol at 4 °C. The ethanol precipitation followed the same procedure described above.
The DNA pellets were dried in vacuo and were dissolved in 10 [tL DNA loading buffer
(containing 90% formamide (v/v)).
In reactions that contained chemically inert BLMA2-Co(III)-OOH, the appropriate
amount of BLM-Co(III)-OOH was mixed with the activated BLMs before they were
added to the final reaction mixture.
Analyzing DNA Cleavage Products by PAGE The sequencing gel (35 cm x 43 cm x 0.6
mm) contained 65 mL 20% acrylamide/bis-acrylamide (19:1 cross-linking) in 8 M urea
and TBE buffer (89 mM Tris-HCl, 89 mM boric acid, and 2 mM EDTA pH 8.3).
Electrophoresis was carried out on a DNA sequencing apparatus (Life Technology Co.,
Model S2). The gel plate was pre-run for 30 min before the samples were loaded in order
to heat the gel apparatus to 55 C. After loading the samples, the gel was run at a constant
power of 90 W for 2.5 h. The gel was then removed from the glass plates, dried in a gel
dryer (Labcono, Model 100) at 70 C for 45 min, and was exposed to a phosphorimage
screen (35 cm x 43 cm) for 12 h. The DNA gels were visualized by the Phosphorimager
Storm 840 (Amersham Biosciences) and quantitation was carried out as described below.
Quantitation of the DNA cleavage bands by ImageQuant 5.0. After the exposure of the
sequencing gel to the phosphorimage screen, the screen was scanned on a Phosphoimager
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(Model: Storm840 Amersham Biosciences). The resolution of the scanning pixel was set
to be 200 tm. The gel image was saved either as a GIF file for immediate visualization or
as a GEL file for the quantitative analysis. The manufacturer's software, ImageQuant5.0,
was used to quantitate the intensity of the DNA bands in the gel. The procedure of the
quantitation has been described previously(13). First, a histogram is generated for each
lane. The x axis of the histogram indicates the relative position of the gel and the y axis
indicates the intensity of the band. The peaks and the base line are then selected based on
the noise level of 0.5 and the sensitivity level of 1 (default settings). The noise level and
the sensitivity level are kept constant for all experiments. If two peaks are overlapping, a
vertical line is drawn from the valley to separate the two peaks(13). In Figure 2.4, two
examples are presented to illustrate this peak picking process. The area and percentage of
each peak are used to calculate ss to ds cleavage ratios at T13 and T38.
Preparation and purification ofpUC18 supercoiledplasmid. The pUC18 plasmid
(2686bp, Stratagen) with the ampicillin-resistant gene was transformed into a wild-type
E. coli DH5c strain. The transformed bacteria were grown in 200 mL Luria-Bertani
media overnight and were harvested by centrifugation at 8, 000 rpm for 20 min to yield 2
g cells (wet weight). The plasmid was purified from the cell pellet using the Qiagen
HiSpeed Plasmid MaxiKit following the manufacturer's protocol. The final yield of the
pUC18 plasmid was 350 tg.
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Figure 2.4 Quantitation of ss and ds cleavage products analyzed by DNA sequencing
PAGE. A, internal [32P]-labeled GT-2 cleaved by 7.5 jiM BLM A5; B, internal [32p]_
labeled GT-2 by 50 jiM CD-BLM.
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Relaxation of supercoiled plasmid DNA by BLMs The supercoiled DNA relaxation assay
has been widely used to measure the ss: ds cleavage ratio by BLM and other DNA-
cleaving agents. The cleavage reaction was carried out using the activated BLM
generated ex situ, similar to the procedure used in the internally labeled hairpin
experiments described above. The final reaction mixture of 20 tL contained 1 tg pUC18
plasmid DNA, 50 mM HEPES, pH 7.5, and 0.2-0.8 EM activated BLM. The BLM was
activated by mixing 50 FM BLM (10 tL) with equal volume and concentration of
iron(II). The activation mixture was incubated at 4 °C for 1 min. An appropriate aliquot
of the activated BLM was added into the reaction mixture to achieve the desired final
concentration. The reaction mixture was incubated at 4 C for 10 min and the reaction
was quenched by adding 5 tL of loading buffer containing 50% glycerol.
The type I (supercoiled), II (nicked), and III (linear) forms of plasmid DNA in the
reaction mixture were separated by a 1% agrose gel electrophoresis in the TBE buffer at a
constant voltage of 80 V for 90 min. The bands were visualized using a Bio-Rad
ChemiDoc XRS UV-trans-illuminator and was quantitated by the manufacturer's
software Bio-Rad Quality One. The numbers of the ss cleavage events (nl) and the ds
cleavage events (n 2 ) can be calculated from the Poisson distribution(]1): f = EXP(-nl-n2 )
and f = n2EXP(-n2). (f, and f: fractions of Type I (supercoiled) and Type III (linear)
plasmid).
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2.3 Results and Discussion
Sequence-specific cleavage of GT-2 by CD-BLM. The internally [3 2Pl-labeled hairpin
DNA technology developed in our group has enabled us to quantitate the site-specific ss
and ds cleavage simultaneously(13, 14). The hairpin DNA sequence used in this study,
GT-2, contains a "hot spot" for ds-DNA cleavage by BLM (T13 and T38 in the 5'-
GTAC-3' sequence, T denotes the cleavage site), as well as several good ss-cleavage site,
including CI0, C43, and T36 (Figure 2.3)(13). The ss and ds cleavages of internally
labeled GT-2 by BLM result in DNA fragments with characteristic lengths for each
cleavage site (Table in Figure 2.3), which can be separated and quantitated using the
DNA sequencing gel electrophoresis(13). The results of a cleavage study of the internally
j32p]-labeled GT-2 using various concentrations of CD-BLM (0 to 50 tM) are shown
Figure 2.5. The intensities of cleavage products mediated by 50 [tM CD-BLM (Lane 6 in
Figure 2.5) are analyzed in Figure 2.4B and are compared to the cleavage patterns by
BLM A5 (7.7 tM BLM A5, Figure 2.4A). Under these assay conditions, 50 FM CD-
BLM produced approximately the same extent of overall cleavage (12%) as 7.5 [tM BLM
A5 (10%), indicating that CD-BLM is at least 5 fold less efficient in the cleavage of GT-
2 than BLM A5. The reduced overall DNA cleavage ability could be attributed to the
cyclodextrin group, which would be expected to reduce the affinity of CD-BLM for
DNA. It might also be related to the slower activation and/or faster degradation rate of
the activated species, CD-BLM-Fe(III)-OOH. At present, a distinction cannot be made
between these two possibilities.
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Figure 2.5 Cleavage of internally [32p] labeled GT-2 by CD-BLM. Lane I: Maxim-
Gilbert G+A reaction. Lane 2-5: 0, 12.5, 25, 37.5, 50 !J.MCD-BLM.
Although CD-BLM is less efficient in overall DNA cleavage than BLM A5, the
results reveal similar ss-DNA cleavage patterns (Figure 2.4). Thus, the bulky CD-BLM
substituent and its presumed hindrance to intercalation do not seem to interfere with its
ability to H-bond with G, 3' to the pyrimidine cleavage site.
The relative intensities of the cleavage products at each ss cleavage site (T13, T13,
CIO, C43, A32, and T36 of GT-2) for CD-BLM are also quite similar to BLM A5 (Figure
2.4) and the previously studied BLM A2(13). The predominant cleavage sites in GT -2 are
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T13 and T38, with C10/C43 >> T36 > A32. A notable difference between CD-BLM and
BLM A5 is the relative intensity at T13 and T38. CD-BLM produced almost equal
amounts of cleavage products at these two sites, while BLM A5 and A2(13) cleaved the
T38 site with twice the efficiency relative to the T13 site (Figure 2.4). The difference of
the cleavage intensities between T13 and T38 for natural BLMs was used by Absalon et
al. to suggest that T38 might be the primary ss-cleavage site in the dsDNA cleavage(13).
The change of the relative cleavage intensity at T13 and T38 for CD-BLM may reflect
the affinity difference at these two cleavage sites between CD-BLM and normal BLMs.
Site-Specific dsDNA cleavage mediated by CD-BLM In addition to ss DNA cleavage,
CD-BLM mediated dsDNA cleavage at T13 and T38 (Figure 2.4B and Figure 2.5). To
ensure that the ds-cleavage is not associated with two independent ss cleavage events, the
cleavage assay was carried out in the presence of 0.6 gg/tL unlabeled calf thymus DNA
to ensure "single-hit" conditions. Quantitative analysis of the cleavage product intensity
at each ss-cleavage site indicates that the amount of the ss-cleavage product increased
linearly with the concentration of CD-BLM (Figure 2.6). In addition, the amount of the
ds-cleavage also increases linearly with the CD-BLM concentration (denoted by filled
circles () in Figure 2.7). The ss to ds cleavage ratio at T13 and T38 sites was
determined in triplicate to be 6.7+1.2, which is higher than the ratio for BLM A2 (3.4,
Absalon) or A5 (3.1-+0.3) in the same sequence context. The ss to ds cleavage ratio for
CD-BLM remains constant over the range of 12.5 to 50 tM CD-BLM (Figure 2.8),
indicating that the observed dsDNA cleavage at T13 and T38 can not come from two
coincidental ss cleavage events.
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Figure 2.6 Concentration-dependent cleavage at each ss cleavage site in GT-2.
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The ss to ds cleavage ratio by CD-BLM (6.7±1.2) is both statistically and
mechanistically significant. The separation of the T13 and T38 ss cleavage bands (Figure
2.4) enabled the quantitative estimation of the amount of ds cleavage due to two
coincidental ss cleavage events. At 50 M CD-BLM concentration, the percentages of ss-
cleavage at T13 (2.01%) and T38 (2.44%) give rise to the calculated random ds-cleavage
of 0.054% (2.01% x 2.44%), which is 17 times smaller than the observed ds cleavage
(0.92%). The calculated random ds-cleavage percentages at different CD-BLM
concentrations were plotted in Figure 2.7 (U). This calculation, together with the
concentration-independent ss to ds cleavage ratio, suggests that the observed ds cleavage
by CD-BLM is mediated either by a single CD-BLM molecule, or by the cooperative
binding of a second CD-BLM.
The total extent of cleavage in the above study is 3.3 to 14% (12.5 to 50 EM CD-
BLM). To investigate whether the observed ss to ds cleavage ratio would change under
conditions of <1% cleavage, additional studies were carried out with calf thymus DNA
increased from 0.6 tg/tL to 5 tg/~tL. The cleavage reaction mixture was analyzed by the
DNA sequencing gel and is shown in Figure 2.9. The overall cleavage at 20 tM CD-
BLM is 0.6%. The ss to ds cleavage ratio determined in this experiment, 7.8+2.4, (in a
separate measurement, 7.3+1.4) is consistent with our previous studies (6.7+1.0). The
error in the analysis largely comes from the background, which is likely due to a
combination of non-specific cleavage by hydroxyl radicals generated by CD-BLMs,
radiation damage of GT-2 from [32P] decay, and spontaneous depurination. The non-
specific cleavage by CD-BLM is perhaps the major source of the background because the
amount of the laddering (non-specific cleavage) increases with the CD-BLM
80
concentration. The presence of the background limits of the ss to ds cleavage ratio that
can be determined to -20:1. The previously observed limit of detection by Absalon et al.
for the hairpin DNA method was 7:1(14), which was largely determined by ds cleavage
generated by two ss cleavage events. When the overall cleavage is less than 1%, the
random ds cleavage at T13 and T38 is estimated to be approximately 0.002%, far less
than the background, which is usually 0.01%. As a result, the background becomes the
predominant factor to set the limit of the quantitation in the present studies.
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Figure 2.7 Concentration-dependent cleavage at the GT-2 ds-cleavage site (T13+T38).
The filled circles () are observed ds cleavage in percentage at T13 and T38. The filled
squares () represent the calculated percentage of random ds-cleavage. The number is
the product of the percent cleavage at the two ss-cleavage sites (T13 and T38).
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Figure 2.8 Log/log plot of the percentage of T 13+T38 ss-cleavage versus T 13/T38 ds-
cleavage using the data from Figure 2.5 with the concentrations of CD-BLM from 12.5 to
50 FM. The linear least-square fit of data (Y= 0.862 + 0.992X) indicates that the ratio of
ss to ds cleavage remains constant over a 4-fold range in CD-BLM concentration. The
value of the Y intercept, 0.862 from the equation, is consistent with the log value of the ss
: ds cleavage ratio (6.7+1.2). ( %ss/%ds = c ~ log (%ss) = log c + log(%ds), c: the
ss:ds cleavage ratio )
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Figure 2.9 Cleavage of internally C2p] labeled GT-2 by CD-BLM. Lane 1-4,0, 5, 10,20
~M CD-BLM. The total amount of DNA cleavage was 0.6% for Lane 4. The extent of
cleavage has been quantitated by the phosphorimage method for 20 ~M CD-BLM (Lane
4). The data are summarized in the table.
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Ds-cleavage of GT-2 by CD-BLM is mediated through cooperative binding. To determine
whether the observed dsDNA cleavage by CD-BLM is due to a single CD-BLM
molecule or due to the cooperative binding of a second CD-BLM molecule, the cleavage
of internal 32PI-GT-2 by CD-BLM was further investigated in the presence of the
chemically inert BLM-Co(III)-OOH. Originally used by Absalon et al.(14), this
competition assay was designed to provide additional support for the model that a single
BLM molecule can mediate dsDNA cleavage. In this model, the second cleavage is
effected by the bound BLM via re-organization and the ss to ds cleavage ratio is
determined by the relative rate of dissociation versus re-organization after the first
cleavage event. Thus, the single molecule model predicts that the presence of the
unreactive BLM-Co(III)-OOH will not be able to compete for the second cleavage site
and that the ss to ds ratio should remain the same. The cooperative binding model
requires binding of a second BLM molecule to effect the ds cleavage and it predicts that
BLM-Co(III)-OOH can compete for the second binding event and would increase the
observed ss to ds ratio.
The cleavage of the internally labeled GT-2 by CD-BLM was analyzed by DNA
sequencing gel and is shown in Figure 2.10 with 0 (Lane 2-4), 0.5 (Lane 5-7), or 0.25
(Lane 8-10) equivalent BLM-Co(III)-OOH/CD-BLM. The presence of BLM-Co(III)-
OOH suppresses cleavage at both ss and ds sites. However, the ds cleavage is affected
much more than the ss cleavage. This effect is best demonstrated by analysis of Lane 4
(20 tM CD-BLM), Lane 10 (20 tM CD-BLM + 5 tM BLM-Co(III)-OOH), and Lane 7
(20 [iM CD-BLM + 10 M BLM-Co(III)-OOH) (Histogram A, B, and C in Figure 2.11)
quantitatively. The results (Table in Figure 2.11) indicated that BLM-Co(III)-OOH
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suppressed the ds cleavage much more than the ss cleavage. The ss to ds cleavage ratio
increases from 7.3+1.4 (no BLM-Co(III)-OOH) to 12.5±2.5 (0.25 equivalent BLM-
Co(III)-OOH/CD-BLM) to 21+14.2 (0.5 equivalent BLM-Co(III)-OOH/CD-BLM). The
ss to ds cleavage ratio measured with 0.5 equivalent of BLM-Co/CD-BLM, 21+14.2, is
close to the lower limit of our detection and represents the background cleavage process
(Histogram C in Figure 2.11). For comparison, the competition assays using BLM A5
were also performed with 0 or 5 equivalent of BLM-Co(III)-OOH (Lane 11 and 12 in
Figure 2.10). The analysis is shown in Histogram D and E in Figure 2.11. The ss to ds
cleavage ratio remains largely unchanged (3.6 +0.9) in the presence of 5 equivalent
BLM-Co(III)-OOH compared to BLM A5 alone (3.1±0.3). These results suggest that
CD-BLM mediates the ds-DNA cleavage by cooperative binding of a second CD-BLM
molecule after the first cleavage events, while BLM A5 mediates ds-cleavage by one
BLM molecule, similar to the results previously observed by Absalon et al. with BLM
A2(14).
Ss:ds cleavage ratio determined by the supercoiled plasmid relaxation assay. The
supercoiled plasmid relaxation assay has been widely used to determine the ss to ds
cleavage ratios by BLM(11, 23-25). The number of the ss and ds cleavage events can be
calculated from the fraction of Type II (relaxed) and Type III (linear) plasmid using the
Poisson distribution as described in the experimental section(11). The ss to ds cleavage
ratio measured using this method is not sequence-specific and reflects the averaged ratio
for the whole plasmid DNA.
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Figure 2.10 Competitive inhibition of CD-BLM-mediated DNA cleavage by the
chemically inert BLM-Co(lII)-OOH. Lane 1: Control. Lane 2-4: 5, 10,20 f..tMCD-BLM.
Lane 5-7: 5, 10,20 f..tMCD-BLM with 0.5 equivalent BLM-Co(III)-OOH. Lane 8-10: 5,
10,20 f..tMCD-BLM with 0.25 equivalent BLM-Co(III)-OOH. Lane 11: 5 f..tMBLM A5.
Lane 12: 5 f..tMBLM A5 with 5 equivalents BLM-Co(lII)-OOH (25 f..tM).
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Figure 2.11 Quantitation of CD-BLM mediated cleavage (from Figure 2.10) and its
attenuation by BLM-Co(III)-OOH. A, 20 [M CD-BLM (Lane 4); B, 20 MM CD-BLM +
5 pM BLM-Co(III)-OOH (Lane 10); C, 20 FM CD-BLM + 10 pM BLM-Co(III)-OOH
(Lane 7); D, 5 pM BLM A5 (Lane 11); E, 5 pM BLM A5 + 25 pM BLM-Co(III)-OOH
(Lane 12). (* The intensities of the bands are calculated in arbitrary units) For
comparison, Linegraph D (20 MM CD-BLM) and E (5 MM BLM A5) are normalized to
the intensity of the T38 ss cleavage band.
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CD-BLM is also shown to mediate dsDNA cleavage using the supercoiled plasmid
relaxation assay. Figure 2.12 shows the image the agarose gel separating the two types of
products (linear and nicked) from the starting pUC 18 supercoiled plasmid. CD-BLM
showed 500/0 of the cleavage efficiency compared to BLM A5 in this assay. The UV
densitometry analysis of the gel is presented in Figure 2.13. Surprisingly, the ss to ds
cleavage ratio determined for CD-BLM is 2.8 to 1, higher than that observed for BLM
A5 (5.8 to I) or A2 (7.3 to I). For comparison, PLM, which is a poor ds cleavage agent,
shows a ss : ds ratio of 47 to I. However, the mechanistic interpretation of these ratios is
complicated by the fact that the ss to ds ratio measured in the supercoiled DNA relaxation
assay is not sequence specific. It is likely that there exist some hot spots or secondary
structures that are especially sensitive for CD-BLM mediated ds cleavage. In addition,
the supercoiled DNA relaxation assay cannot distinguish site-specific cleavage from non-
specific hydroxyl radical cleavage. Therefore, it is also likely that the observed ds
cleavage by CD-BLM is over-estimated by the presence of closely spaced random ss-
cleavage sites.
2 3 4 5 6 7 8
Figure 2.12 BLM and CD-BLM induced relaxation of supercoiled plasmid pUCI8. Lane
1,1.0!-!g pUCI8; Lane 2, pUCI8 + 1 !-lMFe(II); Lane 3, pUCI8 +0.2!-lM BLM A2;
Lane 4, pUCI8 + 0.2!-lM BLM A5; Lane 5-6, pUCI8 + 0.2 and 0.4!-lM CD-BLM; Lane
7-8, pUCI8 + 0.2 and 0.4!-lM PLM.
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C 0.4 ~M CD-BLM 680.506 258.85 2486.15 2.8
D 0.4 ~M PLM 665.481 15.1 2611.563 47
Figure 2.13 Quantitation of the cleavage products of pUC18 by BLMs, PLM, and CD-
BLM using the supercoiled DNA relaxation assay (Figure 2.12). A, 0.2 !J.MBLM (Lane
3); B, 0.2 !J.MBLM AS (Lane 4); C, 0.4 !J.MCD-BLM (Lane 6); D, 0.4 !J.M PLM (Lane
8). The data are summarized in the table.
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Interaction of CD-BLM with duplex DNA CD-BLM was designed to preclude the
intercalation of the bithiazole tail. It has been technically challenging to demonstrate
intercalation in ligand-DNA interaction. The classic method is to detect unwinding of the
supercoiled DNA using agarose electrophoresis(26). This technique requires a gram-scale
material that is unavailable for CD-BLM. In addition, this method is not capable of
detecting weak intercalators that are in fast exchange or only intercalate at limited
sequences. For example, results from studies with PLM were interpreted to indicate a
non-intercalative binding mode(27-29). However, it is later demonstrated by NMR
spectroscopy that PLM can intercalate in a duplex DNA containing the 5'-GTAC-3'
sequence(30). At this stage, the only way to address whether CD-BLM intercalates or not
is to titrate it with DNA and monitor the chemical shift changes of the bithiazole protons,
if a 1:1 complex of CD-BLM/DNA can be obtained in slow exchange on the NMR time
scale.
The cooperative binding model of CD-BLM-mediated ds-cleavage requires the
potentiation of binding of a second CD-BLM molecule after the first cleavage event. This
model predicts that CD-BLM would have a higher affinity for ss-lesioned DNA than for
the intact DNA. The identity of the ss-lesioned DNA that is responsible for the
potentiation of binding is not clear at this stage. The 3'-phosphoglycolate/5'-phosphate
lesion (Figure 2.2) was shown to be present at the first cleavage site in all BLM-mediated
ds-cleavage and might play a role in recruiting the second CD-BLM(31) (Section 1.6,
Chapter 1). Alternatively, a precursor to this lesion could also be involved in potentiating
binding of BLM to the second strand(32, 33). The dissociation constant (KD) of CD-BLM
with 3'-PG/5'-P lesioned DNA can be measured by monitoring the fluorescence
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quenching of the bithiazole upon binding to DNA and would provide additional support
for the cooperative binding model.
Alternative sites for BLM-mediated ds-DNA cleavage? Recently, an unusual ds cleavage
site was identified by the Hecht group in the Dickerson-Drew dodecamer(34) (Figure 1.7,
Chapter 1). This site does not conform to the postulated selectivity rules. Structural
studies using 2D NMR methods of BLM-Zn(II) bound to this dodecamer were interpreted
to indicate that the metal binding domain of BLM-Zn(II) was located halfway between
the two cleavage sites with the bithiazole tail in the minor groove (Figure 1.7 B and C,
Chapter 1). In this study, however, BLM-Zn(II) is in fast exchange with the DNA on the
NMR time scale and the chemical shifts of bithiazole protons could not be assigned. The
scarcity of the NOE information between BLM-Zn(II) and DNA (total 12 NOE distance
restraints, 3 of them are involved in the bithiazole tail as shown in Figure 1.7 A, Chapter
1) prevented modeling of a unique conformation of the bithiazole tail. Furthermore, our
attempt to reproduce the ds-cleavage pattern observed by Hecht et al. on the Dickerson-
Drew dodecamer has been unsuccessful (Appendix B). Therefore, the significance of this
unusual ds-cleavage site and the model structure proposed by Hecht et al. remains
unclear.
2.4 Conclusion
A BLM analog (CD-BLM) with cyclodextrin attached to the bithiazole tail, designed
to prevent binding to DNA by partial intercalation, was synthesized to investigate the
importance of this binding mode in dsDNA cleavage. Fe(II)-CD-BLM mediates the same
sequence-specific DNA cleavage pattern as BLM A2 and A5, although 5 fold less
efficient. Internal [32 P]-labeled hairpin DNA technology was used to demonstrate that
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Fe(II)-CD-BLM mediates dsDNA cleavage by cooperative binding of a second CD-BLM
molecule, in contrast with BLM A5 and A2. The results support the essential role of
partial intercalation of the bithiazole tail in a single BLM-mediated dsDNA cleavage.
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Appendix A. Synthesis of P3-cyclodextrin-tethered BLM A5 (CD-BLM) (Figure 1)
Material Bleomycin As was purchased from CalBioChem. -cyclodextrin and other
chemicals were purchased from Sigma-Aldrich. Dioxane was purified by refluxing over
KOH, followed by distillation over Na. NMR spectra were measured on Bruker 400 MHz
or Varian XL 500 MHz spectrometers. H and 13C NMR chemical shifts are expressed in
parts per million using tetramethylsilane as a reference.
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Figure I Synthesis of CD-BLM (1)
Synthesis of mono-6-deoxy-6-(p-tolylsulfonyl)-I-cyclodextrin (3) from It-
cyclodextrin (2)
(a) Preparation of p-toluenesulfonic anhydride(Ts 2O). A mixture of p-toluenesulfonyl
chloride (8 g, 0.043 mol) and p-toluenesulfonic acid (2 g, 0.011 mol) in 50 mL of CH 2 CI2
was stirred at 20 °C overnight. The reaction mixture was then filtered through 100 g silica
gel (particle size 40-63 pm, EM Science). The product in the filtrate was precipitated
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from hexane to give 6 g of Ts2O (75% yield, reported 88%).
(b) Synthesis of 3 from 2 using Ts 2 O. Ts 2O (2.45 g, 7.5 mmol) was added to a
suspension of -cyclodextrin (2) (5.75 g, 5 mmol) in 125 mL of H20. The reaction
mixture was stirred at 20 °C for 2 h. A solution of NaOH (2.5 g, in 25 mL of H20) was
then added to the reaction mixture. The unreacted Ts 2O was removed by filtration. The
filtrate was brought to pH -8 by the addition of 6.7 g of solid NH4CI. The solution was
kept at 4 °C overnight to precipitate out the mono-6-deoxy-6-(p-tolylsulfonyl)-3-
cyclodextrin as white solid 2.58 g (35%). m.p. 184 °C (reported: 179 °C). H NMR
(Bruker 400 MHz, DMSO-d 6): 6 7.75 (d, J= 8.1 Hz, 2H), 7.43 (d, J = 8.08 Hz, 2H),
5.89-5.65 [m, 14H, (OH 2, OH 3)], 4.83 [br s,5H (Hi)l, 4.76 br s, 2H (H,)I, 4.55-4.38 m,
6H (OH6)I, 4.32 [m, 1H (H 6 b)], 4.17 [m, 1H (H6 a)1, 3.75-3.43 [m, 28 H (H3, H5, H6a, H6b)1,
3.42-3.15 [m, overlaps with HOD (H2, H4)j, 2.42 Is, 3H (CH3). ESI-MS for
C4 9 H76 0 37 SNa [M + Na]+: calcd: 1311.3678; obsd: 1311.3715.
Synthesis of mono-6-deoxy-6-azido-l-cyclodextrin (4).
Mono-6-deoxy-6-(p-tolylsulfonyl)-3-cyclodextrin (3) (300 mg, 0.232 mmol) was
suspended in dry DMF (1.0 mL) and warmed to 63 °C over a period of 15 min to obtain a
homogeneous solution. Potassium iodide (19 mg, 0.115 mmol) and sodium azide (151
mg, 2.32 mmol) were added and the reaction mixture was stirred at 60-65 °C for 24 h.
The reaction mixture was then cooled to 20 °C and was treated with Amberlite MB-3
resin (Sigma) to remove salts. Acetone (50 mL) was added to the effluent providing a
white precipitate. The precipitate was collected by suction filtration and dried under
vacuum to yield 242 mg of the title compound (90%) as a single product. m.p. 204 °C (
reported 206 ° C, slow decomposition). TLC (silica): Rf 0.71, (i-PrOH:H 20:EtOA:conoc.
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NH4OH = 5:3:1:1. H NMR (Bruker 400 MHz, DMSO-d 6): 5.85-5.60 m, 14H, (OH, 2
& 3 positions)l, 4.87 br s,lH (H1)], 4.82 br s, 6H (H1)], 4.60-4.45 [m, 6H (OH, 6-
position))], 3.80-3.45 m, 28 H (H3, H5, H 6 a, H6b)l, 3.42-3.22 [m, overlaps with HOD (H2,
H4)I. ESI-MS for C 42H 69N3 0 34 Na, M + Na]+: calcd: 1282.3655, obsd: 1182.3653.
Synthesis of mono-6-deoxy-6-amino-p-cyclodextrin (5).
Mono-6-deoxy-6-azido-13-cyclodextrin (4) (0.23 g, 0.198 mmol) and
triphenylphosphine (115 mg, 0.438 mmol) were dissolved in DMF (4 mL) and 30% NH3
(1.0 mL ) was added. The mixture was stirred at 20 °C for 5 h and 30 mL acetone was
added to give the crude product as white precipitate. The crude product (80 mg) was
dissolved in 6 mL H2 0 and was loaded on a Sephadex CM-25 column (2.5 x 8 cm). The
column was eluted with 100 ml of water then 0.1 N NH4OH (100 mL). The fractions
were collected and the solvent was removed under vacuum to give 50 mg 5 (62%).
'H NMR (Varian 500 MHz, D 2 0): 4.92 [m, 7H, (H1 )l, 3.86-3.78 [m, 7H (H3)j, 3.77-
3.66 m, 19 H (H5, H6a, H6b)], 3.54-3.46 m, 7H (H2)l, 3.46-3.39 m, 6H (H4), 3.33 [m,
1H (H4 )J, 2.98 [d, 1 H (H 6b)I, 2.74 dd, 1 H (H6a. '3C NMR (400 MHz, D20): 102.1 (C1),
101.8 (C1), 83.1 (C4), 81.3 (C4), 81.1, 73.3 (C3), 72.3 (C5), 72 (C2), 71.5, 67.6 (C6),
60.5 (C6). ESI-MS: calculated for C 42 H7 1N10O3 4 [M + H]+ 1134.3930, found 1134.3956.
Synthesis of 6 by coupling of 5 with adipic acid monomethyl ester.
Adipic acid monomethyl ester (5.23 mg, 0.033 mmol) was added to a solution of 5
(35 mg, 0.031 mmol) in 0.6 mL of DMF. After the solution was cooled to -10 C, DCC
(7.63 mg, 0.037 mmol) and HOBt (5 mg, 0.037 mmol) were added. The resulting reaction
mixture was kept for stirring at 20 C for 24 h. Insoluble materials were removed by
filtration and 10 mL acetone was added to the filtrate. The precipitate was collected and
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dried in vacuo to give 30 mg of crude product (6). Crude product was purified by silica
gel column chromatography (1.5 x 10 cm column). 25 mg of the crude product was
dissolved in n-BuOH/EtOH/H 20 (5:4:3) and silica gel (g) was added, solvents were
removed to make the mixture anhydrous. The dried silica gel adsorbed with the
compound was loaded on the top of a column prepacked with silica gel (dry packing)
with a funnel. The compound was eluted with the same solvent, n-BuOH/EtOH/H 20
(5:4:3) under pressure. 5 mL fractions were collected. Fractions were collected based on
TLC [silica, n-BuOH/EtOH/H 20 (5:4:3)1. Solvents were removed under vacuo to give 23
mg of 29 (70%). H NMR (Bruker 400 MHz, DMSO-d 6): 6.07-5.61 m, 14H, (OH 2,
OH3), 4.94-4.73 [m,7H (H,)I, 4.63-4.5 [m, 6H (OH6 )j, 3.81-3.52 [m, 29 H (H3, H5, H 6 a,
H 6 b, OMe)|, 3.47-3.11 [m, overlaps with HOD(H 2, H4)], 2.30-2.28 Im, 2H (Ha)], 2.20-
2.08 m, 2H (Hd), 1.58-1.30 4H, (Hb, Hc)]. ESI-MS for C 49 H8lNO 3 7 [M + H]+
1276.4560, found 1276.4565.
Synthesis of 7 by hydrolysis of the methyl ester derivative of P-cyclodextrin (6)
To a solution of 6 (39 mg, 30.58 ~tmol) in 0.8 mL of dioxane /H20 (3:1), 25.6 L 2 M
NaOH (51.2 tmol) was added and the reaction mixture was stirred at 20 °C for 6 h. The
reaction mixture was neutralized with glacial acetic acid and the solvent was removed to
give 40 mg crude solid product. The crude product was dissolved in 2 mL water and was
precipitated by adding 50 mL acetone to remove sodium acetate. The crude product (40
rmg) was then purified by reverse phase C18 column chromatography (10 mL column).
The column was run with 100 mL of water and followed by 5% MeOH/H 20. Fractions
were collected and solvent was removed to give 20 mg 7 as white solid in 52% yield. 'H
NMR (Bruker 400 MHz, D20): 5.05-4.95 [m, 7H (H,)I, 3.95-3.68 [m, 27H (H3, H 5, H 6 a,
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H6b)l, 3.60-3.45 [m, 13H (H2, H4)J, 3.40-3.3 [m, H, H4], 3.26 ldd, J56a = 6.4 Hz, J6a6b =
14.3, 1 H (H 6 a) 1H, H6a], 2.25-2.16 [m, 2H (Ha)l, 2.15-2.08 [m, 2H (Hd)l, 1.59-1.45 4H,
(Hb, Hc)l. ESI-MS: calculated for C48H78NO37 [M - H1- 1260.4247, found 1260.4278.
Coupling 30 with Cu(II)BLMA 5 :
To a solution of 30 (2.5 mg, 1.98 [tmol) in 0.3 mL of DMF at rt was added
diisopropylethylamine (0.51 mg, 3.96 [tmol, 10 tL from a solution of 34.5 1tL in 500 mL
of DMF) followed by BOP reagent (0.88 mg, 1.98 tmol, 10 jtL from a solution of 44 mg
in 500 tL of DMF). The reaction mixture was stirred for 2 min at rt and the resulting
solution was added to a anhydrous mixture of Cu(II)BLMA 5 (1.98 tmol) in 0.2 mL of
DMF at 0 °C. Amount of Cu(II)BLMA 5 was measured from its aqueous solution by UV
(£ of Cu(II)BLMA 5 = 17400) and it was made anhydrous by removing water and repeated
evaporation from dry DMF (4 x 1 mL) followed by drying under vacuum. The reaction
mixture was stirred at 4 °C for 36 h.
Solvent was removed in vacuo to give a blue product which was dissolved in 520 itL
of water and purified by reverse phase HPLC. Column: Econosil C18 10 pt (Altech, =
250 mm, id = 4.6 mm), solvent: linear gradient of 0-50% acetonitrile in 0.1 M NH4OAc (
pH 6.8) over 60 min; flow rate 1.0 mL/min.
Cu(II)BLMA 5 was eluted at 34.9 min and the major product was eluted at 27.8 min
(Fig 40). Fractions were collected by monitoring the absorption at 292 nm. Fraction of
the major product was yophilized to give 31 as a bluish solid. Yield of the product 48%
(the fraction having RT = 27.8, considering same E = 17400 as of Cu(II)BLMAs at X
292).
UV and 'H NMR spectra were recorded. Cu(II) being a paramagnetic species, the
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product could not be characterized by H NMR; it gave only some broad signals. UV
spectrum looks exactly similar to that of Cu(II)BLMA 5 and having absorption at 292 and
592 nm. High resolution mass (ESI): calculated for C105 H66N 200 57S2Cu IM2+] 1372.9716,
found 1372.9767 (Corresponding M + = 2745.9534).
Synthesis of metal-free P-cyclodextrin-tethered BLM A5 (CD-BLM, 1)
The copper complex form of CD-BLM (8, 0.81 tmol) was dissolved in 0.6 mL 15%
Na2EDTA (pH 4.65) and the reaction mixture was stirred at 4 °C for 20 h. The reaction
mixture was then purified by RP-HPLC using a Econosil C18 column (4.6 x 250 mm)
with a linear gradient of 20-50% methanol in 0.1 M NH4OAc (pH 6.8) over 50 min. The
flow rate is 1.0 mL/min. Compound, retention time, yield: 1, 28.2 min, 61%. The
chemical shifts of 1 was listed in Table 1. ESI-MS: calculated for C 1o05H168N20057S2 [M +
2H12+ 1342.5146, found 1342.5163 (Corresponding M + = 2683.0326).
100
Table 1 Chemical shifts of different protons of Tethered BLMA5 and BLMA2
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Protons BLMA2 Tethered Protons BLMA2 Tethered
BLMA 5 BLMA 5
P CclcH 2.62 2.61 B CuH 3.24 3.25
CocH' 2.69 2.66 C[H 3.60 3.61
CPH 3.96 3.99 C5H 8.20 8.27
CH3 2.01 1.92 CS'H 8.00 8.06
H CaH 5.05 5.06 G C1H 5.25 5.26
C3H 5.26 5.28 C2H 4.01 4.00
C2H 7.79 7.79 C3H 4.09 4.00
C4H 7.26 7.26 C4H 3.84 3.82
CSH 3.99 3.97
C6H 3.40 3.42
C6H' 3.53 3.52
A CuH 3.84 3.92 M C1H 4.99 4.98
Cf3H 2.83 2.68 C2H 4.04 4.04
CH' 2.88 2.76 C3H 4.68 4.65
C4H 3.78 3.77
C5H 3.78 3.77
C6H 3.78 3.77
C6H' 3.92 3.90
V aCH3 1.10 1.07 a,d 2.2
yCH3 1.12 1.09 b, c 1.52
C(uH 2.45 2.41 e 3.17
C3H 3.70 3.70 f 1.56
CyH 3.86 3.86 g 1.68
T CH3 1.08 1.01 h 3.04
CctH 4.21 4.19 i 3.1
C[H 4.08 4.06 2.02
k 3.52
Appendix B. Re-examination of the proposed ds-cleavage site in the Dickerson-Drew
dodecamer (Figure 1).
4~ 4~ ~o;45 o T
5'-CGCGAATTCGCG-3' 5'-CGCGAATTCGIIII T
3'-GCGCTTAAGCGC-5' 3' -GCGCTTAAGCCCCC T
t A 30 25 20 T
1 ~~~~~2
Figure 1. Sequence of Dickerson-Drew dodecamer (1) and a hairpin DNA (2) containing
the sequence of 1. The proposed ds cleavage site in 1 is indicated by the solid arrows.
The dashed arrow indicates the symmetry-related ds cleavage site. The proposed ss-
cleavage sites (AS, C31, and I11) in 2 is indicated by the arrows. The A5/C31 cleavage
sites in 2 are equivalent to the ds-cleavage site in 1.
The cleavage pattern of the [5'- 32 P|-hairpin DNA (2, Figure 1) containing the
Dickerson-Drew dodecamer sequence (1) by BLM was re-examined under two assay
conditions. The first assay condition followed exactly the same procedure as described by
Keck et al. ( J. Am. Chem. Soc., 2001, 123, 8690-8700). The reaction mixture of 100 tL
contained 5x 106 cpm (2 pmol) [5'- 32p]-2 in 10 mM NaCl, 50 mM sodium cacodylate, pH
6.5. An equal amount of Fe(II) (as (NH 4)2Fe(SO4 )2) and BLM A2 was added separately
into the reaction mixture from a 100 [tM stock solution to achieve final Fe(II)-BLM
concentration of 0, 1, 2, 5 M. The reaction mixture was incubated at 0°C for 30 min.
The reaction mixture was then mixed with 100 tL of 2 M piperidine. The mixture (200
[tL) was heated at 90 °C for 30 min and the DNA cleavage products were precipitated
from the solution by adding 3 mL of 2% LiCIO4 in acetone. The solution was centrifuged
at 22,000 g for 30 min at 4 °C. The supernatant was discarded and the pellet was washed
with 0.5 mL 95% ethanol at 4 °C. The solution was centrifuged again at 22,000 g for 30
min at 4 °C. The pellet was dried in vacuum and was re-dissolved in 20 tL loading buffer
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containing 8 M urea. The samples were analyzed by 20% DNA sequencing gel and was
visualized by a phosphorimager. The gel analysis are shown in Figure 2A and is
compared to the results obtained by Keck et at. (Figure 2B). Our results reveals very little
cleavage at the expected A5 cleavage site, contrast to that observed by Keck et al. We
also observed extensive non-specific cleavage products under this assay condition. This
observation is possibly due to the random hydroxyl radical damage to DNA, which could
result in extensive strand breaks after the alkaline treatment.
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Figure 2 DNA sequencing gel (20%) analysis of the cleavage reaction of [5'_32p]_2with
BLM A2. A, the result from our group. B, the result from the Hecht group (Adapted
from Figure 8A in Keck et at., J. Am. Chern. Soc. (2001) 123,8690-8700). The assay
conditions were exactly the same for A and B. The sequence of 2 is shown with the
proposed cleavage sites (A5, 111, and C31) indicated by the arrows.
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The cleavage pattern of [5'_32p]_2 by BLM A2 was also analyzed using the procedure
described in Section 2.2, Chapter 2. There are several differences between the two assay
conditions. Under our assay conditions, BLM A2 was activated ex situ and the reaction
mixture contained 0.6 I-lg/I-lLcalf thymus DNA. After the reaction, no alkaline treatment
was carried out. The DNA sequencing gel analysis is shown in Figure 3. Consistent with
the observation in Figure 2, our results indicate no ss cleavage at A5 within the limit of
the dection.
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Figure 3. DNA sequencing gel (20%) analysis of the cleavage reaction of [5' _32p]_2 with
BLM A2. The sequence of 2 is shown with the proposed cleavage sites (A5, 111, and
C31) indicated by the arrows. The assay conditions are described in Section 2.2, Chapter
2.
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Chapter 3. Mechanistic studies on BLM-mediated blunt-ended cleavage
3.1 Introduction
Bleomycins (BLMs) are a family of natural glycopeptides that have potent anti-tumor
activity against a variety of cancers(l, 2). The cytotoxicity of BLMs is proposed to be
related to their ability to cause both single-stranded (ss) and double-stranded (ds) DNA
damage in the presence of required cofactors (Fe(II), 02 and reductant)(3-7). As
discussed in detail in Chapter 1 (Section 1.3), BLM initiates DNA damage by generating
a 4'-radical intermediate(8), which leads to two types of ss-DNA lesions depending on
the availability of 0 2(Figure 3.1). Although in vitro studies have showed that ssDNA
cleavage by BLMs occur much more frequently than dsDNA cleavage(9-13), the ds DNA
cleavage has long been believed to be the major source of BLMs' cytotoxicity because of
the severe cellular consequences associated with ds DNA breaks(7, 14). These
consequences include mutagenesis, necrosis, and apoptosis. The mechanism of BLM-
mediated ds-DNA cleavage has been the focus of our research.
BLM mediates ss- and ds-DNA cleavage in a sequence selective fashion. Ss-cleavage
occurs predominantly at pyrimidines 3'-to a guanine (5'-GC-3' 5'-GT-3' >> 5'-GA-3', _
denotes the cleavage site)(15). Povirk et al. also proposed a set of sequence-selectivity
rules (Figure 1.4, Chapter 1) for ds-cleavage by analyzing 30 ds-cleavage sites in a
limited sequence space using native and denaturing DNA gel electrophoresis(16, 17). The
rules are that the first cleavage site is a good ss cleavage site. Depending on the local
sequence context, the secondary cleavage site can be either staggered to the 5' end or
directly opposite to the first cleavage site (Figure 1.4, Chapter 1).
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Figure 3.1 DNA cleavage pathways by BLM.
The dsDNA cleavage is proposed to be effected by a single BLM molecule, which
has only one active site (Section 1.4, Chapter 1)(13, 16, 18). A structural model for the
mechanism by which a single BLM molecule can mediate two cleavage events has been
proposed by our group based on the structure of an activated BLM analog (BLM-Co(III)-
OOH) bound to the "hot spot" for ds-cleavage (5'-GTAC-3'/3'-CATG-5', _ indicates the
cleavage site)(19, 20). In this model, the bithiazole moiety of BLM intercalates itself 3' to
the first cleavage site with the metal binding domain positioned adjacent to (and within
I--bonding distance of) the guanine 5' to the cleavage site in the minor groove (Figure
1.5A, Chapter 1). To initiate the second cleavage event, BLM rotates around the bond
connecting the two thiazole rings to re-position itself to the second cleavage site, which is
18 A away (Figure 1.6, Chapterl). The rotation is proposed to be triggered by the lesion
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(3'PG/5'P)(20) or its precursor(21) on the first strand.
The reorganization model is straightforward in explaining the staggered-end cleavage
product generated by activated BLM, in which the symmetry of the primary and
secondary cleavage sites requires little re-adjustment of the linker region(19, 20).
However, BLM also mediates blunt-ended ds-cleavage, in which the second cleavage site
is directly opposite the first cleavage site(16) (Figure 1.4, Chapter 1). We have proposed
that the reorganization model can explain both types of ds-cleavage. Computer modeling
by docking BLM-Co(III)-OOH onto duplex DNA containing a 5'-GG Pg PC-3' site (Figure
3.2A), a potential blunt-ended cleavage site whose structure has been solved by 2D
NMR(22), suggests that with a proper adjustment of the linker region, BLM can be re-
positioned to the second cleavage site that is directly opposite to the first cleavage site as
required by the blunt-ended cleavage (Figure 3.2B).
Our model would be more appealing if experimental evidence for the reorganization
required for the blunt-ended cleavage process could be observed. We have previously
provided evidence for our model for ds-cleavage by examining the structure of the
3'PG/5'P lesion generated within a defined DNA duplex using 2D NMR methods and
titrating it with BLM-Co(III)-OOH (Chapter 1, Section 1.6)(23). We have now applied
this methodology in an effort to obtain structural information on the blunt-ended
cleavage. In this chapter, we first identified a "hot spot", 5'-GTCA-3'/3'-CAGT-5' (
indicates the cleavage site), for blunt-ended cleavage using the internally 32 P]-labeled
hairpin DNA technology(24). Duplex DNAs containing this intact "hot spot" and the 5'-
G-PG P-CA-3' lesioned "hot spot" were synthesized and their interactions with BLM-
Co(III)-OOH were studied using D and 2D NMR methods. Titration of the duplex DNA
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containing the 5' -GTCA-3' sequence with BLM resulted in formation of multiple
complexes as revealed by 1D NMR. Analysis of the major species (-60%) by 2D NMR
suggests that BLM binds to the predicted ss-cleavage site by partial intercalation,
consistent with our model.
A
5' ~ 3'CCAAAGGC CTGGG
7 8 9
19 18
G G T T T C C G GA C C C
3' 5'
B
Re-organization..
5' PG f 3'
CCAAAG~i~TGGG
19 18
G G T T T C C G ~A C C C
3' 5'
Figure 3.2 Molecular modeling of BLM-Co(III)-OOH bound to duplex DNA containing
a 3'PG/5'P gap in a blunt-ended ds-cleavage event. A, A cartoon rendition showing the
reorganization in blunt-ended cleavage and the sequence of the 13mer duplex DNA
containing a 3'PG/5'P lesion used in the computer modeling. B, the computer-modeled
structure of the complex in Figure 3.2A (right) after reorganization. The yellow arrow
indicates the OOH group and the white arrow indicates the 4'-H atom (white sphere) of
T 19 to be abstracted.
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Titration the 5'-G-PG P-CA-3' lesion with BLM-Co(III)-OOH, however, resulted in a
mixture of complexes in fast exchange on the NMR time scale, making chemical shift
assignments and structural calculation not possible. These results reflect the complexity
in studying the blunt-ended cleavage event by NMR, which requires tight binding and
homogeneous species in solution. Nevertheless, this chapter presents the first mechanistic
study on the blunt-ended cleavage mediated by BLM. Searching for more favorable
blunt-ended cleavage sites in a larger sequence space and identifying alternative
structural triggers for reorganization are required for future structural studies.
3.2 Experimental section
Materials The oligonucleotides were purchased from Invitrogen Inc. or from Midland
Certified Reagents Co. BLM A2 was purchased from CalBiochem as a metal-free form.
DNA-sequencing gel solutions were purchased from National Diagnostics Co. BLM A2-
Co(III)OOH was prepared and purified following the published procedure(25). The
concentration of BLM-Co(III)-OOH was determined by A2 90 ( 290=2.1 x 10 4 M-'cm-')(25).
D 20 (99.96%) was purchased from Cambridge Isotopes Lab. The semi-preparative
reverse-phase C18 column (Econosil, 250x10 mm, 10 tm) was purchased from Alltech
Co. Other chemicals were purchased from Sigma-Alrich Co.
Determination of ss to ds cleavage ratio using hairpin DNA technology. Five hairpin
DNA oligomers containing blunt-ended cleavage sites (Figure 3.3) were internally 132 P]
labeled (dG in bold, Figure 3.3) following previously published procedures(24). The ss to
ds cleavage ratios by BLM at theses sites were determined as described in Chapter 2.
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C13 T15$ CT 5 A A
5'-CGAATTC GTCA GCGTTTCCC A
GTCA 3'-GCTTAAG CAGT CGCAAAGGG
t * t A A
C34 A29
A37
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GTCC 5'-CGAATTC GTC CTTTCCC A
3'-GCTTAAG G GAAAGGG A
t t A A
A36 A27
A33
G9
|C10 T12
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CGCC 5'-CGAATTC I GGCG TTTCCC A
3'-GCTTAAG CCGC AAAGGGt AAI * A A
A26
C31
A12
C9
$ y ' A A
GTTA 5'-CGAATTCGC TAAC CTTTCCC
3'-GCTTAAGCG ATTG GAAAGGG A
t t AA
C38 A29
T34
T13
C9 C1 I i
A A
GTTT 5'-CGAATTCGCGC GTTI CCC A
3'-GCTTAAGCGCG CA GGG Att t A A
C34 C32 A27
A29
Figure 3.3 Sequences of hairpin DNA containing internal blunt-end cleavage sites. The
predicted ds-cleavage sites are indicated by large arrows and other ss-cleavage sites are
indicated by small arrows. The [32p] labeled dG is in bold. * denotes the putative
secondary cleavage site in the 5'-GTTT-3' sequence.
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Purification of 5 'd(CCAAAGTCATGGG)-3' (1) and 5 'd(CCCATGAC77TGG)-3' (2).
Compound 1 and 2 were synthesized on a 10 ~tmol scale by Invitrogen Inc. with the 5'-
dimethoxytrityl (DMT) group retained to facilitate the purification by reverse phase
HPLC (RP-HPLC). The crude oligonucleotides were purified by RP-HPLC using a
semipreparative C18 column (Econosil C18,10x250 mm, 10 tm from Alltech). Solution
A contained 0.1 M ammonium bicarbonate, pH 8.0. Solution B contained 100%
acetonitrile. The elution was performed with a linear gradient from 10 to 40% B over 30
min and a flow rate 3 mL/min. The fraction containing 5'-DMT oligonucleotides
(retention time: 25 min) were collected and lyophilized to dryness. The 5'-DMT group
was cleaved from the oligonucleotides by dissolving the pellet in 5 mL 80% acetic acid at
25 C for 1 h. DMT was removed from the reaction mixture by extracting the aqueous
reaction solution twice with 5 mL ether. The organic layer containing DMT was
discarded and the aqueous layer was lyophilized to dryness. The purified
oligonucleotides were then re-dissolved in 1 mL deionized water. The yield of 1 (£260:
129.7 mM'cm -1) was 4.2 tmol and the yield of 2 ( 2 6 0 : 118.2 mM-'cm -') was 5.7 mol.
NMR sample preparation of duplex (3) composed of 1 and 2. Equal amounts (1.0 lamol)
of 1 and 2 were mixed in 1 mL solution containing 20 mM HEPES and 1 mM EDTA, pH
7.5 (HE buffer) and were annealed by heating to 95 C, followed by cooling to 20 °C
over 1 h. The resulting duplex (3) was further purified by the anion-exchange HPLC
using a DNAPac 100 semi-prep column (Dionex, 10 x 250 mm). The elution involved
solution A (25 mM HEPES, pH 8.0) and solution B (200 mM NaClO 4, 25 mM HEPES,
pH 8.0) and a linear gradient from 10 to 90% B over 20 min with a flow rate of 3
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mL/min. The fractions containing 3 (retention time: 16.5 min, yield: 91%) were collected
and dialyzed using the Spectra/Por 7 dialysis membrane (molecular weight cutoff: 1000
Da) against 4 x 2 L deionized water changed periodically over 2 days before being
lyophilized to dryness. The sample was then exchanged into D2 0 by lyophilization from
2 x 1 mL 99.96% D2 0 and was re-dissolved in 630 ~tL 99.96% D20. The pH of the
solution was adjusted by adding 70 tL 0.5 M sodium phosphate, pH 6.8 in 99.96% D 20.
The final NMR sample (700 tL) contained 1.27 mM 3 in 50 mM sodium phosphate, pH
6.8.
Titration of 3 with BLM-Co(III)-OOH monitored by ID NMR spectroscopy. For the
titration of 3, BLM-Co(III)-OOH (10 mM in D2 0) was added to 3 (1.27 mM, 700 tL) in
small aliquots. After each addition, a D NMR spectrum was acquired as described
below.
NMR Experiments. All NMR experiments were performed in D 2 0 at 20 °C on a custom-
built 750 MHz or 591 MHz spectrometer at the Francis Bitter Magnet Laboratory. The
raw data were transferred to a Silicon Graphic workstation and were processed using
Felix 2001 (Acceryls Inc.). Proton chemical shifts were referenced to an internal
standard, sodium 3-(trimethylsilyl)-1-propanesulfonate (TSP) at 0.00 ppm. One-
dimensional NMR experiments were performed on a 591 MHz NMR spectrometer with a
spectrum width of 7022.5 Hz. The D spectra were acquired in 32,768 complex points
with 128 scans. The raw D data were exported to Felix 2001 and were processed with
an exponential window function (line broadening of 2 Hz). For 2D NMR experiments,
NOESY (100 and 200 ms mixing times) and TOCSY (60 and 110 ms mixing times)
spectra were recorded on either the 750 MHz or 591 MHz spectrometer. For NOESY and
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TOCSY experiments, datasets of 4096 (t2) x 512 (ti) complex points were acquired with
the spectral width of 8012.4 Hz (750 MHz) or 7022.5 Hz (591 MHz) in both dimensions
and 32 scans per t increment. A presaturation pulse (2 s) was applied during the recycle
delay period to suppress solvent signals in all NMR experiments. In all datasets, tl
dimensions were linear-predicted to 4096 points and the data were processed with an
exponential window function.
Synthesis of 5 (Figure 3.9). The precursor (5, Figure 3.9) to the 3'-PG/5'-P lesioned
duplex DNA (4) with hexaethyleneglycol linkers on each end was synthesized by
Midland Certified Reagents Co. on a 1 tmol scale. Compound 5 was purified by anion-
exchange HPLC as described below (retention time: 20.1 min). The yield of 5 was 0.535
[tmol (53.5 %). Compound 5 was analyzed by the MALDI-TOF MS (IM-H-: 8585.7;
calculated:8589.8).
Oxidation of 5 to 6 Compound 5 was converted to the 3'-PG/5'-P lesioned duplex DNA
following previously published procedures(22, 26). The reaction mixture in a final
volume of 1 mL contained 535 tM 5 and 20 mM NaIO4 and was incubated at 0 °C. The
reaction of 5 was monitored by anion-exchange HPLC using a Dionex DNA Pac-100
analytical ion exchange column (4 x 250 mm). Buffer A contained 25 mM sodium
acetate in 90% water/10% acetonitrile, pH 6.0. Buffer B contained 1 M sodium chloride
in Buffer A. The starting material (5) and the product (6, Figure 3.9) were separated by a
linear gradient from 40 to 55% B over 30 min with a flow rate of lmL/min). Compound 5
and 6 eluted at 20.1 and 20.6 min, respectively. The reaction was completed in 2.5 h and
was quenched at 0 °C by addition of 0.25 mL of 0.2 M methionine in H20. The pH of the
reaction mixture was adjusted to 5.0 by adding 150 ~tL 0.2M NaH2PO4 in H20. To this
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reaction mixture was added 25 [tL of 0.2 M freshly prepared sodium hypochlorite and the
reaction mixture was incubated at 25 °C. The reaction was monitored by anion-exchange
HPLC as described above. Compound 6 and the product, 4, eluted at 20.6 and 24.2 min
respectively. The reaction was completed in 2 h and was quenched by addition of 25 [tL
of 0.2 M Na 2SO 3 in H20. The pH of the reaction mixture was adjusted to 6.0 by adding
100 tL of 0.1 M NaOH. The final product, 4, was purified from the reaction mixture by
the anion-exchange HPLC as described above with a retention time of 24.2 min (yield:
0.324 tmol, 65% starting from 5). The product was collected and dialyzed using the
Spectra/Por 7 dialysis membrane (molecular weight cutoff: 1000 Da) against 4 x 2 L
deionized H 20 changed periodically over 2 d before being yophilized to dryness. The
sample was then exchanged into D2 0 by yophilization in 2 x 1 mL 99.96% D20. The
final NMR sample (300 tL) contained 0.5 mM 2 in 50 mM sodium phosphate, pH 6.8.
The MALDI-TOF MS analysis gave the m/s ([M-HI-) of 8565.8 (Calculated: 8567.3).
Characterization of 4 by enzymatic digestion. Compound 4 (5.6 nmol) was incubated in
a final reaction mixture of 100 FtL containing 0.02 U of snake venom phosphodiesterase I
(PDE-1, Sigma, Catalogue No. P4631, 1 U is defined as the amount of enzyme to
hydrolyze 1.0 tmol bis(p-nitrophenyl)phosphate per min at 37 °C), 100 U DNase
I (Roche, Catalogue No. 10776785001, 1 U is defined as the amount of enzyme to effect
an absorbance increase of 0.001 per min at 260 nm at 25 °C in 1 mL solution containing
40 [tg/mL calf thymus DNA) in 25 mM Tris-HCI, 10 mM MgCI2, pH 7.4. The reaction
mixture was incubated at 37 °C for 2 h and the reaction was quenched by heating the
solution at 95 °C for 5 min. The protein was removed by centrifugation and 20 U calf
intestine alkaline phosphatase (Roche, Catalogue No. 1097075, 1 U is defined as the
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amount of enzyme to hydrolyze 1 tmol 4-nitrophenyl phosphate in 1 min at 37 °C) was
added to the solution. The reaction mixture was incubated at 37 °C for 30 min and the
digestion mixture was analyzed by ion-pair RP-HPLC using an Alltech Adsorbosphere
Nucleotide-Nucleoside column (4.6 x 250 mm). Buffer A contained 60 mM KH2PO4, 5
mM tetrabutylammonium phosphate, pH 4.3 and Buffer B contained 5 mM
tetrabutylammonium phosphate in methanol. The elution was performed with a linear
gradient from 0 to 50% B over 20 min and 50% to 90% B from 20 to 30 min (flow rate 1
mL/min). Compound, retention time: dC, 11.64 min; dG, 14.40 min; T, 14.82 min; dA
16.70 min; dG-phosphoglycolate, 21.71 min; dG-hexaethyleneglycol, 22.84 min. The
peaks were quantified by comparison to four external nucleoside standards (dC, dG, T,
and dA).
Titration of 4 with BLM-Co(III)-OOH monitored by ID NMR spectroscopy. For the
titration of 4, BLM-Co(III)-OOH(4 mM in D20) was added to 4 (0.5 mM, 300 tL) in
small aliquots. After each addition, a 1D NMR spectrum was acquired as described
above.
3.3 Results and Discussion
Choice of sequences for identification of a "hot spot" for blunt-ended cleavage. To test
our model for BLM-mediated blunt-ended cleavage, we sought to identify a DNA
sequence that is optimal (high ds:ss ratio) for blunt-ended cleavage by BLM. Previous
studies by Povirk's group have generated a set of rules for blunt-ended cleavage mediated
by BLM(16, 17). The first cleavage event occurs at a hot spot for ss cleavage and requires
a pyrimidine 3' to the pyrimidine cleavage site, e.g., 5'-G-Py-Py-3' (Py denotes the first
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cleavage site). The second cleavage site is a purine directly opposite to the first cleavage
site and is usually not a good ss cleavage site for BLM. The 5'-CGCC-3' sequence was
suggested by Povirk(16, 21) to be a potential hot spot for blunt-ended cleavage and this
sequence was initially investigated using our hairpin DNA technology(24), which allows
quantitative assessment of the ds:ss cleavage ratio (Figure 3.3). However, in general, the
5'-G-C-Py-3' sequences are not good candidates for studying the second cleavage event
because on the second strand, 3'-C-G-Pu-5', there are two potential cleavage sites. One is
the G opposite the first cleavage site and the second is the C 3' to the G as a ss cleavage
site. Therefore, in addition to the 5'-CGCC-3' sequence suggested by Povirk, we focused
most of our attention to the 5'-G-T-Py-3' sequences. Five such sequences (5'-CGCC-3',
5'-G-T-C-A-3', 5'-G-T-C-C-3', 5'-G-T-T-A-3', 5'-G-T-T-T-3') were synthesized and
characterized, and the ss: ds cleavage ratios were determined.
Table 3.1 Summary of ss to ds cleavage ratios in different sequence contexts that lead to
a blunt-ended products. The underlined base denotes the cleavage site.
Determination of ss to ds cleavage ratios. The internally 132 P]-labeled hairpin DNAs were
generated as previously described(24). The sequences of hairpin DNAs investigated
containing putative blunt-ended cleavage sites are listed in Figure 3.3. The results of
DNA sequencing gel analysis of BLM-mediated cleavage on these internally [3 2 p] labeled
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hairpins are shown in Figure 3.4 to Figure 3.8 and the ss to ds cleavage ratios are
summarized in Table 3.1. One sequence,S' -GICA-3', has a ss to ds cleavage ratio of 1 to
4.0, which is close to the ss :ds ratio for 5' -GTAC-3' (3.4 to 1), a "hot spot" for the
staggered-ended cleavage that we previously studied. Therefore, the 5' -GTCA-3'
sequence was used in further studies on the blunt-ended cleavage process. The second
cleavage site for this "hot spot" (5'-GICA-3') is 5'-TGAC-3'. It has been observed that
5' -G-A-3' can also be a weak ss cleavage site for BLM(15, 16, 24) with the guanine 5' to
this site potentially mediating H-bonding interactions with the pyrimidine group of BLM
(Figure 1.5B, Chapter 1). This result is consistent with our interpretation of previous
studies on the staggered-ended cleavage "hot spot" (5' -GIAC-3' IS' -GIAC-3') suggesting
that having a good ss-cleavage site on each strand promotes the ds-DNA cleavage by
BLM(24).
o 4.5 9 13.5 [BLM] in J,lM
T9/A37 ss
~ ~ (T9+A37) ds
T9
I C13T15
t ~~ A A
GTCA 5'-CGAATTC,CA IGCGTTTCCC
3'-GCTTAAG CAGT CGCAAAGGG A
t • t A A
C34 A29
A37
Figure 3.4 Cleavage of internal e2p]-GTCA hairpin by BLM.
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Figure 3.5 Cleavage of internal e2p]-GTCC hairpin by BLM.
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Figure 3.6 Cleavage of internal [32p]-CGCC hairpin by BLM.
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Figure 3.7 Cleavage of internal [32p]_GTT A hairpin by BLM.
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Figure 3.8 Cleavage of internal [32p]-GTTT hairpin by BLM.
Choice a/duplex DNA (3) containing the blunt-ended cleavage "hot spot" (5'-GT.CA-3j.
The 5'-GICA-3' site was incorporated into a 13mer duplex DNA (3, Figure 3.9). The
sequence flanking the "hot spot" (5' -CCA AAG TCA TGG G-3') has been used in the
previous NMR studies and the chemical shifts information obtained in those studies
would facilitate the assignments in this study (22, 27). Compound 3was prepared by
annealing equal amounts of 1and 2 (Figure 3.9). The purity of 3was confirmed by anion
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exchange HPLC analysis, which showed a single species with a retention time of 13.2
min (Figure 3.10A). Under the same conditions, the ss 13mer 1 has a retention time of
10.4 min (Figure 3.10B). Furthermore, the 1D NMR spectrum of 3 showed sharp peaks in
the base proton region, indicating formation of a stable duplex (Figure 3. 10C).
1 5 10
1 5'-CCAAAGTCATG
2 3'-GGTTTCAGTAC
26 22 t 17
3 (duplex)
5's
.- CCA4>
6G G T
3'
13
GG-3'
CC-5'
14
COO".
0 OPO32-. 3'I I
AAG C A TGGG.,.
6 8 9 
TTCAGTACCC
21 19 5'
OH
HO
5' 0P0 332-
,,,CCAAAG CA
5 i 6 8 9
6G G T T T C A G T
63' 21 19GGTTTCAGT
3' 21 19
3'
T G G G. .
AC C C6
5'
CHO
5' ?
OP03
2
,.,CCAAAG CAT
6 8 96>
64 G GTTT C AGTA
3' 21 19
3'
G G G.,o
C C C
5'
Figure 3.9 Sequence of duplex DNA(3) containing a hot spot for blunt-ended cleavage
and its analog containing a 3'-PG/5'-P gap (4). Compound 3 was prepared by annealing 1
(5'-CCAAAGTCATGGG-3') and 2 (5'-CCCATGACTTTGG-3') in a 1:1 ratio. Arrows
indicate the proposed primary (large arrow) and secondary (small arrow) cleavage site.
Compound 4 was synthesized from its precursor, 5, by two oxidation steps via an
intermediate, 6.
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Figure 3.10 Analytical anion exchange HPLC analysis of 3
spectrum showing the base proton (H8/H6) region of 3 (C).
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Sequence-specific cleavage of 3 by activated BLM was studied on [5' _32p]_3 with the
f2p] label on either strand. Sequencing gel analysis (Figure 3.11) shows that T7 on the
first strand and A7 on the second strand were the predominant cleavage sites, consistent
with the blunt-ended cleavage pattern. Several additional cleavage bands are also
observed under the assay conditions (indicated by * in Figure 3.11). These minor
cleavage sites are either due to hydroxyl radicals or to non-specific cleavage by BLM.
G G+A (+T
'.,;~ G13
\," ',' G12
,...~ "'.T11
. ;'~< T10
','" T9
(8
'~~' A7
.~'f~ 0 G6
L
1 7 13
32p_51-CCAAAGTCATGGG-31
31-GGTITCAGTACCC -51
51- CCAAAGTCATGGG-31
31- GGTIT CAGTACCC-5'_32p
13 7 1r
Figure 3.11 Cleavage of 3 by Fe-BLM. The duplex was 5' _f2p] labeled at either 1 (first
strand) or 2 (second strand). * indicates minor cleavage sites.
Assignment of proton chemical shifts of 3. Chemical shift assignments of non-
exchangeable protons in 3 were carried out using standard TOCSY and NOESY
experiments in order to facilitate the interpretation of future 10 NMR spectra in which 3
is titrated with BLM-Co(III)-OOH. The deoxyribose protons (HI', H2'/2", and H3') of
each residue were assigned using TOCSY experiments. The H4' and H5' 15" were not
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assigned due to signal crowding. The sequential assignments were made using the NOE
connectivities between the base protons (H8/H6, 6.8-8.5 ppm) and sugar protons (HI' or
H2'/2" or H3'). The dispersion of NOE cross peaks and the chemical shift information
from previous studies on duplex DNA with similar sequences(22, 27) facilitated the
assignments. Two typical regions of the NOESY (200 ms mixing time) spectrum are
shown in Figure 3.12 (base protons to methyl protons of T) and Figure 3.13 (base protons
to HI1' protons) to demonstrate the quality of the spectrum. The proton chemical shifts of
3 are summarized in Table 3.2.
0. 
C)m~4E
--
'r'
Ln3
8.1 7.8 7.5
H1 (ppm)
I 
7.2 6.9
Figure 3.12 NOESY (200 ms mixing time) spectrum of 3 showing the connectivity of
methyl protons of T to the base proton (H8 or H6).
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Figure 3.13 The NOESY (200 ms mixing time) spectrum of 3 showing the NOE
connectivity between base (H8/H6) protons and Hi'. The sequence of 3 is shown above
the spectra. The proposed BLM cleavage site, 5'-GTCA-3', is underlined (the large arrow
indicates the primary cleavage site and the small arrow indicates the secondary cleavage
site). The NOE walk was carried out on both top and bottom strands.
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Table 3.2 Proton chemical shift assignments of non-exchangeable protons of 3
H 1I' H2' H2" H3' H8/H6 H5/Me
C1 5.90 2.00 2.43 4.62 7.69 5.90
C2 5.21 1.95 2.21 4.76 7.48 5.65
A3 5.71 2.71 2.80 5.00 8.19
A4 5.82 2.58 2.80 5.00 8.05
A5 5.91 2.58 2.76 4.94 7.93
G6 5.71 2.30 2.59 4.73 7.30
T7 5.94 2.02 2.42 4.80 7.11 1.02
C8 5.53 2.06 2.39 4.81 7.47 5.55
A9 6.16 2.63 2.86 4.97 8.28
T10 5.59 1.75 2.13 4.75 7.01 1.37
Gi11 5.36 2.29 2.59 4.89 7.75
G12 5.72 2.52 2.67 4.91 7.66
G13 6.06 2.28 2.41 4.57 7.68
C14 5.92 2.14 2.50 4.62 7.76 5.91
C15 5.66 2.12 2.43 4.81 7.58 5.61
C16 5.34 2.11 2.36 4.80 7.49 5.65
A17 6.21 2.66 2.88 4.99 8.30
T18 5.57 1.77 2.19 n.d. 6.98 1.39
G19 5.39 2.58 2.64 4.92 7.75
A20 6.14 2.62 2.83 4.96 8.09
C21 5.70 1.91 2.44 4.60 7.17 5.11
T22 5.98 2.11 2.54 4.82 7.34 1.45
T23 6.08 2.11 2.53 4.85 7.42 1.58
T24 5.68 1.91 2.26 4.82 7.26 1.66
G25 5.60 2.62 2.66 4.93 7.82
G26 6.09 2.30 2.45 n.d. 7.75
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Titration of 3 with BLM-Co(III)-OOH. Compound 3 was titrated with BLM-Co(III)-OOH
in D 2 0 and the progress was monitored by 1ID NMR spectroscopy. The methyl proton
region of the D NMR spectra (1.0-2.0 ppm) was particularly useful for monitoring the
progress of the titration (Figure 3.14). The disappearance of T7-Me (Line A, Figure 3.14)
and T24-Me (Line C, Figure 3.14) of 3 was observed concomitantly with the appearance
of a new peak at 1.38 ppm (Line B, Figure 3.14), which was later assigned as T7-methyl
protons in the 3oBLM-Co(III)-OOH complex. The large chemical shift change associated
with T7 (in 5'-GTCA-3') methyl protons is consistent with its expected close proximity to
BLM-Co(III)-OOH. The titration of 3 with BLM-Co(III)-OOH was continued until the
complete disappearance of the peak associated with the T7 methyl protons (Line A,
Figure 3.14). At the end of the titration, most of the methyl peaks appeared broader and
the spectrum of the 3oBLM-Co(III)-OOH complex was much more complicated than that
of 3 before titration (Figure 3.14).
The titration process was also monitored in the region of DNA base protons and
aromatic protons of BLM-Co(III)-OOH (6.6-9.5 ppm, Figure 3.15). During the course of
titration, several new peaks became apparent outside of the usual chemical shift envelope
for DNA base protons (7.0-8.5 ppm) and are labeled by upward arrows in Figure 3.15
(middle). The feature (9.13 ppm) in the downfield region was assigned to the His H2
proton of BLM in the 3oBLM-Co(III)-OOH complex based on previous titration studies.
The His H2 signal consists of a major sharp peak and two minor peaks (Figure 3.15),
indicating that there were more than one species in slow exchange on the NMR time
scale. The formation of the minor complexes was not due to over-titration because they
were present during the entire titration process.
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Figure 3.14 Titration of 3 with BLM-Co(III)-OOH monitored by 1D NMR. The up-field
regions of the spectra are shown. The assignments of methyl proton chemical shifts in 3
are labeled on the top of the spectra. TEA: Trietheylammonium. * indicates the existence
of the multiple complexes. Positions A, B, and C (indicated by the red dashed line) are
used to monitor the progress of the titration (see the discussion in the text).
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Figure 3.15 Titration of 3 with BLMA2-Co(III)-OOH monitored by 1D NMR. The
downfield regions of the spectra are shown. The assignments of base proton chemical
shifts in 3 are labeled on the top of the spectra. Anows indicate four new peaks that
appear during the course of titration. The assignments of bithiazole H5 and H5' protons
are tentative. (His, Hydroxyhistidine, Bit, Bithiazole)
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Characterization of the major species of 3BLM-Co(III)-OOH. TOCSY and NOESY
experiments were performed on the final titration mixture containing a major 3'BLM-
Co(III)-OOH species and 2 minor components. Cross peaks associated with minor
conformations were observed in many regions of the NOESY spectra. The presence of
multiple species, severe line-broadening, and peak-overlap complicated the analysis of
chemical shifts and NOE cross peaks. Only 60% of the non-exchangeable protons in 3
could be unambiguously assigned for the major 3oBLM-Co(III)-OOH species (Table
3.3). In addition, only 10 BLM-Co(III)-OOH protons could be assigned due to spectral
overlap. Figure 3.16 shows two NOE cross peaks associated with His H2 of BLM-
Co(III)-OOH in 3BLM-Co(III)-OOH. These two cross peaks (His H5-Thr Me and His
H5-Val cMe) have also been present in previous structures of BLM-Co(III)-
OOH°DNA(23, 28), but not in free BLM-Co(III)-OOH(25). In addition, cross peaks that
are associated with two other conformations are also present (indicated by arrows in
Figure 3.16). Quantitation of the cross peak volumes suggests that the relative abundance
of the major conformation to the two other conformations is approximately 60: 30: 10.
The presence of multiple conformations and our inability to assign the majority of
protons in 3-BLM-Co(III)-OOH preclude further structural studies.
Despite the complexity, we hoped that NOESY experiments might provide some
insight into the conformation of the bithiazole moiety in the complex. Our model predicts
that the bithiazole group will partially intercalate between T7 and C8 of 3. Previous
studies suggest that this partial intercalative binding mode will produce characteristic
NOE cross peaks between bithiazole H5' and protons associated with T7 and between
bithiazole H5 and protons associated with G19 and/or A20 on the other strand.
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Table 3.3 Proton Chemical shift assignments of 3 in 3oBLM-Co(III)-OOH. Only 60% of
the non-exchangeable protons could be unambiguously assigned due to line broadening
and signal overlapping.
Base H 1I' H2' H2" H3' H8/H6 H5/Me
C1 5.97 7.75 5.94
C2 5.36 2.10 2.38 4.84 7.57 5.71
A3 5.96 2.77 2.96 5.07 8.25
A4 5.78 2.65 2.74 5.05 8.16
A5 6.08 2.45 2.86 5.04 7.90
G6 5.44 2.23 2.61 7.75
T7 5.88 7.21 1.50
C8 5.33 2.18 2.39 7.54 5.70
A9 6.23 2.67 2.89 5.02 8.34
T10 5.65 6.75 1.38
Gll
G12
G13
C14 5.98 7.80 5.95
C15 5.71 7.61 5.65
C16 5.12 7.58 5.92
A17 6.31 2.79 2.95 8.35
T18 5.33 2.18 2.34 7.04 1.43
G19 5.29 2.53 2.59 7.52
A20 6.16 2.65 2.92 8.10
C21 5.41 2.05 2.16 7.21 5.24
T22 5.99 7.47 1.53
T23 5.71 1.85 2.44 7.29 1.71
T24 5.72 1.93 2.29 7.27 1.67
G25
G26
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Figure 3.16 NOEs between His-H2 (9. 13ppm) to Thre-Me (1.21 ppm) and to Val-aMe
(O.65ppm) of ~LM-Co(III)-OOH in the complex. (The arrows denote the peaks
associated with two other conformations).
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1 7 8 13
5'-CCAAAGT CATGGG-3'
3 3'-GGTTTCA GTACCC-5'
26 20 19 14
6.86 ppm (Bit HS')
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Figure 3.17 NOESY (200 ms mixing time) spectrum of 3eBLM-Co(III)-OOH. The
sequence of 3 and the predicted binding mode of BLM-Co(III)-OOH are shown above
the spectrum. The region of base protons (H6/H8) to T-methyl protons is shown. A, the
cross peak between T7-methyl protons and the signal at 6.86 ppm, which is assigned as
the bithiazole H5' proton.
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Figure 3.18 NOESY spectrum (200 ms mixing time) of 3- BLM-Co(III)-OOH showing
the region of base protons (H6/H8) to H2' /H2". The sequence of 3 and the predicted
binding mode of BLM-Co(III)-OOH are shown above the spectrum. Vertical lines are
drawn to connect H2' and H2". A and B, cross peaks associated with the signal at 6.89
ppm.
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Figure 3.19 NOESY spectrum (200 ms mixing time) of3-BLM-Co(III)-OOH showing
the region of base protons (H6/H8) to HI'. The sequence of 3 and the predicted binding
mode of BLM-Co(III)-OOH are shown above the spectrum. Cross peak A and B,
between the signal at 6.89 ppm and G 19 HI' or G 19 H3'. Crosspeak C, between G 19 H8
and G 19 H3'. (Bit,bithiazole)
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It is challenging to assign H5 and H5' protons of the bithiazole moiety because they
are isolated from other spin systems, i.e., they have no through-bond connectivities with
other protons. Previous studies have shown that intercalation of bithiazole between base
pairs causes a large up-field shift of bithiazole protons from 7.82 ppm (H5') and 8.17
ppm (H5) to 6.8-6.9ppm(20, 28), which is upfield from the chemical shift window of
most base protons (7-8.5 ppm). The base proton region in the 1D NMR spectrum of the
3oBLM-Co(III)-OOH reveals three peaks that have chemical shifts less than 7.0 ppm, all
of which are associated with formation of the 3oBLM-Co(III)-OOH complex (Figure
3.15, in a red box). The signal at 6.75 ppm was assigned as the base proton (H6) of T10
based on the NOE connectivities in the base-methyl proton region (Figure 3.17). The
other two peaks at 6.86 ppm and 6.89 ppm are tentatively assigned as H5' and H5 of the
bithiazole protons. Because not all base protons have been assigned, it is possible but
unlikely that these two peaks are associated with the unassigned bases at the termini of 3
(G11, G12, G13, G25, G26). Since these base protons are not adjacent to the proposed
binding site, it is unlikely that their chemical shifts are perturbed from 7.7-7.8 ppm in free
DNA to 6.8-6.9 ppm in the complex. The intensities of the two peaks at 6.86 ppm and
6.89 ppm (Figure 3.15) also suggest that they are unlikely to be associated with the two
minor conformations.
The assignments of the two peaks at 6.89 ppm and 6.86 ppm (Figure 3.15, red box) as
the bithiazole H5 and H5' protons are supported by a number of intermolecular NOE
cross peaks associated with the two signals (Table 3.4). The 6.86 ppm signal shows a
cross peak with T7 methyl protons (cross peak A in Figure 3.17). In addition, the 6.89
ppm signal shows cross peaks with G19 H2'/H2" (cross peak A and B in Figure 3.18) and
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with G19 HI' and H3' (cross peak A and B in Figure 3.19). It is very unlikely that any of
the unassigned base protons (G11, G12, G13, G25, and G26) would produce this NOE
pattern. Based on previous studies of oligonucleotideoBLM-Co(III)-OOH(20, 28), this
NOE pattern is best explained by an intercalative binding mode of the bithiazole tail
between T7-A20 and C8-G19 base pairs.
Table 3.4 Intermolecular NOE interactions between 3 and two protons associated with
signals at 6.89 and 6.86 ppm, which are tentatively assigned as the bithiazole H5 and H5'
protons, respectively.
Intensity
6.89 ppm ( H5) G 19 H1' strong
G 19 H2'/H2" medium
G19 H3' weak
A20 H8 medium
6.86 ppm ( H5') T7-Me medium
Synthesis and characterization of 4 The titration of BLM-Co(III)-OOH with 3 indicated
formation of -60% of a 1:1 complex. NOE information on this 3.BLM-Co(III)-OOH
complex suggests that BLM-Co(III)-OOH binds 3 with the bithiazole tail intercalating
between T7 and C8 as predicted by our model. Test whether the 3'PG lesion in 5'-GTCA-
3' sequence is sufficient to re-position BLM at the cleavage site on the opposite strandas
our model predicts, we prepared compound 4, a duplex DNA containing a 3'PG/5'P gap
(Figure 3.9) from the precursor, 5, by a two-step oxidation procedure. The difference in
retention times of 4, 5, and 6 (Figure 3.9) on anion exchange HPLC chromatography was
used to monitor the course of the reaction (Figure 3.20). The final product of 4 was
purified further by anion exchange HPLC. The nucleoside composition of 4 was
quantitated by complete enzymatic digestion of 4 with DNase I, PDE-1, and alkaline
phosphatase followed by ion-pairing RP-HPLC (Figure 3.21). The relative amount of
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each nucleoside was quantitated and was consistent with the expected ratio (dC: dG: T
dA: dG-PG: dG-hexaethyleneglycol, 7.3: 4.0: 5.3: 6.3: 1.0: 1.8; calculated: 7: 4: 5:
6: 1: 2). The purity and the duplex formation of 4 in the NMR sample were confirmed
by the analytical anion-exchange HPLC, in which a single peak was observed, and by the
ID NMR, in which the base proton region showed sharp peaks with good dispersion
(Figure 3.22). In addition, in the less crowded region of the D NMR spectrum in Figure
3.22 (6.9 ppm - 7.5 ppm, 8.1 ppm - 8.5 ppm), single peaks are observed for each residue,
which further confirms the purity of the sample.
Proton chemical shifts assignment of 4 TOCSY and NOESY experiments were used to
assign the non-exchangeable protons in 4 to help to interpret the subsequent D NMR
titration data. The sequential assignment is exemplified in Figure 3.23, which shows the
NOESY spectrum in the region of base protons (7.0-8.5 ppm) to HI' protons (5.0-6.5
ppm). Analysis of sequential NOE connectivity and cross peak intensities indicated that 4
adopts typical B-type conformation and that a single conformation is observed.
Sequential NOE connectivity was detected from C1 to G6 and from C8 to G13 and the
3'PG/5'P gap introduced the expected break into the NOE walk (Figure 3.23). Sequential
NOE connectivity was also observed on the opposite strand (C14 to G26), especially
from G19 to A20 to C21, in which A20 is the base opposite to the 3'PG/5'P gap. This
result suggests that the unpaired base, A20, stacks between adjacent bases as in B-form
DNA, similar to what we have previously observed for 3'PG/5'P lesions in other
sequence contexts(22). The proton chemical shift assignments of 4 are summarized in
Table 3.5.
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Figure 3.20 Oxidation of 5 to 4 monitored by analytical anion exchange HPLC. A,
aliquot from the first oxidation reaction mixture containing 1 nmol 5. (* denotes a small
amount of 6 formed before HPLC analysis.) B, aliquot from the second oxidation
reaction mixture containing 1 nmol 6. (the arrow denotes a small amount of 4 formed
before HPLC analysis.) C, aliquot from the second oxidation reaction mixture containing
1 nmol 4.
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Figure 3.21 Ion-pair RP-HPLC analysis of complete enzymatic digestion mixture of 4 by
PDE-1, DNase I followed by alkaline phosphatase treatment. (EG)6, hexaethyleneglycol;
PG, phosphoglycolate.
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Figure 3.22 Analytical anion exchange HPLC analysis of the NMR sample of 4 (2 nmol)
(top) and the 1ID NMR spectrum of 4 showing the base proton region (bottom).
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Figure 3.23 NOESY spectrum (200 ms mixing time) of 4 showing the NOE connectivity
between base protons (H8/H6) to HI' protons. The sequence of 4 is shown above the
spectra.
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Table 3.5 Proton chemical shifts assignment of non-exchangeable protons of 4.
H 1I' H2' H2" H3' H8/H6 H5/Me
C1 6.010 2.323 2.482 4.843 7.752 6.017
C2 5.288 2.002 2.269 4.811 7.515 5.769
A3 5.791 2.817 2.881 5.073 8.286
A4 5.819 2.635 2.812 5.066 8.154
A5 5.957 2.488 2.776 5.006 7.996
G6 5.826 2.460 2.502 4.963 7.666
PG
C8 5.822 2.103 2.484 4.880 7.824 6.019
A9 6.279 2.786 2.955 5.050 8.432
T 10O 5.674 1.869 2.237 4.834 7.148 1.468
G11i 5.495 2.632 2.673 4.970 7.822
G12 5.645 2.539 2.644 5.000 7.722
G13 6.129 2.699 2.591 4.993 7.928
C14 6.054 2.382 2.523 4.866 7.786 6.017
C15 6.004 2.198 2.479 4.887 7.572 5.732
C16 5.429 2.191 2.430 4.878 7.579 5.735
A17 6.298 2.757 2.935 5.059 8.387
T18 5.707 1.796 2.212 4.820 7.074 1.547
G 19 5.707 2.456 2.503 4.921 7.705
A20 6.144 2.628 2.667 4.919 8.098
C21 5.834 2.106 2.492 4.869 7.574 5.757
T22 6.139 2.273 2.629 4.905 7.540 1.680
T23 6.160 2.182 2.641 4.915 7.538 1.739
T24 5.735 1.950 2.260 4.878 7.350 1.776
G25 5.503 2.654 2.681 4.880 7.879
G26 6.171 2.723 2.632 5.004 7.980
Titration of 4 with BLM-Co(III)-OOH monitored by ID NMR. Titration of 4 with BLM-
Co(III)-OOH did not lead to an apparent formation of 1:1 complex. Figure 3.24 shows
the downfield region of 1ID NMR spectra containing base protons of DNA and aromatic
protons of BLM-Co(III)-OOH (6.5-9.5 ppm). During the course of titration, the D NMR
spectra showed evidence of several conformations without a predominant one. This is
apparent in the region around 9.2 ppm, in which the chemical shift of His H2 proton of
BLM-Co(III)-OOH in the DNAoBLM-Co(III)-OOH complex is located. A sharp peak
and two broad peaks are apparent (Figure 3.24). Another region of interest is between 6.5
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and 7 ppm, where the two bithiazole protons (Bit H5 and Bit H5') are expected to appear
upon complex formation with DNA. Several broad features are observed in contrast to
the titration of BLM-Co(III)-OOH with 3 (Figure 3.15). None of these features could be
assigned to specific protons due to lack of NOE interactions with assignable protons from
the 2D NMR experiments.
Previous studies by Oppenheimer et al.(29) and recent studies by our group(23)
suggest that lesioned DNA could increase binding affinity of BLM-Co(III)-OOH relative
to a similar intact sequence. If the 3'PG/5'P lesion made a tighter binding to BLM-
Co(III)-OOH, then the titration of 4 by BLM-Co(III)-OOH would have worked well.
Compared to the 5'-GPG PAC-3'/5'-GTAC-3' sequence that we used previously in titration
studies to obtain a 1: 1 complex(23), the second cleavage site in the blunt-ended cleavage
hot spot, 5'-GPG PCA-3'/5'-GATC, is a weaker ss cleavage site. The ss to ds ratio
measured for 5'-GTCA-3', 4.0 to 1, indicates that the cleavage at the second strand is less
frequent than for the 5'-GTAC-3' sequence (ss to ds ratio 3.4 to 1). In addition, our ds-
DNA cleavage model predicts that the observed ss to ds cleavage ratio reflects the
relative rates of re-organization versus dissociation from DNA. Thus, the blunt-ended
cleavage with a pyrimidine 3' to the 5'-G-Py-3' cleavage site is inherently a rarer event in
comparison to the staggered ds cleavage sites. Our data reveals that the affinity of
between 4 and BLM-Co(III)-OOH is not strong enough to form a 1:1 complex on the
NMR time scale. Thus, no structural model is accessible. The "hot spot" for blunt-ended
cleavage in this study was chosen from a very limited sequence space, it is possible that
there are other hot spots that would be superior for structural studies. New methods to
screen for ds-cleavage "hot spots", such as those recently developed by Boger et al.(30),
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would allow the analysis of the robustness of Povirk's rules for ds-cleavage and may
provide an oligonucleotide sequence amenable to the method described in this chapter.
4 : BLM-Co{III)-OOH
1 :0
1 : 0.5
9.3 9.0 8.7 8.4 8.1 7.8 7.5 7.2 6.9
Hl (ppm)
Figure 3.24 Titration of 4 with BLM-co(III)-OOH monitored by ID NMR spectroscopy.
The regions containing the base protons are shown below. * indicates the existence of
multiple conformations
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3.4 Conclusion
A "hot spot" for blunt-ended ds-cleavage by BLM (5'-GTCA-3'/3'-CAGT-5') was
identified by the internal [32p]-hairpin DNA technology and was used in an effort to
obtain structural insight into the mechanism of the blunt-ended ds-DNA cleavage that is
proposed to be mediated by a single BLM molecule. Titration of 3 with BLM-Co(III)-
OOH resulted in formation of multiple complexes as revealed by 1ID NMR methods.
Analysis of the NOE pattern of the major species suggests that BLM-Co(III)-OOH binds
to the predicted cleavage site by partial intercalation. Titration of 4 with BLM-Co(III)-
OOH also resulted in a mixture of complexes. However, in this case, the complexes were
in fast exchange on the NMR time scale, which precluded structural determination. We
propose that the problems encountered in obtaining a stable 1: 1 complex of DNA°BLM-
Co(III)-OOH are related to the low frequency of the ds-cleavage events relative to the ss-
cleavage. The minor amounts of "complex of interest" remain challenging to
characterize. Identifying more favorable blunt-ended cleavage sites by exploring a larger
sequence space could benefit future mechanistic studies on the blunt-ended ds-cleavage
by BLM.
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Chapter 4. Synthesis and Characterization of duplex DNA containing a 4'-oxidized abasic site
4.1 Introduction
Bleomycins (BLMs) are natural products used clinically in combination with other drugs in the
treatment of a variety of cancers(1). The cytotoxicity of the BLMs is thought to be related to
their ability to bind to duplex DNA and generate both single-stranded (ss) and double-stranded
(ds) DNA lesions via oxidative damage to the deoxyribose backbone(2, 3). Cleavage of DNA
requires the presence of both ferrous iron and 02, the cofactors thought to be required for BLM's
activity in vivo. The difficulty in repairing the ds-lesions has suggested that they are
predominantly responsible for the therapeutic efficacy of the BLMs(4, 5). The sugar damage
generated by BLMs is initiated by 4'-hydrogen atom abstraction from a pyrimidine 3' to a
guanine(6). The resulting 4'-radical can lead to two types of damage depending on the
availability of 02 (Figure 4.1). Under anaerobic conditions, a 4'-oxidized abasic site is generated
which remains part of an intact DNA strand(7, 8). In the presence of 02, a 4'-peroxy radical is
generated which eventually leads to a gapped 3'-phosphoglycolate/5'-phosphate lesion (3'-PG/5'-
P) and elimination of a pyrimidine propenal (base propenal, Figure 4.1)(9). Both types of lesions
are also generated by ionizing radiation and by other natural products such as the enediynes(10).
DNA lesions result from altered nucleic acid bases as well as deoxyribose sugars. DNA
lesions generated by BLM are specifically localized to the sugars (Figure 4.1). If the lesions are
left unrepaired, they may give rise to mutations and ultimately disease(11). Most of the work in
this area has focused on base lesions(12-14). However, estimations based on radiolysis of DNA
suggest that 10 to 20% of the damage is associated with the deoxyribose backbone and
subsequently, frank or indirect DNA strand cleavage(15, 16). The structures of a number of
oxidatively damaged sugars resulting from ionizing radiation(17, 18), chemical oxidants(19), and
a variety of antitumor agents(4, 20) have been characterized. The recent development of more
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sensitive analytical and mass spectrometric methods suggest that additional sugar damage will
likely be identified, a requirement to understand the physiological consequences of the lesions
and the mechanisms of their repair(21).
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Figure 4.1 BLM-mediated DNA cleavage pathways.
Our interest in the mechanism of cytotoxicity of the BLMs has recently led us to develop
synthetic methods to generate gapped 3'-PG/5'-P lesions and to study their structures by 2D
NMR methods(22). As noted in Figure 4.1, BLM also generates 4' -oxidized abasic sites.
However, synthesis of this type of lesion has been challenging due to their chemical instability ..
In this chapter, a convenient synthesis of the 4'-oxidized abasic site lesion has been developed
using a combination of synthetic and enzymatic methods (Figure 4.2), and the characterization of
its stability under physiological conditions is reported. Furthermore, this synthetic method has
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been used to incorporate a 4'-oxidized abasic site into a 13-mer duplex DNA on a [tmol scale
that is suitable for structural studies (Chapter 5) by 2D NMR methods. Our ability to generate
these lesions in any sequence context and knowledge of their structure should facilitate our
understanding of the mechanism of recognition by DNA repair enzymes.
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Figure 4.2 Synthesis of a 4'-oxidized abasic site lesion from 4'-N 3-dUTP using HIV-1 RT and
UDG. The sequences of 3, 4, 5, 6 and 7 are listed in Table 4.1. N: 4'-N3-dU.
4.2 Experimental Section
Materials The oligonucleotides were synthesized by the MIT Biopolymers Laboratory or by
Invitrogen Inc. The following extinction coefficients were calculated as reported(23)
(Compound, 260): 1, 124.3 mM-lcm-'; 2, 132.5 mM-lcm-'; 3, 144.8 mM-lcm-l; 4, 274.0 mM-lcm-t ;
5,333 mMlcm-'; 6, 210 mM-t cm-1; 7, 201 mM-lcm-'; 8 or 9, 242 mM-lcm-1; 12, 62 mM-lcm-l; 13,
115.9 mM-'cm-'; 14, 184.5 mM-lcm-1; 15, 129.3 mM-'cm-'; 16, 121.2 mM-lcm-t ; 17, 174.7 mM-
cm -' (Table 4.1 and 4.2). N,O-bis(trimethysilyl)trifluoroacetamide (BSTFA),
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trimethylchlorosilane (TMCS), and tris-(2-carboxyethyl)-phosphine (TCEP) were purchased
from Pierce. All other chemicals were purchased from Sigma-Aldrich Co.
Table 4.1 Sequences of the oligonucleotides used for developing synthetic methodology.
Sequence information *
5'-AAA AXA AAA-3'
5'-AAA AUA AAA-3'
5'-CTG AGC TCC AAA G-3'
5'-CTG CCG GCC CGG TAC TTT GGA GCT CAG-3'
5'-CTG
3'-GAC
AGC TCC AAA GNA CCG
TCG AGG TTT CAT GGC
4
GGC CGG CAG-3'
CCG GCC GTC-5'
5'-CTG AGC TCC AAA GNA CCG GG-3'
5'-CTG AGC TCC AAA GYA CCG GG-3'
5'-CTG AGC TCC AAA GYA CCG GG-3'
3'-GAC TCG AGG TTT CAT GGC CC-5'
5'-CTG AGC TCC AAA GXA CCG GG-3'
3'-GAC TCG AGG TTT CAT GGC CC-5'
* X: a normal abasic site. N: 4'-N 3-dU. Y: a 4'-oxidized abasic site. The underlined sequence
denotes the NgoM IV recognition sequence and indicates the cleavage site.
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Table 4.2 Sequence information of oligonucleotides used for preparing the NMR samples
containing a 4'-oxidized abasic site. *: N: 4'-N3 dU. X: a 4'-oxidized abasic site. **: the
calculated values are in parentheses).
MALDI-Sequence* MALDI-TOF MS**
12 5'-CCA AAG-3' 1786.31(1786.23)
3942.4713 5'-CCC GGT ACT TTG G-3' 3942.47(3942.62)
4348.105'-biotin-13 5'-Biotin-CCC GGT ACT TTG G-3' 4347.62)(4347.62)
14 5'-CCA AAG NAC CGG G-3'
3'-GGT TTC ATG GCC C-biotin-5'
3995.7415 5'-CCA AAG NAC CGG G-3' 3995.74
(3996.60)
3877.47
16 5'-CCA AAG XAC CGG G-3' 3877.47
(3877.52)
17 5'-CCA AAG XAC CGG G-3'
3'-GGT TTC ATG GCC C-5'
E. coli uracil-DNA glycosylase (UDG, 1 U releases 60 pmol uracil per min from ds uracil-
containing DNA), DNA polymerase I-Klenow fragment (1 U converts 10 nmol dNTPs to an
acid-insoluble form in 30 min at 37 °C), and NgoM IV (1 U digests 1ing adenovirus-2 DNA in 1
h at 37 °C) were purchased from New England Biolabs. Alternatively, UDG was purified
subsequent to expression from pET21a-UDG kindly supplied by Dr. James Stivers, Johns
Hopkins University, as previously described(24). Nuclease P1 (1U catalyzes the hydrolysis of 1
rmol phosphodiester linkage in yeast RNA in 1 min at 37 C) and alkaline phosphatase from calf
intestine (AP, 1 U catalyzes the hydrolysis of 1 tmol of 4-nitrophenyl phosphate in 1 min at 37
°C) were purchased from Roche. HIV-1 reverse transcriptase (HIV-1 RT, 1 U incorporates 1
nmnol dNTP in 20 min at 37 C, pH 8.3) and snake venom phosphodiesterase-1 (PDE-1, 1 U
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hydrolyzes 1 tmol p-nitrophenyl thymidine-5-phosphate in 1 min at 25 C, pH 8.9) were
purchased from Worthington Biochemical Co. Alternatively, HIV-1 RT was purified following
the published protocol(25) from E. coli DH5c containing the p66(his)/51 plasmid (provided by
Dr. Paul Boyer and Dr. Stephen Hughes, National Cancer Institute). AMV reverse transcriptase
(AMV RT, 1U incorporates 1 nmol TMP into acid-insoluble product in 10 min at 37 C) was
purchased from USB. RAV-2 reverse transcriptase (RAV-2 RT, 1 U incorporates 1 nmol TMP
into acid-insoluble product in 10 min at 37 C with poly (rA)/polyT as the primer/template) was
purchased from Amersham Pharmacia Biotech. Human polymerase P (1U incorporates 1 nmol
dNTP into acid-insoluble product in 1 h at 37 C) was purchased from Trevigen. Yeast formate
dehydrogenase (FDH, 1 U oxidizes 1.0 ~tmol formate to CO2 per min using at pH 7.5, 37 °C) was
purchased from Sigma.
Ethanol precipitation of oligonucleotides was carried out in a volume of 1 mL by adding 0.3
M sodium acetate, pH 5.2 and 71.4% (v/v) ethanol. The mixture was incubated at -80 °C for 1 h
and was centrifuged at 10,000 g for 30 min. The supernatant was decanted and the pellet was
washed with 500 [tL ice-cold 75 % ethanol. The mixture was centrifuged again at 10,000 g for
30 min. The supernatant was removed and the pellet was dried in vacuo.
Reverse-phase HPLC (RP-HPLC) was carried out using a Nucleotide-Nucleoside Column
(Alltech, 250 mm x 4.6 mm). Two different chromatographic elution programs were used. The
first (System A) involved solution A (50 mM ammonium acetate, pH 7.0) and solution B
(methanol) using a linear gradient of 0-50%B over 30 min with a flow rate of 1 mL/min. The
second (System B) involved solution A (60 mM KHPO4, 5 mM tetrabutylammonium phosphate,
pH 4.7) and solution B (5 mM tetrabutylammonium phosphate in methanol) using a linear
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gradient of 0-50% B over 20 min and 50-90% over an additional 10 min with a flow rate of 1
mL/min.
Anion-exchange HPLC was carried out using a DNAPac 100 column (Dionex, 250 mm x 4
mm). The elution (System C) involved solution A (25 mM HEPES, pH 8.0) and solution B (200
mM NaCIO4 , 25 mM HEPES, pH 8.0) using a linear gradient of 25-100% B over 15 min with a
flow rate of 1 mL/min.
The GC/MS experiments were carried out on a Hewlett-Packard Agilent 5973N with an HP
Restek Rtx-1 column (30 m x 250 ~tm x 1 tm). The oven temperature was maintained at 100 °C
for 5 min followed by a linear gradient of 100 °C to 250 °C over the next 15 min.
Matrix-assisted laser desorption/ionization (MALDI)-mass spectrometry (MS) experiments
were carried out on a Bruker Daltonics OminiFlex MALDI-TOF mass spectrometer. The
MALDI matrix solution was prepared by mixing 2 volumes of 52.5 mg/ml 3-hydroxyl-picolinic
acid in 50% acetonitrile/water (v/v) with 1 volume of 0.1 M diammonium citrate. Samples
containing -200 pmol oligonucleotide were loaded onto 10 tL C18 ZipTip (MilliPore) and were
desalted by washing twice with 20 tL H20. The desalted oligonucleotides were eluted with 1 ptL
MALDI matrix solution and were spotted on the target. The instrumental parameters were: ion
source 1, 19 kV; ion source 2, 17 kV; lens, 8.6 kV; extraction time, 200 ns; sample rate, 1 per ns.
The detector was set in a linear, positive mode.
Synthesis of 5'-AAA AXA AAA-3' (1, X denotes an abasic site) as a control. 1 (Table 4.1) was
synthesized by treating crude 5'-AAA AUA AAA-3' (2) with UDG. The reaction mixture
contained in a final volume of 200 tL: 178 nmol 2, 20 mM Tris-HCl (pH 8.0), 1 mM EDTA, 1
mM DTT, and 100 U UDG. The reaction was allowed to proceed at 37°C for 4.5 h. 1 was
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purified by RP-HPLC System A. (Compound, retention time, yield: uracil, 7.8 min, 114 nmol; 1,
20.2min, 110 nmol).
Reduction of 1to 1a by NaBH4 or NaBD 4 and enzymatic digestion of 1a with Nuclease PI and
AP (Figure 4.3). 1(20 nmol) was incubated with 50 mM NaBH4 in 100 mM Tris-HCl (pH 8.3),
in a total volume of 200 ~L at 4 °C for 30 min. Acetic acid (20 ~L) was added to neutralize the
reaction mixture and la was separated by RP-HPLC System A. (Compound, retention time,
yield: la, 20.3 min, 19.2 nmol).
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Figure 4.3 Characterization of oligonucleotides containing an abasic site (1) or a 4'-oxidized
abasic site (7) by enzymatic digestion followed by GCIMS. Similar experiments have been
performed with NaBD4' 1d and 7d were subjected to GCIMS analysis.
Nuclease PI digestion of 18 was carried out in a final volume of 100 ~L containing: 15 nmol
la, 0.1 M NaOAc, pH 5.3, 0.1 mM ZnCI2, and 15 U Nuclease Pl. The reaction mixture was
incubated at 37°C for 1 h. The mixture was then diluted to 200 ~L containing 50 mM Tris-HCl
(pH 8.5), 0.1 mM EDTA, and 20 U AP. The incubation was carried out at 37°C for 30 min. The
reaction was stopped by heating the reaction mixture at 95 °C for 10 min. The protein was
removed by centrifugation and the products were separated by RP-HPLC System A to give the
compound, retention time, and yield: 1b, 17.4 min, 12 nmol; dA, 21.0 min, 85 nmol.
159
Alternatively, the products of the enzymatic digestion of la (5 nmol) were analyzed by RP-
HPLC System B to give the compound, retention time, and yield: dA, 14.9 min, 27.4 nmol; lb,
19. lmin, 4.3 nmol.
The reduction of 1 by NaBD4 and the subsequent enzymatic digestion were carried out under
the same conditions as described above. The ESI-MS ([M-H]-) for lb (NaBH4 ): calcd,
448.1239, found, 448.1231; lb (NaBD4): calcd, 449.1302; found 449.1301.
GC/MS analysis of 2-deoxy-pentitols (Ic) derived from lb. lb (8 nmol) was incubated in 50 mM
Tris-HCI (pH 8.3), 10 mM MgCI2 and 2 U PDE-1 in a total volume of 20 tL. The reaction was
allowed to proceed at 37 C for 2 h. The reaction was stopped by heating the reaction mixture at
95 C for 10 min. The protein was removed by centrifugation. Half of the reaction mixture was
subjected to RP-HPLC (System B) and the product was found to co-elute with 5'-dAMP. The
other half was lyophilized and transferred to a 0.3 mL reaction vial (Pierce) by dissolving in
methanol followed by evaporating to dryness in vacuo. c (4 nmol) was silylated with a 20 tL
1:1 acetonitrile:BSTFA (with 1% TMCS) at 100 °C for 30 min to produce ld (Figure 4.3). An
aliquot (1 tL) of the silylation mixture was then analyzed by GC/MS. ld was eluted at 17.4 min
(224 °C).
Synthesis of 4'-azido-2'-deoxyuridine-5'-monophosphate (4'-N3-dUMP). 4'-Azido-2'-
deoxyuridine (4'-N 3-dU) was synthesized as previously reported(26). It was converted to 4'-N3-
dUMP using a modification of the method of Yoshikawa et al.(27). 4'-N3-dU (50 mg, 0.186
mmol) was dissolved in 0.5 mL of freshly distilled triethylphosphate. Freshly distilled POCI3
(74.6 tL, 0.80 mmol) was then added dropwise with stirring at 4 °C. The reaction mixture was
slowly warmed to room temperature and stirred for an additional 12 h. The mixture was then
diluted into 50 mL of ice cold water and titrated with NaOH until the pH was between 7 and 7.5.
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The 4'-N 3-dUMP was purified on a DEAE Sephadex A-25 column (2.5 cm x 22 cm) using
a linear gradient of 0-0.4 M triethylammonium bicarbonate (TEAB, 1L x 1L). The flow rate was
2.7 mL/min and the fraction size was 28 mL. 4'-N3-dUMP eluted at 0.25 M TEAB and the
fractions were pooled and concentrated in vacuo until the triethylamine was removed. The
product was characterized by H NMR: (D 20, HDO = 4.81 ppm, 6): 2.48 (2H, m, H2'/H2"), 4.09
(2H, m, H5'/H5"), 4.59 (1H, m, H3'), 5.81 (1H, d,J = 7.9 Hz, H5), 6.33 (1H, m, HI'), 7.71 (1H,
d, J = 7.9 Hz, H6). The overall yield was 50%.
Synthesis of 4'-azido-2'-deoxyuridine-5'-triphosphate (4'-N3 -dUTP). 4'-N3-dUTP was prepared
from 4'-N 3-dUMP via the method by Hoard and Ott(28). 4'-N3-dUMP (34 rmol) was dissolved
in 0.5 mL DMF and tributylamine (8.1 tL, 34 ~tmol) was added. The solvent was removed in
vacuo and the salt was rendered anhydrous by evaporation with dry DMF (4 x 0.25 mL), dry
pyridine (2 x 0.25 mL), and dry DMF (2 x 0.25 mL). The resulting product was then dissolved
in 0.3 mL DMF and 27.5 mg 1,1'- carbonyldiimidazole (171 tmol) in 0.3 mL of DMF was
added. The reaction mixture was stirred for 12 h at room temperature under argon. Then, 272
[trnol of H 2 0 in 9.8 ~tL H2 0/DMF (1:1) was added and the reaction mixture was stirred for
another 30 min at room temperature. Tributylammonium pyrophosphate (169.9 tmol) in 2 mL
DMF, which was prepared following the published procedure(28), was added and the reaction
mixture was stirred for an additional 24 h. The supernatant was collected and the precipitate was
washed 5 times with 0.5 mL DMF. The combined supernatant and washes were mixed with 5 ml
methanol and the solvent was removed in vacuo. The pellet was dissolved in 15 mL cold water.
The product was purified on a DEAE Sephadex A-25 column (2.5 cm x 15 cm) with a linear
gradient (0.65 L x 0.65 L, 0 to 0.8 M) of TEAB, pH 8.5. The flow rate was 3 mL/min and the
fraction size was 17.5 mL. The major peak eluted at 0.6-0.68 M TEAB. The fractions were
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pooled and concentrated in vacuo. The product was characterized by H NMR (D 2 0, HDO =
4.81 ppm, 6): 2.52 (2H, m, H2'/H2"), 4.25 (2 H, m, H5'/H5"), 4.83 (1 H, m, H3'), 5.93 (1 H, d, J
= 8.1 Hz, H5), 6.42 (1 H, m, H1'), 7.85 (1 H, d, J= 8.1 Hz, H6). The yield of 4'-N 3-dUTP was
50%.
Incorporation of 4'-N3-dU into duplex DNA using a primer/template extension method. The
reaction mixture contained in a final volume of 1 mL: 10 tM primer (3, Table 4.1), 10 ~tM
template (4, Table 4.1), 1 mM dNTPs (dATP, dGTP and dCTP), 0.1 mM 4'-N3-dUTP, 50 mM
Tris-HCI (pH 8.3), 50 mM KCI, 10 mM MgCI2, 0.5 mM DTT and 300 U HIV-1 RT. 3 and 4
were annealed by heating at 100 °C for 5 min followed by cooling to room temperature over 1 h
before dNTPs and HIV- 1 RT were added. The reaction mixture was incubated at 37 °C and the
reaction was monitored using 15'-32 PJ-3. Aliquots were taken (2 tL) at various incubation times
and analyzed by a 12% sequencing gel (35 cm x 42 cm). The gel was run at constant power of 90
W for 3 h and was then dried, exposed to a storage phosphor screen (Molecular Dynamics, now
Amersham Biosciences), and visualized on a Storm 840 PhosphorImager (Molecular Dynamics,
now Amersham Biosciences). The reaction was complete in 2 h and the product, 5, was
separated from the reaction mixture by ethanol precipitation.
Isolation of ss oligonucleotide containg 4'-N3-dU (6, Table 4.1)from ds 5. ss-DNA is required
for UDG to remove uracil from 4'-N3-dU. 5 was designed with an NgoM IV restriction site
(Table 4.1). The reaction mixture of 200 [tL contained 5 (5 nmol), 120 U NgoM IV in a buffer
(50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, and 1 mM DTT, pH
7.9) and was incubated at 37 °C for 12 h. 6 (Table 4.1, 20-mer) was separated from its
complimentary strand (24-mer) on a 12% polyacrylamide gel (20 cm x 20 cm) at constant
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voltage of 350 V for 2 h. The gel was visualized by UV shadow. 6 was recovered from the gel in
50% yield.
Removal of uracilfrom 6 using UDG. The reaction mixture of 160 tL contained 10 FM 6, 160 U
UDG, 20 mM HEPES, pH 8.0, and 1 mM EDTA. The reaction was incubated at 37 °C and uracil
release was monitored by RP-HPLC System A (Compound, retention time: uracil, 7.8 min, 6,
23.0 min, 7, 21.5 min). The reaction was completed in 2 h.
Quantitation of azide release using formate dehydrogenase (FDH). The release of azide was
monitored using the procedure by Blanchard and Cleland(29). The assay mixture in 500 tL
contained: 1.7 mM sodium formate, 10 mM NAD+, 100 mM HEPES (pH 7.5) and 0.025 U FDH.
The rate of the reaction was measured by change in A 3 40nm (£ = 6.2 mM -' cm-'). A standard curve
was generated by addition of various amounts of azide (50 to 200 nM) to the reaction mixture
and the decrease in rate was plotted against the azide concentration. To quantitate the azide
release during the conversion of 6 to 7, 6 (3.2 nmol) was treated with UDG under the conditions
described above. The reaction mixture was analyzed by RP- HPLC System A. Uracil was
quantitated and the flow-through of the column (retention time 2.5 min to 3.5 min, 1 mL) was
collected. Aliquots were added to the FDH assay mixture and the azide concentration was
quantitated by the inhibition based on the standard curve.
Reduction of 7 to 7a by NaBH4 or NaBD4 and digestion of 7a by Nuclease P1 and AP.
Compound 7 (2.2 nmol) was reduced by NaBH4 under the conditions described above for the
abasic site control. The reaction mixture was neutralized by addition of 20 tL acetic acid and the
reduced product, 7a, was purified by RP-HPLC System A to give the compound, retention time,
yield: 7a, 21.7 min, 2.0 nmol.
163
7a was then digested by Nuclease P1 and AP as described above (Figure 4.3). 7b has a
retention time identical to thymidine using RP-HPLC System A. Therefore, 7b was isolated
using ion-pairing RP-HPLC (System B). 7b was yophilized and desalted using RP-HPLC
System A. Its retention times were identical to lb in both RP-HPLC System A and System B.
The reduction of 7 by NaBD4 and the subsequent enzymatic digestion were carried out under the
same conditions as described above.
Conversion of 7b to 2-deoxypentitol (7c) and 5'-dAMP followed by GC/MS analysis. 7b (2.0
nmol) was digested with PDE-1 and silylated to give 7d as described above for the abasic site
oligonucleotide. 7d was eluted at 17.4 min (224 °C).
Stability of the duplex DNA (8) containing a 4'-oxidized abasic site. 8 (10 gM) was generated by
annealing 7 with its complementary strand in 100 mM NaCl and 10 mM sodium phosphate (pH
7.0) at 70°C for 1 min followed by cooling to 20°C in a heat block over 1 h. Compound 8 was
incubated at 37 C and aliquots were analyzed by anion exchange HPLC at 10 h intervals from 0
to 70 h. The stability of the abasic site lesion (9, Table 4.1) in the same sequence context was
monitored under identical conditions.
Incorporation of 4'-N3dU into a 13mer duplex DNA (14 in Table 4.2) by HIV-1 RT The reaction
mixture of 25 mL contained 40 [tM primer (12, Table 4.2), 40 ~tM template (5'-biotin-13, Table
4.2), 1 mM dNTPs (dATP, dGTP and dCTP), 40 ~tM 4'-N3-dUTP, 50 mM Tris-HCl (pH 8.3), 50
mM KCl, 10 mM MgCl2, 0.5 mM DTT, and 1 tM HIV-1 RT. The primer (12) and the template
(5'-biotin-13) were annealed by heating the reaction mixture at 55 C for 5 min followed by
cooling to 4 C over 1 h before dNTPs and HIV-1 RT were added. The reaction mixture was
incubated at 10 C and the reaction progress was monitored by the analytical anion-exchange
HPLC using 5 tL aliquots as described above (Compound, retention time: 12, 6.5 min; 5'-
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biotin-13, 13.8 min; partially extended primer/template, 15.0 min; 14, 16.2 min). The reaction
was complete in 48 h.
Isolation of 13-mer single-stranded (ss) DNA containing 4 '-N3dU (15, Table 4.2) The primer-
extension reaction mixture from the previous step (25 mL) was loaded onto a column (1.5cm x 6
cm) containing 10 mL streptavidin-agarose resin (Sigma-Aldrich Co.) equilibrated with HE
buffer (20 mM HEPES, lmM EDTA, pH 7.0) at 4 °C. The column was washed with 20 mL HE
buffer twice at 4 °C. The ss-product, 15, was then eluted with 20 mL HE buffer at 75 °C in an
incubator. The average yield of 15 from the starting primer/template is 95%. MALDI-TOF
MS analysis of 15 indicated the incorporation of 4'-N3-dU ([M+H]+ observed, 3995.74;
calculated, 3996.60).
Conversion of 15 to 13-mer ss-DNA containing a 4'-oxidized abasic site (16) by UDG. The
reaction mixture of 2 mL contained 400 FtM 15 and 6 tM UDG in HE buffer. The reaction was
incubated at 37 °C and uracil release was monitored by the preparative RP-HPLC (Compound,
retention time: uracil, 6.2 min; 16, 16.8 min). The reaction was complete in 6 h and the average
yield of 16 was 85-90%.
Preparation of duplex DNA (17, Table 4.2)for analysis by 2D NMR methods A 1:1 ratio of 13
(0.65 ffmol) in 1 mL deionized water was added directly into the RP-HPLC fractions from the
previous step (22.5 mL containing 0.65 ftmol 16, 50 mM ammonium acetate, pH 7.0, and 20%
acetonitrile). The mixture was heated to 55 °C for 1 min and was cooled to 4 °C over 1 h to give
17. The solution was then dialyzed extensively against 4 x 2 L deionized water periodically
changed over 2 days. The solution containing 17 was evaporated in vacuum to reduce the total
volume to 2 mL. Compound 17 was further purified by the preparative anion-exchange HPLC as
described above. The fractions containing 17 were combined and dialyzed against 4 x 2 L
165
deionized water over 2 days. The sample was then exchanged into D 2 0 by lyophilization in 3 x 1
mL 99.996% D20 (Cambridge Isotopes). Compound 17 (2.0 mM) in 325 tL of 10 mM sodium
phosphate, 0.2 mM EDTA, pH 6.5 was used for NMR studies.
Reduction of 14 and 15 by tris-(hydroxymethyl)-phosphine (THMP). The reduction of 14 or 15
by THMP was carried out in a reaction mixture of 200 tL contained 20 tM 14 or 15 (4 nmol), 1
mM THMP, and 50 mM ammonium acetate, pH 6.8. The reaction was incubated at 37 C for 2 h
and uracil release was monitored by RP-HPLC System A (Compound, retention time: uracil, 7.8
min, 15, 16.3 min, product from 15, 14.9 min, product from 14, 18.3 min). The product of the
reduction reaction from 15 was analyzed by MALDI-TOF MS.
4.3 Results
Incorporation of 4'-N3 -dU into duplex DNA. Two general methods have been developed to
incorporate nucleotide analogs into oligonucleotides. The most widely used strategy is
generation of the appropriately blocked phosphoramidite of the unnatural nucleoside and use of
solid phase DNA synthesis methods(30) to generate ss-DNA. The second requires chemical
synthesis of the nucleoside 5'-triphosphate analogs and use of a primer/template and a DNA
polymerase to make duplex DNA. The latter method is often required when the nucleotide
analog phosphoramidites are unstable to the solid phase methods. Both approaches have been
reported for incorporation of 4'-azidothymine into oligonucleotides. Gibson et al. reported the
synthesis of 4'-azidothymidine phosphoramidite and its incorporation into ss-DNA by the
standard solid phase DNA synthesis method(31). Unfortunately, neither the starting material, 4'-
azidothymidine phosphoramidite, nor the final oligonucleotide product was characterized. In our
hands, 4'-N3-dU is not stable to the concentrated ammonia conditions required to remove
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oligonucleotide from the solid support. Therefore, this approach for incorporation of 4'-N3-dU
into DNA is problematic.
The studies of Chen et al. showing that 4'-azidothymidine-5'-triphosphate can be incorporated
into duplex DNA using HIV-1 reverse transcriptase(32), suggested that the
primer/template/polymerase approach for incorporation of 4'-N3-dU would be successful.
Incorporation of unnatural nucleotides using polymerases often encounters problems with either
slow incorporation or slow extension subsequent to incorporation. Recently, the simultaneous
use of two DNA polymerases has been applied to overcome these shortcomings(33).
We investigated a number of DNA polymerases (including Klenow fragment, AMV RT,
human DNA polymerase 3, RAV-2 RT, and HIV-1 RT) for their efficiency of incorporation of
4'-N3-dUTP and extension into duplex DNA. The Klenow fragment failed to incorporate 4'-N3-
dUTP under all conditions. AMV RT could incorporate 4'-N3-dU, however, extension resulted in
significant amounts of truncated products. Human DNA polymerase 3, RAV-2 RT, and HIV-1
RT were all found to incorporate 4'-N3-dUTP and to generate complete duplex DNA. The ability
to isolate large amounts of HIV-1 RT from an over-expression system and its efficiency at
incorporation and extension to generate intact duplex DNA was the basis for our choice of HIV-
1 RT for further studies.
Using [5'-32 P]-(3) as the primer and 4 as the template (Table 4.1), the time dependent
incorporation of 4'-N 3-dUTP into an oligonucleotide by HIV-1 RT was monitored by PAGE
(Figure 4.4). The gel reveals some stalling in extension of the primer subsequent to the
incorporation of 4'-N3-dU. However, in 2 h, all of the primer can readily be converted to product
(Figure 4.5, lane 2). The overall yield of 5 was 95%. The actual primer extension product is one
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nucleotide longer than the template due to the terminal nucleotide addition activity of HIV -1 RT
(Figure 4.4, lane 6)(34).
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Figure 4.4 Monitoring incorporation of 4' -N3dU into duplex DNA using primer [S'_32P]_3and
template 4 with HIV-I reverse transcriptase. Lane 1, [S'_32P]_3(I3mer); Lane 2-6, 0, 10,20,30
and 60 min incubation time; Lane 7, [S'_32P]-27meras a MW marker. At 2 h, all stalled
oligonucleotides were converted to product (see Figure 4.S).
Isolation of 6 from 5 (Table 4.1). Our strategy to generate 4'-oxidized abasic site is shown in
Figure 4.2. The key step is to use UDa to remove uracil, generating a 4'-azido abasic site
intermediate that we predicted would rapidly lose azide to generate the desired lesion. Previous
studies of Lindahl and Stivers have demonstrated that both ss- and ds-DNA containing
deoxyuridine are substrates of UDa with ss-DNA being hydrolyzed 20 times more efficiently .
than ds-DNA(35, 36). Our efforts to use UDa to convert 4'-NrdU to a 4'-oxidized abasic site in
duplex DNA, however, were unsuccessful. No uracil release was observed even with lS0,000
times the amount of enzyme used in the cleavage of uracil from deoxyuridine and extended
incubation times. Thus, to use UDa to release uracil, we needed to separate the two strands of
the duplex.
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To achieve this separation, one end of the duplex DNA (5) was designed to contain an NgoM
IV cleavage site (Table 4.1). Digestion of the duplex with this restriction endonuclease resulted
in production of two oligonucleotides: a 24-mer and the desired 20mer (6). The size difference
was sufficient for strand separation using denaturing PAGE. The bands were visualized by "UV
shadow" as shown in Figure 4.5. Compound 6 was purified from the gel by the "crush and soak"
method in 50% overall recovery. NgoM IV digestion also eliminated the variable end of the
extended primer, present due to HIV-l RT's non-templated nucleotide addition activity. The
MALDI-TOF MS analysis of 6 showed [M+H] : 6155.65 (calculated: 6154.97). To further
characterize 6, it was digested with nuclease PI and AP. The resulting nucleosides were analyzed
by RP-HPLC System A, giving ratios of dC/dG/T/4'-N3-dU/dA as 5.5:6:2.1: 1.1:4.9, consistent
with the expected ratios (6:6:2: 1:5, Figure 4.6).
1 2 3
Figure 4.5 Denaturing PAGE allows separation of ss-DNA containing 4' -N3dU from its
complement subsequent to treatment of the duplex DNA with NgoM IV. Lane 1: The primer (3)
only. Lane 2: The primer extension reaction mixture containing the intact duplex (5) which is a
27mer. Lane 3: The two ss-DNA fragments generated by restriction enzyme digestion: a 24mer
and one 20mer (6). In addition, unreacted duplex is also present in Lane 3.
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Figure 4.6 Characterization of 6 via digestion with Nuclease P1 and AP followed by separation
of the resulting nucleosides by RP-HPLC (Solvent system A).
Conversion of 6 into a 4'-oxidized abasic site containing oligonucleotide (7) by UDG. The
isolated ss-6 was incubated with UDG to determine whether the desired 4'-oxidized abasic site
containing oligonucleotide (7) could be generated. Uracil release, monitored by HPLC (Figure
4.7), was quantitative. However, the amount of UDG required for efficient uracil release was
3,000 fold greater than that used to quantitatively generate uracil from deoxyuridine in the same
sequence context. The product, 7, was analyzed by MALDI-MS. The [M+H] + observed was
6033.21, suggesting that the product is a ring-closed or a ring-opened 1'-hydrated aldehyde
(calcd: 6033.03). No ring-opened, unhydrated species (calcd: 6015.02) was detected. Previous
studies examining an abasic site labeled at Cl' with 13C and 170 revealed that the aldehydic (ring-
opened) form and its hydrate constituted less than 1% of total species, with the majority of the
abasic site being a ring-closed mixture of ct/3 anomers(37, 38). Based on the MALDI-MS
analysis and these previous studies on the normal abasic site, we propose that the dominant form
of 7 is the ring-closed hemiacetal.
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Figure 4.7 Conversion of 6 into 7 concomitant with formation of uracil release as monitored by
reverse phase HPLC. The void volume of the column was analyzed for azide release. (* denotes
the partially degraded products)
Quantitation of azide release during the conversion of 6 to 7. Our synthetic scheme (Figure 4.2)
predicts that a stoichiometric amount of azide should accompany uracil release. Previous studies
of Blanchard and Cleland have shown that azide is a potent inhibitor of formate dehydrogenase
with K = 7 nM(29). A standard curve for azide inhibition of FDH was generated (Figure 4.8).
The flow-through of the RP-HPLC column was used in the FDH assay to quantitate the azide
release. Comparison of inhibition caused by the azide in the flow-through relative to the standard
curve revealed that azide and uracil were released in a 1:1 ratio.
Enzymatic digestion of 7 and GC/MS analysis of the deoxypentitols (7c). The structure of the 4'-
oxidized abasic site (7) was further characterized as outlined in Figure 4.3 following the strategy
of Rabow et al.(8). An abasic site standard (1) was characterized as a control for the sequence of
reactions described in Figure 4.3. 7 was converted to 7a by reduction with NaBH4 (or NaBD4).
7a was enzymatically digested into its nucleoside components using Nuclease P1 and AP. The
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-products were then analyzed by ion-pairing RP-HPLC (System B), giving ratios of
dC/dG/T/dA/7b as 5.5:6.0:2.0:4.0:0.9, consistent with the expected ratios of 6.0:6.0:2.0:4.0:1.0
(Figure 4.9). 7b co-migrated with an authentic sample of this species generated from the
digestion of the abasic site control (lb).
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Figure 4.8 Quantitation of azide release during the conversion of 6 to 7 by the FDH inhibition
assay. *, Standard azide concentrations; x, azide released via UDG reaction.
To further support the structural assignment of 7b, it was hydrolyzed by PDE-1 to produce 2-
deoxypentitol (7c) and 5'-dAMP. 7c was silylated and GC/MS analysis revealed two products
(7d) associated with the diastereomers resulting from reduction of the ketone group at C4'. The
mass spectrum of both products revealed a fragmentation pattern identical to that observed with
Id (Figure 4.10). The mass spectrum of NaBD4 reduced 7d unambiguously established the
incorporation of two deuterium atoms: one at Cl' and the second at C4' (Figure 4.10). The MS
data in conjunction with the degradation studies establish that the 4'-oxidized abasic site lesion
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can be generated in 50% yield from the starting primer/template. More recently, the overall yield
has been improved to -90% by using a biotinylated template to facilitate the separation of the
template from the ss-product (see the discussion below).
C0o
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Figure 4.9 Ion-pair RP-HPLC (System B) of the products generated when 7 was reduced by
NaBH4 followed by digestion with Nuclease P1 and AP.
Stability of a duplex DNA (8) containing a 4'-oxidized abasic site relative to an abasic site in the
same sequence context (9). As with abasic sites, 4'-oxidized abasic sites are also chemically
labile. The ring opened, aldehydic form of this compound has been proposed to be susceptible to
elimination of the 3'-phosphate and, consequently, DNA strand scission(39). A preliminary
experiment was carried out to examine the stability of this lesion under conditions that mimic
physiological pH and ionic strength. The elimination process was monitored using anion
exchange chromatography under conditions in which the duplex DNA remained intact. The
stability of the duplex DNA containing a normal abasic site (9, Table 4.1) in the same sequence
context as 8 was also examined under the same conditions. The result establishes that the 4'-
oxidized abasic site, which has a half-life of 26 h, is chemically more labile than the abasic site,
which has a half-life of 130 h (Figure 4.11).
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Figure 4.10 GC/MS of trimethylsilylated 2-deoxy-pentitol generated from NaBH4 and NaBD4
reduced abasic sites (ld, top) or 4' -oxidized abasic sites (7d, bottom).
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Figure 4.11 Stability of a duplex DNA containing a 4'-oxidized abasic site (8) monitored by
anion exchange HPLC. A: HPLC profiles of 8 incubated at 37 °C in 50 mM NaPOi, 100 mM
NaCI at pH 7.0 for 0, 10 and 20 h. * indicates the hexameric ss-oligonucleotide (10) and the
arrow indicates the 13-mer/20-mer duplex (11, C). B: A plot of In % remaining 8 versus time (h).
The degradation of 8 is pseudo-first order with a kapparent 2.7 x 10 -2 h-' (t,12 = 26 h). C: Proposed
structures of degradation products of 8 as observed by anion exchange HPLC.
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Synthesis of J 3mer duplex DNA containing a 4'-oxidized abasic site (17, Table 4.2) for structural
characterization by 2D NMR methods To generate the 4' -oxidized abasic site in a 13mer duplex
DNA, a hexameric oligonucleotide primer (12) was annealed to a 13-mer template (5' -biotin-13,
Table 4.2) at 4°C. The melting temperature of the resulting primer/template pair was estimated
to be'" 15°C. Therefore, the 4' -N3dU incorporation and the subsequent primer extension were
performed at 10°C. The reaction was monitored using [5'_32P]_12 and DNA sequencing gel
analysis (Figure 4.12). Alternatively, the progress of the reaction was monitored by analytical
anion-exchange HPLC. Under the assay conditions, the starting material, the partially extended
product, and the final full-length product had distinct retention times, which allowed monitoring
of the progress of the reaction (Figure 4.13). The reaction was completed in 48 h.
2 3 4 5
Figure 4.124' -N3dU incorporation and primer extension reaction catalyzed by HIV -1 RT and
monitored by 5'_[32p] labeled primer, 12. Lanes 1-5, extension reaction quenched at 0,3,6, 17,
48 h. (* denotes the over-extended product, usually an extra adenosine at 3', due to HIV-l RT's
terminal nucleotidyltransferase activity.)
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Figure 4.13 4'-N 3dU incorporation and primer extension reaction catalyzed by HIV- RT
monitored by anion-exchange HPLC. (* denotes the over-extended product, usually an extra
adenosine at 3', due to HIV-1 RT's terminal nucleotidyltransferase activity.)
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Our previous method to separate two DNA strands in the ds product containing 4'-N 3dU
involved time-consuming steps of restriction enzyme digestion, denaturing polyacrylamide gel
electrophoresis, and extraction of ss DNA from the gel. This procedure suffered from a low yield
and was only suitable for obtaining -nmol amounts of ss-products. For the preparation of
material on the ~tmol scale for structural studies, a biotin tag was incorporated at the 5' of the
template strand. Subsequent to completion of chain extension, the mixture from the primer
extension reaction was passed through a column containing streptavidin-agarose resin at 4 °C.
The column was washed with HE buffer to remove HIV-1 RT and unincorporated dNTPs. The ss
product (15) was isolated from 14 by eluting the column with HE buffer at 75 °C (the Tm for 14
was calculated to be -45 °C). The incorporation of 4'-N 3dU into 14 and 15 was confirmed by
complete enzymatic digestion with Nuclease P1 and alkaline phosphatase followed by the
quantitation of individual nucleosides using RP-HPLC (Figure 4.14 B and C, respectively). The
results showed that the incorporation of 4'-N3dU is stoichiometric: the ratio of dC: dG :T :4'-
N3 dU: dA for 14 was 7.9: 8.1:4.0:1.0: 5.1 (calculated, 8: 8 :4: 1: 5) and for 15 was 4.0:
4. 1: 0:0.95: 4.1 (calculated, 4:4:0: 1: 4).
Conversion of 15 to 16 by UDG was monitored by RP-HPLC. The reaction was complete in
6 h and the conversion was quantitative (Figure 4.15). MALDI-TOF MS analysis of 16 indicates
a species with a m/s (IM+Hl+) value of 3877.47, which is consistent with a ring-closed
hemiacetal (calculated: 3877.52).The final NMR sample of duplex DNA (17) was obtained by
mixing a 1:1 ratio of 16 and 13, heating the mixture to 55 °C for 1 min, and cooling to 4 °C over
1 h. Compound 17 was further characterized by reduction with NaBH4 followed by digestion
with Nuclease P1 and alkaline phosphatase. The resulting nucleosides were analyzed by ion-
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pairing RP-HPLC, giving ratios of dC/dG/T/dA/7b as 7.9:8.0:4.1:4.0:0.9, consistent with the
expected ratios of 8.0:8.0:4.0:4.0:1.0 (Figure 4.16).
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Figure 4.14 Incorporation of 4'-N3dU confirmed by nucleoside composition analysis using
complete enzymatic digestion of oligonucleotides followed by RP-HPLC analysis. A:
Nucleoside standards. B: Nucleoside composition of 14. C: Nucleoside composition of 15. The
sequences of 14 and 15 are also shown in each panel (N: 4'-N3dU).
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Figure 4.15 Conversion of 15 to 16 monitored by analytical RP-HPLC.
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Figure 4.16 Ion-pairing RP-HPLC analysis of the nucleosides from the duplex DNA 17 after it
was reduced by NaBH4 followed by digestion with Nuclease P1 and AP.
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4.4 Discussion
4'-Oxidized abasic sites are common DNA lesions generated by ionizing radiation damage, the
BLMs, and the enediynes. The preparation of these lesions has posed a synthetic challenge due
to their chemical instability. During the course of the study, Kim et al. reported a chemical
synthesis of a phosphoramidite stable to standard solid phase DNA synthesis, which upon
photolysis, can generate a 4'-oxidized abasic site(39). This light-mediated method involves a
seven-step synthesis of the phosphoramidite precursor from deoxyribose with an overall yield of
9%. The mixture of 4'-diastereomers makes spectroscopic analysis of each synthetic step
difficult. While no details of oligonucleotide synthesis were presented, chain extension of the
"unnatural C4' diastereomer" during the solid phase synthesis is expected to be less efficient. In
addition, conversion of the precursor to the 4'-oxidized abasic site by photolysis at 300 nm
causes non-specific photo-mediated damage to DNA, which makes this method problematic to
generate the 4'-oxidized abasic site on a large scale or in vivo.
We also have focused on the generation of a precursor to the 4'-oxidized abasic site.
Subsequent to its incorporation into DNA, this precursor could be transformed into the desired
lesion by under mild conditions to avoid the problem of DNA strand scission or non-specific
DNA damage. Ideally, we also want to generate the lesion inside the cell and study its
physiological consequences.
The success of 3'-azido thymidine (AZT) as an AIDS therapeutic resulted in synthesis of a
number of other azido modified nucleosides including 4'-azido nucleosides(26). These
compounds appeared to be potential precursors to the 4'-oxidized abasic site if a polymerase
could be identified to catalyze their incorporation into DNA. Previous studies of Chen et al. (32)
and recent studies with other unusual nucleotides(40, 41) suggested that HIV-1 RT is sufficiently
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promiscuous not only to incorporate the modified nucleotides, but also to catalyze chain
extension to generate full-length duplex DNA. Once incorporated, several routes were
envisioned that could lead to the desired product without phosphodiester bond cleavage. As
noted above (Figure 4.6 and 4.14), incorporation proceeds efficiently and quantitatively.
To examine the generation of the desired lesion, we first investigated reductants such as
thiolates and water-soluble phosphines(42). Reduction of 4'-azido group should result in the
generation of a 4'-amine, which could potentially collapse to a 4'-imine abasic site (Figure 4.17).
The 4'-imine could then be hydrolyzed to a ketone and ammonia. Reduction proceeded rapidly
with a variety of thiolates. Unfortunately, due to the basic conditions required to generate
thiolates, the rate of phosphodiester bond cleavage was comparable to the rate of the azide
reduction. This approach was consequently abandoned.
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Figure 4.17 Proposed mechanism to generate 4'-oxidized abasic sites from 4'-N 3dU via the
reduction of the 4'-azido group.
A water soluble phosphine, tris-(2-carboxyethyl)-phosphine (TCEP), was also examined as a
potential reductant (the Staudinger reaction)(42). The reduction proceeded rapidly and efficiently
on the nucleoside (4'-N 3-dU). When this nucleoside was within the context of DNA, however,
the rate of reduction was drastically reduced, presumably due to the electrostatic clash between
the DNA and the carboxylate groups of TCEP.
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To circumvent this electrostatic problem, a non-charged water-soluble phosphine, tris-
(hydroxymethyl)-phosphine (THMP), has also been tested for the direct reduction of the azide
within the duplex. THMP was shown to release uracil from both 15 and 14 (Figure 4.18 B and C,
respectively). However, MALDI-TOF analysis indicated that the THMP-reduced product
([M+H]+: 3957.02) from 15 is inconsistent with the expected product, 16 ([M+H]+: 3877.52,
Table 4.2).
The identity of the THMP-reduced product from 14 was also investigated by treating the
product with NaBH4 followed by enzymatic digestion with Nuclease P1 and alkaline
phosphatase. The nucleosides were analyzed with ion-pair RP-HPLC (Figure 4.19). The resulting
HPLC profile, when compared with those from 4'-oxidized DNA prepared by the UDG
treatment (Figure 4.9 and Figure 4.16), indicated that none of the expected Compound 7b
(Figure 4.3) was present.
0.12 A 1
0.08
0.04
0
0 5 10 15 20 25
Retention Time (min)
0.3
0.2
0.1 Uracil
0 
0 5 10 15 20 25
Retention Time: (min)
I
8 cI
I
I
5
Retention time (min)
Figure 4.18 Reduction of 4'-N3dU-containing DNA by THMP monitored by RP-HPLC. A: 15
alone. B: Reaction of 15 with THMP. C: Reaction of 14 with THMP.
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Figure 4.19 Ion-pairing RP-HPLC analysis of the nucleosides from the duplex 14 after it was
treated with THMP, reduced by NaBH4 , and digested with Nuclease P1 and AP. The expected
retention time (21.7 min) under these conditions is indicated by the arrow.
These results prompt us to re-examine the mechanisms of the reduction by THMP (Figure
4.20). According to the mechanism of the Staudinger reaction(43, 44), THMP would react with
the 4'-azido group first to generate a 4'-iminophosphorane-dU intermediate (I, Figure 4.20).
Species I could collapse after releasing uracil to generate a 4'-iminophosphorane abasic site (II).
Alternatively, species I could be hydrolyzed to generate 4'-amino-dU, which would collapse to a
4'-amino abasic site (IV and V) after uracil release. Both mechanisms could explain the uracil
release observed experimentally (Figure 4.18). Species II might also be hydrolyzed to a 4'-amino
abasic site. Ideally, the 4'-amino abasic site would be converted to the desired 4'-oxidized abasic
site after hydrolysis of the 4'-imino residue in the ring-open form (IV).
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The M+HI + value measured for the reduction product from 15 ([M+H]*: 3957.02) showed a
+79.5 shift from the value expected for 16 (M+H+: 3877.52), which currently cannot be
assigned to any intermediate in this proposed mechanism. It is likely that species II, IV, or V
could undergo further rearrangement. Further characterization of the reduction product generated
with THMP is essential to modify the reaction conditions so that desired lesion can be generated.
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Figure 4.20 Proposed mechanisms for the reduction reaction of 4'-N3dU-containing DNA by
THMP (R: -CH2OH).
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Because of the problems associated with chemical reduction, we focused our effort on the
enzymatic conversion by UDG. This reaction leads directly to uracil release and subsequently
azide release, generating the desired product (Figure 4.2). While previous studies have shown
that both ss- and ds-DNA containing deoxyuridine are substrates of UDG, the reduced reactivity
of 4'-N3-dU with UDG has limited the substrate to ss-DNA. Therefore, we use the biothinylated
template to facilitate the isolation of ss-DNA from the ds-DNA product using the streptavidin-
agarose column and elution under denaturing conditions. With this technical improvement, we
are able to generate this lesion in vitro in quantities sufficient for structure determination and
analysis with DNA repair enzymes.
The half-life of a 4'-oxidized abasic site was measured by Kim et al. and found to be 7.8 h (37
°C, 100 mM NaCI at pH 7.5) in ss-DNA(39). The rate constant is faster by a factor of three
relative to the one we have measured in ds-DNA (26 h at 37 °C, 100 mM NaCI at pH 7).
Although the pH conditions and the sequences are different in the two studies, we believe duplex
DNA stabilizes the lesion. A similar effect of DNA structure has recently been reported for the
2-deoxyribonolactone abasic site lesion(45). Its half-life was found to be 20 h in ss-DNA and 32-
54 h in ds-DNA (37°C, 150 mM NaCI, 2 mM MgCl2 at pH 7.5)(45). Stability of sugar lesions,
not surprisingly, appears to be sensitive to both sequence and sequence context (ss versus ds).
It is desirable to generate the 4'-oxidized abasic site in duplex DNA in vivo. As noted above,
our attempts, thus far, have failed to directly generate the lesion in duplex DNA. It has not been
reported whether the photolysis method can generate this lesion in duplex DNA. In addition, the
photolysis would cause unwanted DNA damages and trigger UV-induced responsed inside the
cells. In our case, we are hopeful that, given the availability of a variety of 4'-azido-substituted
deoxynucleotides (U, G, T, A, and C)(26), mismatch repair DNA glycosylases will allow
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generation of 4'-oxidized abasic sites in duplex DNA(46). If one of these enzymatic approaches
is successful, the lesion could be generated in vivo, which is not possible by the light-mediated
approach. Otherwise, our method will require transformation of ss-DNA into the cells(47, 48).
Oxidative damage occurs to both the bases and the sugars of DNA(I1). Damage to the bases
and the mutagenic consequences of this damage have been much more extensively
investigated(12-14) than damage to the deoxyribose sugars. Previous studies have been reported
on the generation of 4'-oxidized abasic sites using BLM (Figure 4.1)(49, 50). Unfortunately, the
cleavage of DNA by BLMs is not very sequence-specific and consequently, generation of the 4'-
oxidized abasic site at the primary site also results in lesions at secondary sites. The difficulty of
preparing this lesion homogeneously using BLMs has thus limited its examination with DNA
repair enzymes. Studies of Demple et al. on a 36-mer containing a single 4'-oxidized abasic site
generated with BLM have demonstrated that Apel can catalyze phosphodiester bond cleavage 5'
to the lesion, resulting in a 3'-OH end and a 5'-phosphorylated-lesioned deoxyribose(50).
Although a detailed kinetic analysis was not carried out, the efficiency of cleavage was
suggested to be similar to Apel catalyzed reaction on an abasic site.
Recently, using the phosphoramidite approach, the 4'-oxidized abasic site has been studied
with a variety of DNA polymerases(51). The results suggest that DNA polymerases in E. coli
preferentially incorporate an A opposite to the 4'-oxidized abasic site. In addition, the 4'-
oxidized abasic site also induced an unusual three-nucleotide deletion(52). Our ability to
generate the 4'-oxidized abasic site lesion in any sequence context now allows us to understand
the structure of the lesions (both ss- and ds-lesions) and the efficiency with which they are
repaired by Apel and 3-polymerase and to further characterize other repair proteins.
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Chapter 5. Structures and dynamics of duplex DNA containing a 4'-oxidized and a normal abasic
site
5.1 Introduction
Bleomycins (BLMs) are clinically important chemotherapeutic agents for the treatment of a
variety of cancers(l). BLMs are proposed to cause cancer cell death by generating both single-
stranded (ss) and double-stranded (ds) DNA lesions(2-4). Cleavage of DNA requires the presence of
both ferrous iron and 02, which generates the "activated BLM" that is responsible for the oxidative
damage to the deoxyribose sugar of DNA (Figure 5.1). The sugar damage is initiated by 4'-H atom
abstraction from a pyrimidine 3' to a guanine(5). The resulting 4'-radical intermediate can lead to
two types of DNA damage products: a gapped 3'-phosphoglycolate/5'-phosphate lesion (3'-PG/5'-
P)(6) under 0 2-rich conditions and a 4'-oxidized abasic site under 02 -depleted conditions(7,
8)(Figure 5.1). The knowledge of how these lesions are recognized and repaired in vivo is essential
to understanding the cytotoxicity and drug resistance of BLM in cancer cells.
Our group has been interested in the 4'-oxidized abasic site lesions, which is a common DNA
damage product generated by a variety of agents, including BLM(7, 8), enediynes(9, 10), and
reactive oxygen species(11). Recently, we have developed a synthetic method to generate the 4'-
oxidized abasic site in any sequence context (Chapter 4)(12). In this method, a precursor, 4'-azido-
deoxyuridine, is incorporated site specifically into the primer using a defined template by HIV-1
reverse transcriptase and, subsequent to strand separation of the duplex product, is converted to the
4'-oxidized abasic site using uracil-DNA glycosylase. During the course of our study, the Greenberg
group reported a chemical synthesis of a phosphoramidite precursor to the 4'-oxidized abasic site
that was stable to the standard solid phase DNA synthesis. Upon photolysis, this precursor can
generate the 4'-oxidized abasic site (13). This light-mediated reaction is slow and can cause
photolytic DNA damage, which limits its application to in vitro studies on a small scale. The ability
to generate an 4'-oxidized abasic lesions in duplex DNA by our method thus offers the opportunity
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to study their physiological consequences in DNA repair and mutagenesis in vitro and in vivo(14,
15).
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Figure 5.1 Pathways of BLM-mediated DNA cleavage. (3'PG/5'P, 3'-phosphoglycolate/5'-
phosphate)
In humans, the 4'-oxidized abasic sites are thought to be recognized and repaired by Apel,
which is part of the base excision repair (BER) pathway (Figure 1.8, Chapter 1)(16). The
predominant substrate for Apel in vivo is duplex DNA containing an abasic sites, generated by
spontaneous base loss or repair of damaged bases by DNA glycosylases(17). Questions remains as
to how DNA repair enzymes like Apel specifically recognize DNA lesions such as normal or 4'-
oxidized abasic sites.
In this chapter, we present the first solution structural study using 2D NMR methods on duplex
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DNA containing the 4'-oxidized abasic site (denoted by X), d(CCAAAGXACCGGG)od(CCC
GGTACTTTGG) (1). As a comparison, the structure of the duplex DNA containing a normal abasic
site (denoted by Y) in the same sequence context, d(CCAAAGYACCGGG)od(CCC
GGTACTTTGG) (4), has also been determined. Using NMR derived restraints, a structural model
of 1 has been determined, in which the deoxyribose is a ring-closed hemiacetal in the a anomeric
state. Both the abasic deoxyribose and the opposite base in 1 are intrahelical. Two structural models
have also been determined for 4: one of the a anomer at the abasic site (4a) and the other of the 3
anomer at the abasic site (4p). With both 4a and 4p, the abasic site is partially extrahelical without
significant distortion of the DNA backbone and the base opposite the abasic site is well stacked
within the duplex DNA. Molecular dynamics calculations using the NMR structures suggest that the
normal abasic site (4ac and 41) is conformationally more flexible than the 4'-oxidized abasic site (1).
These structural studies are the first step to understanding the mechanism(s) of recognition of these
lesions by DNA repair enzymes.
5.2 Experimental Section
Material The oligonucleotides were synthesized on a 10-tmol scale by Invitrogen Inc. and were
further purified by the anion-exchange HPLC as described below. E. coli uracil-DNA glycosylase
(UDG) was purified from expression plasmid pET21a-UDG kindly supplied by Dr. James Stivers,
Johns Hopkins University, as previously described(18). All other chemicals were purchased from
Sigma-Aldrich Co.
High performance liquid chromatography (HPLC) to analyze the purity of or to purify
oligonucleotides The analytical reverse-phase HPLC (RP-HPLC) was carried out using a
Nucleotide-Nucleoside column (Alltech, 250 mm x 4.6 mm). The standard chromatographic elution
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program involved solution A (50 mM ammonium acetate, pH 7.0) and solution B (methanol) and a
linear gradient from 0% to 50% B over 30 min with a flow rate of 1 mL/min. The preparative RP-
HPLC was carried out using an Econosil C18 column (Alltech, 10 tm, 250 mm x 10 mm). The
elution program involved solution A (50 mM ammonium acetate, pH 6.8) and solution B
(acetonitrile) and a linear gradient from 0% to 40% B over 20 min with a flow rate of 3 mL/min.
Analytical anion-exchange HPLC was performed on a DNAPac 100 column (Dionex, 250 mm x 4
mm). The elution involved solution A (25 mM HEPES, pH 8.0) and solution B (1 M NaCI, 25 mM
HEPES, pH 8.0) and a linear gradient from 30% to 60% B over 20 min with a flow rate of 1
mL/min. The preparative anion-exchange HPLC was carried out using a DNAPac 100 semi-prep
column (Dionex, 250 mm x 10 mm). The elution was identical to that described above except that
the flow rate was 3 mL/min.
Preparation of 1 (Table 5.1)for analysis by 2D NMR methods The synthesis and characterization of
1 was described in Chapter 4. Compound 1 (2.0 mM) in 325 tL of 10 mM sodium phosphate, 0.2
mM EDTA, pH 6.5 (D20 or 10% D2 0/ 90% H2 0 (v/v)) was used for NMR studies.
Preparation of 4 (Table 5.1)for analysis by 2D NMR methods Duplex DNA (4, Table 5.1)
containing a normal abasic site in the same sequence context as 1 was prepared following the
published procedure(19). Conversion of 2 to 3 was carried out in a reaction mixture of 2 mL
contained 450 ~tM 2 and 2 ~tM UDG in 20 mM HEPES, 1 mM EDTA, pH 7.0. The reaction was
incubated at 37 C and uracil release was monitored by the analytical RP-HPLC (Compound,
retention time: uracil, 6.2 min; 2, 20.2 min, 3, 16.8 min). The reaction was complete in 6 h.
MALDI-TOF MS analysis of 3 indicates a species with a m/s (M+H] + ) value of 3861.43
(Calculated:3861.52). Compound 3 was isolated from the reaction mixture by the preparative
RP__HPLC with a yield of 94% (0.86 [tmol). The NMR sample containing 4 was prepared following
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the method described in Chapter 4. A 1:1 ratio of the template (d(CCCGGTACTTTGG), 0.86 tmol)
in 1 mL deionized water was added directly into the RP-HPLC fractions from the previous step
(22.5 mL containing 0.86 tmol 3, 50 mM ammonium acetate, pH 7.0, and 20% acetonitrile). The
mixture was heated to 55 °C for 1 min and was cooled to 4 °C over 1 h to give 4. The solution was
then dialyzed extensively against 4 x 2 L deionized water periodically changed over 2 days. The
solution containing 4 was evaporated in vacuum to reduce the total volume to 2 mL. Compound 4
was further purified by the preparative anion-exchange HPLC. The fractions containing 4 were
combined and dialyzed against 4 x 2 L deionized water over 2 days. The sample was then
exchanged into D 2 0 by lyophilization in 3 x 1 mL 99.996% D20 (Cambridge Isotopes). The final
NMR sample contained 4 (2.7 mM) in 325 tL of 10 mM sodium phosphate, 0.2 mM EDTA, pH 6.5
in D20 or 10% D20/90% H20 (v/v).
Table 5.1 Sequence information of oligonucleotides in this study.
HPLC MALDI-TOF
Sequence* Retention time MS***
(min)**
5'-CCA AAG XAC CGG G-3' 
3'-GGT TTC ATG GCC C-5' 13.3
2_ 5'-CCA AAG UAC CGG G-3' 20.2b 3955.63)
(3955.63)
5'-CCA AAG YAC CGG G-3' 16 7 b 3861.43(3861.52)
5'-CCA AAG YAC CGG G-3' 134a
3'-GGT TTC ATG GCC C-5' 13.4
(* N, 4'-N 3dU; X, the 4'-oxidized abasic site; Y, the normal abasic sites; ** The HPLC conditions
are indicated as the superscripts: a, analytical anion-exchange HPLC; b, analytical RP-HPLC; ***
the calculated values are in parentheses).
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NMR experiments The NMR experiments were performed on custom-built 750 MHz and 591 MHz
spectrometers at the Francis Bitter Magnet Laboratory. The raw data were transferred to a Silicon
Graphic workstation and were processed using Felix 2001 (Acceryls Inc.). Proton chemical shifts
were referenced to an internal standard, sodium 3-(trimethylsilyl)-1-propanesulfonate (TSP) at 0.00
ppm. NOESY (100 ms, 200 ms, and 400 mixing times), TOCSY (60 ms and 110 ms mixing times),
and E-COSY were recorded at 25 °C in D20. For NOESY and TOCSY experiments, datasets of
4096 (t2) x 512 (tl) complex points were acquired with the spectral width of 8012.4 Hz (750 MHz)
or 7022.5 Hz (591 MHz) in both dimensions and 32 scans per t increment. For the E-COSY
experiment, datasets of 4096 (t2) x 1028 (ti) complex points were acquired with 48 scans per ti
increment. A pre-saturation pulse (2 s) was applied during the recycle delay period to suppress
solvent signals in all NMR experiments carried out in D 2 0. Watergate-NOESY experiments (200 ms
and 400 ms mixing times) in 90% H 20/10% D20 were recorded at 4 °C. Datasets of 4096 (t2) x 512
(ti) complex points were acquired with spectral widths of 13020.8 Hz (591 MHz) in both
dimensions and 32 scans per t increment. For all the datasets, tl dimensions were linear-predicted
to 4096 points and the data were processed with an exponential window function.
1 1H-3C GE-HSQC experiments(20) were acquired on the 591 MHz spectrometer at 25 °C with
1024 x 512 complex points and a spectrum width of 6009.6 Hz in the H dimension and 16025.64
Hz in the 13C dimension. For each tl increment, 64 transients were recorded. The 13C dimension in
the final datasets was linear-predicted to 1024 points. The spectrum was referenced indirectly
through the transmitter frequency by external calibration on TSP.
Calculation of NMR restraints Distance restraints were derived from the volumes of the cross peaks
in NOESY spectra. The peak volumes were calculated with the peak picking protocol in the Felix
2000 software package. Volumes of cross peaks between H2' and H2" (1.772 A) or between H5 and
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H6 (2.460 A) of cytosine were used to calibrate the proton-proton distances. The cross peak
intensities were classified as weak, medium, or strong with the distance restraints of 1.5-3.0, 2.0-5.0,
or 3.0-6.0 A respectively. Alternatively, a more rigorous approach of iterative relaxation matrix
analysis was applied to estimate the distance restraints using the program MARDIGRAS(21, 22).
MARDIGRAS calculations were carried out on NOESY spectra acquired at various mixing times.
For each NOESY cross peak, an upper and a lower distance restraint was calculated. The final
distance restraints derived from MARDIGRAS calculation agreed well with manual classification.
For 1, a total of 410 distance restraints were used for the subsequent structural calculation. Watson-
Crick H-bond interactions (8) detected in the Watergate-NOESY experiments were included as
restraints. A similar analysis on 4a and 4 gave 482 distance restraints. Dihedral angle restraints of
the deoxyribose moieties were derived from the coupling constants measured in E-COSY
experiments. A total of 43 sugar dihedral angle restraints were included for the structure refinement
for 1 (a total of 57 for 4a and 4p, Table 5.2).
Table 5.2 Summary the statistical analysis of the final 10 structures: root-mean-square deviation
(RMSD) (A), NMR restraints, and NMR violations.
1 4a 4p
Pairwvise RMSD (A)
starting structures 4.80 4.54 4.55
final 10 structures 1.72 1.70 1.56
Number of NMR Restraints
NOE 410 482 482
_ Dihedral angles 43 57 57
Violations of NMR
restraints
NOE violations (A) 0.056 0.14 0.11
Dihedral angle violations (0) 2.33 2.21 2.17
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NMR structure calculation and refinement of 1, 4a, and 4,8 All structural calculations were
performed on an SGI Altix 3700 LINUX server with 128 Intel Itanium 1.3 GHz processors at the
Scripps Research Institute (TSRI) using the SANDER module of AMBER 8.0(23). The starting
model structures were built using the Biopolymer module of Insight 2000 (Acclerys Inc.). Three
starting structures were constructed including an A-form, a B-form and a third form with arbitrary
helical parameters(24). The root-mean square deviation (RMSD) for the three structures was 4.5
A. A generalized Born implicit solvent model was applied to simulate the solvent dielectric
constant(25, 26). The initial model structures were energy minimized by 500 steps of conjugated
gradient minimization followed by 500 steps of steepest descent minimization to remove high
energy interactions introduced during the manual model building. The simulated annealing was
carried out by heating the structure from 300 K to 900 K in 5 ps followed by cooling to 300K over
the next 15 ps. During the cooling process, weak temperature coupling (slow cooling) was applied
for the first 13 ps followed by strong temperature coupling (rapid cooling) for the last 2 ps(24).
NMR restraints were enforced during the annealing process with an increasing force constant from 5
to 50 kcal/mol over the first 3 ps and was maintained at 50 kcal/mol for the rest of the
calculation(24). The annealed structure was then subjected to a 100-ps constant temperature (300 K)
molecular dynamics with NMR restraints. Ten structures for each starting structure (A-, B-, and the
third form) were calculated by sampling conformations during the last 10 ps of the molecular
dynamics at a I-ps interval. The resulting 30 structures have an averaged RMSD of <2.0 , which
indicates a structural convergence after refinement. Ten final structures were chosen from the 30
structures based on the fewest NMR violations to represent the ensemble of the averaged structure.
The statistical analysis of the final ten structures is summarized in Table 5.2.
Molecular Dynamics Simulations with an Explicit Solvent Model The molecular dynamics
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simulations were performed at a constant temperature (300 K) using the software AMBER 8.0
following the protocol described by Dupradeau et al.(27). The averaged structures were first
solvated using the TIP3P solvent model with approximately 6, 000 water molecules in an octahedral
solvent box with a thickness of 10 A. Twenty four sodium ions were also included in the
calculations to neutralize the phosphates of the phosphodiester backbone. The molecular dynamics
calculations were carried out on a 3-ns time scale. The conformation was sampled every 1 ps and
was analyzed by the PTRAJ module in Amber 8.0.
5.3 Results
Preparation of the NMR samples of I and 4 The synthesis and characterization of 1 have been
described in detail in Chapter 4. The purity and the duplex formation of 1 were confirmed by anion-
exchange HPLC analysis, which showed a single species with a retention time of 13.3 min (Figure
5.2 B), different from a 13mer ss-DNA control (10.2 min) (Figure 5.2 A).
To prepare the NMR sample of 4, ss DNA containing an abasic site (3) was synthesized by
treating 2 with UDG following published procedures(19). Compound 3 was purified by semi-
preparative RP-HPLC and was analyzed by MALDI-TOF MS (Table 5.1). A 1:1 ratio of 3 and the
template, d(CCCGGTACTTTGG), was mixed, heated to 55 °C for 1 min, and annealed by cooling
to 4 °C over 1 h to give 4. Analytical anion-exchange HPLC analysis of 4 showed a single species
with a retention time of 13.4 min, similar to 1 (Figure 5.2 C).
Assignments ofproton chemical shifts Standard TOCSY (60 and 110 mixing time) and NOESY
(100, 200, and 400 ms mixing time) experiments were performed to assign non-exchangeable
protons of DNA(28). The chemical shifts of protons associated with the deoxyriboses were assigned
using TOCSY experiments and the results are summarized in Table 5.3 (1) and Table 5.4 (4).
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Figure 5.2 Duplex DNA formation analyzed by analytical anion-exchange HPLC. A, a 13mer ss-
DNA, d(CCCGGTACTTTTG), as a control; B, 1; C, 4.
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Table 5.3 H chemical shift assignments (in ppm) of 1.
-NH2, -
H8/H6 Me/H5 HI' H2' H2" H3' H4' H5'/5" NH, or
H2
CI 7.768 5.995 5.990 2.069 2.510 4.684 4.123 3.769 7123/7.999
4.089/ 6.978/
C2 7.556 5.745 5.346 2.043 2.320 4.833 4.159 4.0806 689746/4.006 8.746
4.119/ 7.549A3 8.258 5.795 2.771 2.850 5.055 4 4.373 500 4.500
A4 8.109 5.804 2.594 2.778 5.043 4.404 4.207 7.216
A5 7.936 5.942 2.455 2.768 4.987 4.202 n.d. 7.354
4.164/G6 7.545 5.858 2.386 2.627 4.913 4.445 4.1264.126
X _____5.155 2.104 1.827 4.559 n.d. n.d.
A8 8.385 6.335 2.815 2.948 5.020 4.411 3.993
C9 7.301 5.306 5.820 2.018 2.395 4.803 n.d. n.d. 6.630/8.132
6.820/CI0 7.355 5.515 5.515 1.848 2.224 4.871 4.207 4.106 85908.590
4.032/ 13.225
GI 1 7.830 5.442 2.212 2.662 4.948 4.294 4.215 13.225
4.215
G12 7.739 5.791 2.594 2.740 4.984 4.386 4.128 13.225
G13 7.776 6.145 2.506 2.363 4.660 4.382 4.242
C14 7.820 5.996 6.010 2.205 2.554 4.687 4.364 3.804 7.085/
._ _ _ _ _ _ _ _ _ _  _ _ _ _ ~~~7 .9 7 9
6.935/C15 7.647 5.707 5.996 2.210 2.465 4.871 4.215 4.067 68950
8.508
6.982/
C16 7.443 5.672 5.587 2.036 2.378 4.856 4.207 4.102 8.6738.673
G17 7.862 5.718 2.617 2.743 4.997 4.360 4.114 13.127
G18 7.637 5.925 2.204 2.474 4.874 4.212 4.080/ 12.7874.056
T19 7.155 1.341 5.843 2.074 2.397 4.815 4.850 n.d.
A20 8.144 6.112 2.562 2.711 4.931 4.369 4.141
C21 7.552 5.540 5.936 2.515 2.717 4.916 4.162 4.086
4.192/ 14.130
T22 7.564 1.625 6.115 2.243 2.625 4.984 4.323 4.166 1.3
~~~~~~~~~~~~~~~~~~~.
T23 7.511 1.713 6.124 2.151 2.585 4.901 n.d. n.d. 14.120
T24 7.349 1.756 5.718 1.973 2.296 4.871 4.220 4.123 14.126
4.220/ 12.995
G25 7.872 5.684 2.678 2.721 4.996 4.360 4.2110/ 12.9954.110
4.229/G26 7.818 6.154 2.521 2.360 4.654 4.364 4.229/
(X, the 4'-oxidized abasic site; n.d., not determined due to either overlapping or weak signals).132(X, the 4'-oxidized abasic site; n.d., not determined due to either overlapping or weak signals).
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Table 5.4 1H chemical shift assignments (in ppm) of 4.
H8/H6 Me/H5 HI' H2' H2" H3' H4' H5'/" -NH2, -NH, orH2
3.744/Cl 7.764 5.968 5.974 2.060 2.504 4.668 4.115 3 / 7,079/8.0063.770
3.995/C2 7.560 5.733 5.321 2.047 2.313 4.825 4.078 .0 6.982 / 8.7194.023
3 997/A3 8.264 5.773 2.770 2.843 5.047 4.365 .97 7.3424.107
A4 8.117 5.783 2.595 2.767 5.031 4.399 4.193 7.210
A5 7.926 5.906 2.428 2.692 4.971 4.360 4.188
G6 7.557 6.096 2.626 2.681 4.898 4.190 4.136
Y-a 5.311 2.045 1.870 4.530 4.388 4.043/
4.124/
Y-D 5.385 1.890 2.108 4.499 4.390 4.124/4.090
A8-a 8.360 6.310 2.786 2940 4.982 4470 4.130/
A8-3 8.366 6.321 4.039
C9-ct 7.322 5.30 4.767 4 193
.............................. 5807 2.016 2.395 4.7............... ~.66 .2143C9-3 7.304 5.292 .807 2.016 2.395 4 .d. 6.607/8.103
C10O 7.338 5.488 5.483 2.021 2.398 4.775 4.193 n.d. 6.607 / 8.103
GIl1 7.830 5.441 2.632 2.671 4.935 4.271 n.d. 13.226
4.143 /G12 7.736 5.786 2.590 2.739 4.976 4.378 4.1 13.224
_ _ _ __ _ _ _  4.115
G13 7.769 6.133 2.499 2.360 4.642 4.224 4.196
3.775/C14 7.822 5.982 5.995 2.178 2.558 4.676 4.138 3.775/ 7.090 / 8.0073.812
C15 7.657 5.694 5.995 2.211 2.470 4.861 4.206 4.062 6.929 / 8.494
4.123/C16 7.448 5.660 5.590 2.013 2.371 4.856 4.193 4. 6.990 / 8.6724.099
G17 7.646 5.716 2.768 2.712 4.997 4.383 n.d. 13.192
-G18-a 7.647 2.480 2.671 4.885 4.384 4.2065.916 - - - - -12.802
G18-3 7.628 2.470 2.658 4.882 4.384 4.203
T19-a 7.142 1.334 5.820 2.005 2.329 4.783 4.384 4.021/4.047
T19-f3 7.115 1.287 5.779 2.005 2.305 4.767 4.389 393.989
A20-a 8.133 6.091 2.553 2.679 4.916 4.363 4.123
-- A-2- . ... 8-15-- --------- -----3 ... 2- --------- 4.916A20-6 8.157 _ __ 6.123 2.540 2.689 4.373 4.125
C21-ca 7.623 -5.619 5.893 2.180 2.506 4.765 4.261 4.123
C2-- 7.673 5.681 5.942 2.217 2.530 4.786 4.279 4.128
T22-ct 1.655 4.123/T22 .7.545 --... 655-- 6.096 2.253 2.619 4.893 4.245 4.13
T22-13 1.663 ____ 4.136
4.130/T23 7.518 1.720 6.102 2.149 2.566 4.890 4.245 4.10 14.1194.190
4.081/T24 7.367 1.757 5.671 1.997 2.292 4.859 4.193 4.081/ 14.1624.117
4.042/G25 7.874 5.658 2.671 2.720 4.976 4.358 40 13.020
4.089
G26 7.819 6.146 2.519 2.363 4.647 4.360 4.109/(Y. _ ~ an_ _ abasic_~ site; nd ntde idd teteo rpi4.206
(Y, an abasic site; n.d., not determined due to either overlapping or weak signals)
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Thesequential connectivities between each base proton (H6 of pyrimidines, H8 of purines) and
the deoxyribose protons (HI', H2'/H2", H3', H4', and most of H5') of the 5' residue were
established mainly by analyzing the 200 ms mixing time NOESY spectra. NOE connectivities
between H5 and H6 protons of cytosines and between methyl and H6 protons of thymidines were
also used to assist the assignments of NOE signals in overlapping regions.
The NOE connectivities between HI' and the base protons of 1 are presented in Figure 5.3. The
NOE connectivities on the 5' and 3' sides of the 4'-oxidized abasic site are shown in red lines and as
expected, is disrupted between G6 and A8 (indicated by x and shown in dashed red lines). NOE
connectivities are also observed on the other strand, with the connectivity from T19 to C21 opposite
to the 4'-oxidized abasic site indicated by red lines (Figure 5.3). This result suggests that the base
opposite to the 4'-oxidized abasic site (A20) adopts an intrahelical conformation, similar to that in
B-form DNA.
The NOE connectivities between HI' and the base protons of 4 are shown in Figure 5.4. The
NOE connectivities adjacent to the abasic site are shown in red lines. Similar to 1, the NOE
connectivity is disrupted by the abasic site between G6 and A8 (indicated by x and red dashed lines
in Figure 5.4, top). Complete NOE connectivities are observed for residues on the opposite strand
(Figure 5.4, bottom). However, in contrast to 1, two distinct sets of NOE cross peaks are observed
for T19, A20, and C21 (red dashed lines in Figure 5.4, bottom), consistent with the a and (3
anomeric forms observed in previous studies with an abasic site in similar sequence context(19).
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Figure 5.3 NOESY (200 ms mixing time) spectra of 1 at 750 MHz showing the connectivities
between the base (H61H8) and the H I' protons. Top spectrum, NOE connectivities on the fIrst
strand; bottom spectrum, NOE connectivities on the second strand. The connectivities adjacent to
the lesion are highlighted in red. The disruption of the NOE connectivity on the fIrst strand at the 4'-
oxidized abasic site is denoted by X. Cross peak A, A8H8-C9H5; B, A20H8-C2IH5.
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Figure 5.4 NOESY (200 ms mixing time) spectra of 4 at 750 MHz showing the connectivities
between the base (H61H8) and the HI' protons. Top spectrum, the connectivities on the first strand;
bottom spectrum, the connectivities on the second strand. The connectivities adjacent to the lesion
are highlighted in red. The disruption of the NOE connectivity on the first strand at the abasic site is
denoted by X (top). Two sets of signals on the second strand that are associated with 4a and 4p are
indicated in red dashed lines. Cross peak A, A8H8-C9H5; B, A20H8-C21H5 (in 4a); C, A20H8-
C2lH5 (in 4P).
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Exchangeable base protons (amino and imino protons) involved in the Watson-Crick base pair
interaction were assigned by Watergate-NOESY experiments in 90% H20/10% 020 at 4°C. For
both 1and 4, 8 imino protons are detected and assigned based on their NOE interactions with their
base pair partners (red dashed line, Figure 5.5). The chemical shifts of imino protons and the NOE
patterns between the two abasic DNAs in the imino region (T-imino to A-H2 and G-imino to C-
amino) are similar (Figure 5.5), which suggests that the two abasic DNAs adopt a similar global
structure. The imino protons on each end of DNA (G 13 and G26) and adjacent to the abasic site (G6
and T19) were not observed due to their fast exchange with solvent on the NMR time scale. These
results suggest that the base pair interactions adjacent to the abasic site are weaker than those in
regular B-form DNA.
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Figure 5.5 Assignments of imino and amino protons of 1 and 4 using Watergate-NOESY spectra
(200 ms mixing time) at 591 MHz in 90% H20/10% 020 (v/v) at 4°C. The red dashed lines indicate
the connectivities between the G-imino proton and C-amino protons. The cross peaks are assigned
as: A, T24-imino/A3-H2; B, T22-imino/A5-H2; C, T23-imino/A4-H2; 0, GI2-imino/CI5-amino; E,
Gll-imino/CI6-amino; F, GI7-imino/CI0-amino; G, G25-imino/C2-amino; H, GI8-imino/C9-
amino.
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Assignments of the 4 '-oxidized abasic site of 4 Chemical shift assignments of protons associated
with the abasic site are essential to identify NOE interactions between this site and adjacent residues.
The proton chemical shift assignments have been obtained from standard TOCSY experiments(28).
For 1, a proton with an unusual chemical shift was observed at 5.155 ppm was observed (X-HI1',
Figure 5.6 A). This chemical shift is considerably upfield from the envelop of H 1' in B-DNA in
which it ranges from 5.3 to 6.5 ppm (Table 5.3). The assignment of this proton to HI' of the 4'-
oxidized abasic site was based on its through-bond connectivities with two other protons: one at
1.827 ppm and the other at 2.104 ppm (red line, Figure 5.6 A), which are assigned to H2'/H2" of the
same residue. Both the H2' and H2" proton also show through-bond connectivity with a proton at
4.559 ppm, which is upfield shifted from all the H3' protons (Table 5.3). The inability to associate
any of these protons with the completely assigned bases and their unusual chemical shifts suggest
that they were associated with the 4'-oxidized abasic site. No evidence of a second anomer was
apparent by any of the TOCSY experiments.
The chemical shift assignment of HI' at 5.155 ppm in the 4'-oxidized abasic site was also
confirmed by an H-13 C GE-HSQC experiment (Figure 5.7 A). The proton signal at 5.155 ppm
shows a cross peak with the carbon signal at 98.41 ppm. This carbon signal is consistent with the
chemical shift previously assigned to Cl' in an abasic site(29) (Figure 5.7 A) and is downfield
shifted relative to C1' carbons in nucleotides (Table 5.5). The region containing cross peaks between
base protons (H8 or H6) and their attached carbons (C8 or C6) is shown in Figure 5.7 B to show the
quality of the H-13C GE-HSQC spectrum of 1. The 13C chemical shift assignments of 1 are
summarized in Table 5.5.
208
A
1.8
1.9
-E (100- 2.0
0--..-:r: 2.1
(2
X-H1'
2.2
2.3
2.4
5.5 5.4 5.3 5.2 5.1
H1 (ppm)
B 1.8
1.9
- 2.0E
0-
S 2.1
..-:r: (2
2.2
2.3
2.4
5.5 5.4 5.3 5.2 5.1
Hl (ppm)
Figure 5.6 Assignments of the protons associated with the abasic sites using TOCSY spectra (60
ms mixing time) at 750 MHz. A, The through-bond connectivities between HI' and H2'/H2" protons
(red line) of the 4'-oxidized abasic site (X) in 1. B, The through-bond connectivities between HI'
and H2' 1H2" protons (red line) of the 4'- abasic site (Y) in 4. The two sets of signals are associated
with the a and ~ anomers revealed by NOESY experiments.
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Table 5.5 13C chemical shift assignments (in ppm) of 1.
CI' H8/H6 H5/Me | C1' H8/H6 H5/Me
C1 87.03 143.27 99.56 G26 84.82 138.85
C2 86.60 143.59 98.93 G25 84.19 138.74
A3 n.d. 141.69 T24 85.24 139.80 14.61
A4 n.d. 141.06 T23 n.d. 139.90 14.61
A5 n.d. 140.96 T22 n.d. 137.90 14.61
G6 85.34 138.21 C21 88.08 142.96 98.72
X 98.41 A20 85.45 141.96
A8 n.d. 141.69 T19 85.35 138.64 14.29
C9 n.d. 142.22 98.41 G18 84.72 137.48
C10 86.61 143.27 98.83 G17 84.19 138.43
G11I 84.29 138.53 C16 86.61 143.38 99.04
G12 84.30 138.11 C15 88.20 143.48 99.14
G13 84.82 138.74 C14 88.19 143.27 99.67
(Y, an abasic site; n.d., not determined due to either overlapping or weak signals)
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Assignments of the abasic site protons of 4a and 4f3 The analysis of the TOCSY spectra of 4
indicates two signals at 5.311 ppm and 5.385 ppm associated with the HI' protons of the normal
abasic site (Y-H1', Figure 5.6 B). As in the case of the 4'-oxidized abasic site of 1, these protons are
also upfield-shifted relative to all of the HI' protons in B-form DNA (Table 5.4). These two signals
show through-bond connectivities with two sets of H2'1H2" protons (red lines, Figure 5.6 B). These
signals are also not associated with any base (all of which have been assigned, Table 5.4),
suggesting that that they are unique to the abasic site. The existence of two sets of distinct signals
are consistent with two anomeric states of the abasic site in solution(29, 30).
Assignments of the a and 13 anomers of I and 4 using NOESY experiments Our group has previously
reported the assignments of each anomer of an abasic site based on the relative NOE intensities of
H2'/H2" to Hl'(19). The assignments of H2' and H2" protons were based on the intensity of each
cross peak with H3', i.e., H2' has a stronger cross peak than H2". The assignment of the anomeric
configuration is based on the relative cross peak intensities between H1'-H2' and H1'-H2". For
example, with the ac anomer, HI' is closer to H2' and produces a stronger NOE cross peak than to
H2". The reverse is true for the 3 anomer.
Analysis of the TOCSY spectra of 1 indicates that only one major species. The cross peak
intensities in its NOESY spectrum suggest that the HI' proton is closer to the H2' proton (B, Figure
5.8A) than to the H2" proton (A, Figure 5.8A). This result is consistent with the cc anomer. The
assignment of a single conformation is also consistent with the NOE cross peak patterns observed in
Figure 5.3, which show a single set of signals adjacent to the 4'-oxidized abasic site (solid red lines,
Figure 5.3).
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Figure 5.8 Determining the anomeric state using the relative intensity of NOE cross peaks
associated with the protons in the abasic sites. A, for 1, one set of signals are present and the
connectivities are highlighted in red. The intensity of the NOE cross peak between HI' and H2"
(cross peak A) is less than that between HI' and H2' (cross peak B), which suggests that this species
is an a anomer. B, for 4, two sets of signals are present (labeled in red and blue, respectively). For
the species labeled in red, the intensity of the NOE cross peak between H I' and H2" (cross peak C)
is less than that between HI' and H2' (cross peak D), suggesting that this species is an a anomer;
For the species labeled in blue, the intensity of the NOE cross peak between HI' and H2" (cross
peak F) is stronger than that between H I' and H2' (cross peak E), suggesting that this species is a ~
anomer.
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In contrast to 1, the TOCSY experiments suggest that there are a and anomers of the abasic
site (4a and 41). These two species are assigned using the same strategy described for 1. The
appropriate 200 ms NOESY spectrum is shown in Figure 5.8B. The ac anomer is indicated in red and
the 1i anomer is indicated in blue. The chemical shift assignments of 4a and 41p are very similar to
the previously reported values for the protons associated with a normal abasic site in a similar
sequence context(19).
Establishing sugar conformations in 1 and 4. E-COSY experiments at 750 MHz were performed to
measure the coupling constants used to assign the sugar puckers for the deoxyribose moieties in 1,
4a and 413 (Table 5.6 A and B, respectively). For 1, the coupling constants of H1'-H2' and H1'-H2"
were measured for all residues except for the 4'-oxidized abasic site. The observed coupling
constants are consistent with a C2'-endo or S-type conformation for these residues, which are
expected in B-form DNA(31). For the 4'-oxidized abasic site, neither JHI'H2' nor JH'H2 could be
determined accurately due to the low intensities of the cross peaks. Therefore, the sugar
conformation of the 4'-oxidized abasic site is not constrained during the NMR structure calculation.
For 4a and 41, the coupling constants were measured for all residues (Table 5.6 B). Except for
the abasic site, the coupling constants are consistent with a C2'-endo or S-conformation (31)
expected for a regular B-form DNA. The coupling constants associated with abasic site protons
(Figure 5.9 and Table 5.6) are similar to those reported for a normal abasic site in a similar sequence
context(19). Comparison of the experimentally determined coupling constants with the calculated
values for different sugar conformations(31) suggests that the a anomer adopts a Ol'-endo
conformation and that the f3 anomer adopts a near S-type Cl'-exo conformation.
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Figure 5.9 Coupling constants between HI' and H2'/H2" measured by E-COSY experiments of the
abasic sites in 4. The chemical shift assignments of these abasic protons are also shown.
Table 5.6 Coupling constants (in Hz) for 1 (A) and 4 (B) derived from E-COSY experiments*.
Table5.6A Cl C2 A3 A4 A5 G6 X AS C9 CIO Gll G12 G13
J HI' H2' 8.2 10.4 9.6 8.8 8.7 9.3 n.d. 8.2 8.8 8.2 10.9 11.5 10.1
J HI' m" 6.6 7.4 7.2 6.8 7.0 6.7 n.d. 6.9 7.3 6.8 7.1 7.6 6.8
G26 G25 1'24 1'23 1'22 C21 A20 T19 G18 G17 C16 C15 C14
J HI' H2' 9.5 11.2 10.7 10.2 8.5 8.6 8.8 9.4 10.5 10.9 9.5 8.9 8.0
J HI' H2" 7.4 6.6 7.8 7.2 7.0 6.8 6.7 7.0 6.9 n.d. 7.2 6.8 6.5
Table 5.68 Cl C2 A3 A4 A5 G6 Y A8 C9 CIO Gll G12 G13
J HI'.H2' 8.1 9.8 9.6 9.6 9.4 8.8 4.3(<<) 8.1 8.1 9.0 8.9 9.9 8.7
5.8(1})
J HI',H2" 6.5 6.0 6.6 6.3 6.2 6.6
1.4(<<) 6.4 7.4 7.6 7.3 7.6 6.34.5(1})
G26 G25 1'24 1'23 1'22 C21 A20 T19 GI8 GI7 C16 C15 C14
J HI'.H2' 8.8 9.6 9.8 9.2 8.2 8.1(<<) 8.8(<<) 7.6 8.8 8.3 9.9 7.9 7.48.0(1}) 8.9(1})
J HI',H2" 6.1 6.0 7.7 6.0 7.0 7.7(<<) 6.7(<<) 7.2 6.4 n.d. 7.2 5.8 6.5
n.d.(I}) 6.8(1})
(* X, the 4' -oxidized abasic site; Y, the normal abasic site; n.d., not determined due to overlapping
or weak signals).
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NOE interactions associated with abasic site protons of 1 and 4 A number of through-space
interactions were detected in the NOE experiments (100 ms mixing time) between A8H8 and Hi',
H2'/H2" and H3'of either the abasic site (4a and 4I) or the 4'-oxidized abasic site (1) (Figure 5.10
A-C and Table 5.7). These NOE interactions provide crucial insight into the conformation of the
abasic sites. For 1, Figure 5.10A shows a medium and a weak NOE signal of A8H8-XH2" and
A8H8-XH2", respectively. In B-form DNA, the distances between H2'/H2" to the neighboring 3'
base proton are 3.3A/2.3 A, respectively, which produce medium NOE signals. This is illustrated by
the NOE signals between A3H8 and C2H2'/H2" of 1 in Figure 10A (red line). The unusually weak
interaction between A8H8 and the H2" proton of the 4'-oxidized abasic site suggests that this lesion
adopts a distinct conformation from that of B-form DNA.
For both 4a and 41, weak NOE interactions are observed between A8H8 and YH2'/H2" (Figure
5. OB, arrow). This result contrasts with that expected for the same interaction in generic B-form
DNA compared to the similar cross peaks in B-form DNA where the signal is of medium strength.
(Figure 5. 10B, red line). In addition, a medium A8H8-YH3' NOE signal is observed for both 4a
and 4P (Figure 5. 10C). In B-form DNA, the distance between H3' to the adjacent 3' base proton is
4.4 A, which usually produces a weak NOE signal as demonstrated by the NOE cross peak between
A3H8 and C2H3' in Figure 5. 0C (the red arrow in Figure 5. 0C). These unusual NOE interaction
patterns suggest that the conformation of the abasic site sugar in 4 is distinct from B-form DNA.
Table 5.7 NOE restraints involving the protons associated with the abasic sites to their adjacent
baseprotons*.
The 4'-oxidized abasic site (1) The normal abasic site (4)
NOE cross peak Intensity Distance in final NOE cross peak intensity Distance in final
~~~~__ ~~structure (A) structure (A)
XH2'-A8 H8 medium 2.59 YH2'-A8 H8 weak 3.38(a) 4.24(13)
XH2"-A8 H8 weak 4.22 YH2"-A8 H8 weak 3.67(a) 4.15(13)
YH3'-A8 H8 medium 2.69(ac) 2.94(13)
(*X, the 4'-oxidized abasic site; Y, the normal abasic site)
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Figure 5.10 NOE interactions associated with the protons of the abasic site and the adjacent 3'-base
proton (A8H8) studied by NOESY (100 ms mixing time) at 750 MHz. A, A8H8 of 1 shows a
medium NOE with the H2' proton of the 4' -oxidized abasic site (X-H2') and a weak NOE with the
X-H2" proton (indicated by the arrows). The NOE between A3H8 and C2H2'1H2" are indicated by
the red line. B, the A8H8 protons of 4a and 4p show weak NOE interactions with the H2' 1H2"
protons of the abasic site (Y -H2' 12") as indicated by the arrows. The NOE between A3H8 and
C2H2' 1H2" are indicated by the red line. C, the A8H8 protons of 4a and 4P show medium NOE
interactions with the H3' proton of the abasic site (Y -H3') as indicated by the arrows. The NOE
between A3H8 and C2H3' in 4 is indicated by the red arrow.
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The averaged structures The experimentally determined distance and dihedral angle constraints
were used to calculate an ensemble of ten structures of 1, 4a, and 41. None of these structures
contain any NOE distance violations larger than 0.5 A or dihedral angle violations larger than 5°.
Overlays of these ten structures for 1, 4ct, and 413 are shown in Figure 5. 11A. The averaged
structures are shown in Figure 5.1 lB. The structures share two features in common: they are B-form
DNA and the base (A20) opposite to the lesion (colored in blue, Figure 5. 11A) is intrahelical and
stacks between adjacent base pairs, as in B-form DNA (see also in Figure 5.12A-C).
Sugar conformations at the abasic sites Despite the overall similarities in global conformations of 1,
4a, and 4p, the sugar conformations at the abasic site are distinct as revealed in the 10 structures
(Figure 5. 11A, red) and the averaged structures (Figure 5.1 B and 5.12). For 1, the 4'-oxidized
deoxyribose adopts an intrahelical conformation (Figure 5.12 A). This conformation requires a
relatively short (2.59 A) H2'-A8 H8 and long (4.22 A) H2"-A8H8 distances (Figure 5.13 B, dashed
red line) compared to those in a B-form DNA (Figure 5.13 A, dashed red line). This conformation
is consistent with the intensities of NOE cross peaks involving these protons (Figure 5.10A).
In contrast to 1, for the both 4a and 41, the deoxyribose of the abasic site is partially
extrahelical (Figure 5.12B and C). The extrahelical conformation predicts that the H2'/2" protons of
the abasic site move away from A8H8 in both 4a and 4p (red dashed lines, Figure 5.14 B and D)
compared to that in B-form DNA (Figure 5.14 A and C). The observed conformation is dictated by
and consistent with the weak NOE interactions involving A8H8 and the H2'/2" protons of the abasic
site (Figure 5.10 B). In addition, in this conformation, the H3' proton of the abasic site is much
closer to A8 H8 (blue dashed lines in Figure B and D) than that in B-form DNA (blue dashed lines
in Figure A and C), also consistent with the observed medium NOE signals between A8H8 and H3'
of the abasic site (Figure 5.10 C).
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Figure 5.11 NMR structural refinement of 1, 4a, and 4p. A, an overlay of the ten final structures;
B, the final averaged structures.
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Figure 5.12 The stereo view of the abasic site and the neighboring base pairs in the final structures.
A, 1; B, 4a; C, 4ft The abasic site and the opposite base (A20) are colored in CPK.
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Figure 5.13 The conformation of the 4'-oxidized abasic site in 1 compared to that in a theoretical
B-form DNA. A, The computer-modeled conformation of the 4' -oxidized abasic site in a B-form
DNA. The distance between A8H8 and the H2'/H2" protons are 3.3/2.3 A, respectively (indicated
by the red dashed lines). B, The conformation of the 4' -oxidized abasic site in the final structure.
The distance between A8H8 and the H2' IH2" protons are 2.59/4.22 A, respectively (indicated by the
red dashed lines).
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Figure 5.14 The conformation of the normal abasic site in 4a and 4~ compared to that in a
theoretical B-form DNA. The distance between A8H8 and Y-H2'/2" is colored in red and the
distance between A8H8 and Y-H3' is colored in blue (Y, the abasic site). A, The computer-
generated conformation of the abasic site (a anomer) in a B-form DNA. The distance between
A8H8 and Y-H2' /H2" is 3.3/2.3 A. The distance between A8H8 and Y-H3' is 4.4 A. B, The
conformation of the abasic site in the final structure of 4a. The distance between A8H8 and Y-
H2'/H2" is 3.4/3.7 A. The distance between A8H8 and Y-H3' is 2.7 A. C, The computer-generated
conformation of the abasic site (~ anomer) in a B-form DNA. The distances between A8H8 and
H2' /H2" /H3' are the same as in A. D, The conformation of the abasic site in the final structure of
4~. The distance between A8H8 and Y-H2'/H2" protons is 4.2/4.2 A. The distance between A8H8
and Y-H3' is 2.9 A.
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Molecular dynamics simulations To probe the conformation flexibility at each abasic site, the final
averaged structure of 1, 4a, and 4t was subjected to molecular dynamics simulations. Water
molecules and counter ions (Na+) were included in the calculation to better simulate the solution
state of DNA molecules. To monitor the time-dependent extrahelical motion, the distances between
CI' of the abasic site and the N1 atom of the opposite base (A20 N1) in 1, 4a, or 4p were monitored
during the course of the simulation (Figure 5.15 A-C). In B-form DNA, the C1'-N1 distance, -6.2 A,
is restrained by Watson-Crick base pairing. As an example, the distance between T24-C1' and A3-
N1 in 1, 4a, or 4P (blue traces in Figure 5.15 A-C) was monitored during the simulation and
showed a very small fluctuation (<0.5 A) from 6 A. In contrast, for the normal or 4'-oxidized abasic
site, because of the lack of the base-pairing interactions, the distance between CI' of the lesion and
N1 of A20 is sensitive to the motion of the abasic site (red traces in Figure 5.15 A-C, see the
discussion below). Specifically, the extrahelical motion of the abasic site would likely cause an
increase of this distance.
The analysis of the molecular dynamics simulation of 1 reveals that the 4'-oxidized abasic site is
mainly intrahelical (the red trace in Figure 5.15 A). The average distance between Cl' of the 4'-
oxidized abasic site and N of A20 is 6 A, similar to the value in a normal B-form DNA.
However, the extrahelical motion of this site is also present during the simulation indicated by the
increase of the distance between Cl' and A20-N1 (Figure 5.15 A). The fluctuation of this distance is
less than 2.5 A. Interestingly, transient H-bond interaction between 1'-OH of the 4'-oxidized abasic
site with N1 of A20 is also observed, resulting in the decrease of the distance between Cl' of the
lesion and A20-N1 (arrow in Figure 5.15 A). A stereo view of this transient H-bond interaction is
presented in Figure 5.15 D.
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Figure 5.15 Time-dependent extrahelical motion of the abasic site in 1, 4a, and~. The extrahelical
motion was monitored by the distance change between C l' of the abasic site and the N 1 atom of the
opposite base (A20 Nl) (red trace). The blue traces represent the distance between A3Nl and
T24Cl'. A, 1. The arrow in A indicates the transient H-bond formation between l'-OH and A20Nl.
B, 4a. C, 411. D, A stereo view of the snap shot of 1 with a transient H-bond between l' -OH and
A20Nl (indicated by the arrow in A).
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For both 4a and 413, the analysis indicates that there is a larger extrahelical motion associated
with the abasic site in comparison with 1 as reflected by the large fluctuation of the distance between
C ' of the abasic site and N1 of A20 (> 4 A) (Figure 5.15 B and C, red trace). In addition, the
extrahelical motion occurs approximately every 50 ps (Figure 5.13 B and C), much more frequent
than that in 1.
5.4 Discussion
The long-range goal of this structural study is to understand how both ss and ds lesions
generated by BLM can be recognized and repaired by DNA repair enzymes. BLM generates two
types of ss-DNA lesions: a 3'-PG/5'-P gap and a 4'-oxidized abasic site (Figure 5.1)(6-8). Since the
5'-GTAC-3' sequence has been identified to be a "hot spot" for BLM-mediated ds cleavage(32), this
sequence has been used in structural studies of DNA lesions by our group. A 3'-PG/5'-P gapped
lesion in this sequence context (5'-G -P G P-AC-3') has been synthesized and its structure has been
characterized by 2D NMR methods(33). No NOE information was observed between the 3'PG
group and adjacent residues, suggesting a flexible conformation of this lesion. In addition, the
interaction between 5'-GPG P-AC-3' and BLM-Co(III)-OOH studied by 2D NMR offers structural
insight into the mechanism of BLM-mediated ds-DNA cleavage(34). Our group has also carried out
extensive 2D NMR spectroscopic studies of a normal abasic site in the 5'-GTAC-3' sequence as a
structural analog for the 4'-oxidized abasic site(19). Structural modeling based on NMR-derived
distance and dihedral angel restraints suggested that the deoxyribose at the abasic site adopted an
extrahelical conformation in both the cc and the anomer(19). The extrahelical conformation of the
abasic site in this sequence could be used as the structural element for recognition by Apel, the
major DNA repair enzyme proposed in vivo to repair the abasic sites(1 7).
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In this study, we present the first structure model of duplex DNA containing a 4'-oxidized abasic
site (1) using 2D NMR methods. The overall structure of 1 is similar to B-form DNA based on
distance and dihedral angle restraints calculated from 2D NMR experiments. The deoxyribose of the
lesion adopts an intrahelical conformation, however, its conformation is different from that in B-
form DNA. The conformation is largely derived from two unique NOE interactions between
H2'/H2" of the lesion and the base proton 3' to the lesion. Molecular dynamics simulations were
carried out to characterize the conformational flexibility of the 4'-oxidized abasic site. The results
indicate that the deoxyribose at the lesion remains largely intrahelical with infrequent extrahelical
motion (every -500 ps).
As a structural comparison, we also determined the structure of a duplex DNA with a normal
abasic site (4) in the same sequence context as 1 (5'-CCAAAGYACCGGG-3'). The results indicate
that there are two species in solution for 4, which are assigned to the c and 3 anomers based on the
NOE interactions associated with the sugar protons at the abasic site. Structural models of each
anomer using these restraints have been determined. In both structures, the deoxyribose of the lesion
adopts an extrahelical conformation. This conformation is largely dictated by observed NOE
interactions between the sugar protons of the lesion and the base proton 3' to the lesion. These
results are consistent with our previous studies of an abasic site in a very similar sequence context
(5'-CCAAAGYACTGGG-3')(19). Molecular dynamics simulations carried out on each anomer
revealed that the normal abasic site is conformationally more flexible than the 4'-oxidized abasic site
in this particular sequence. Large extrahelical motions are observed at greatly increased frequency
relative to the 4'-oxidized abasic site (every 50 ps).
The difference in the structure and conformational flexibility between the 4'-oxidized abasic site
and the normal abasic site may have important implications for their recognition by DNA repair
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enzymes, such Ape l. The crystal structure of Apel in complex with an abasic site analog (THF)
shows that the THF moiety is flipped completely out of helix (Figure 1.10, Chapter 1) and into a
specific binding pocket of Apel(35). A similar extrahelical conformation has been observed in the
structures of a number of abasic site-protein complexes, including Endo IV(36), uracil
glycosylase(37), and 3-methyl adenine glycosylase(38). However, it remains unclear whether the
repair enzyme selectively recognizes the flipped-out abasic site or whether it actively flips the abasic
site by recognizing conformational flexibility around the abasic site. Our results for the normal
abasic site suggest that in solution, the deoxyribose of the abasic site is flexible and adopts a wide
range of extrahelical conformations. Therefore, it is likely that the pre-existing extrahelical
conformation of the abasic site, although it might only constitute a small fraction of the
conformation space in solution, could be recognized by DNA repair enzymes.
Compared to the normal abasic site, our study suggests that the 4'-oxidized abasic site in 1 is
largely intrahelical and is less flexible. Biochemical studies on the repair of the 4'-oxidized abasic
site (in a mixture with 3'-PG/5'P gaps generated by BLM) by Apel suggest that this lesion is
repaired 3 times slower than the normal abasic site in the same sequence context(16). The rate-
limiting step of the catalysis by Apel remains unclear. Based on the greatly reduced rate on the
substrate analog containing a phosphothioate group (39), Strauss et al. proposed that the chemical
step of the hydrolysis of the phosphodiester bond (or some proceeding step) is rate-limiting(40).
However, the rate of the product release has not been determined and it is possible that the substrate
analog changes the rate-limiting step of the catalysis by Apel . Therefore, it is not clear whether the
observed rate reflects the recognition of the lesion.
The 4'-oxidized abasic sites belong to a family of DNA lesions with an oxidized
deoxyribose(41). This type of DNA damage is proposed to be repaired via the BER pathway(17).
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The structure of another oxidized abasic site lesion, a 2'-deoxyribonolactone (also known as the '-
oxidized abasic site), has been solved using 2D NMR methods(42). In that study, the 2'-
deoxyribonolactone lesion (L) was incorporated into a 1 lmer duplex DNA, 5'-ACLCA-3'/3'-
TGTGT-5'. The structural modeling revealed that the lactone ring at the abasic site adopted an
intrahelical conformation based on two medium NOE interactions between H2'/H2" of L and the 3'
base proton. The base (T) opposite L is intrahelical, as suggested by the unperturbed NOE
connectivities between the base protons and the HI', H2'/H2" protons. Interestingly, in contrast to 1
and 4, stable bas-pair interactions were observed on both sides of L as revealed by the observed
imino protons. Kinetic analysis of the repair of L in a 30mer duplex (5'-CALAC-3'/3'-GTATG-5')
DNA by Ape 1 (43) showed that a kcat for L (2.3 s-') is similar to that for a normal abasic site (2.4 s- )
in the same sequence context with 5 fold higher Km for L (98 nM compared to 21nM for the abasic
site). Since the structural information of L or the abasic site in the 5'-CALAC-3'/3'-GTATG-5' is
not available, no conclusions can be drawn about the importance of the conformational flexibility in
recognition by Apel. The structural studies described in this chapter present a starting point to probe
the conformational diversity of different abasic site lesions. Further studies on a fast time scale in
pre-steady state should yield information that can correlate the difference in structures of abasic sites
to the recognition and repair by Ape 1.
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Chapter 6. Influence of the base (N) opposite an abasic site (X) on the conformation of
d(5'-CCAAAGXACCGGG-3')/d(3'-GGTTTCNTGGCCC-5')
6.1 Introduction
The integrity of the genome is under constant threat of endogenous and exogenous
DNA damaging agents, which produce a variety of DNA damage products. Our group's
interests in understanding the mechanism of bleomycin (BLM)-mediated DNA damage
have led us to the study of the repair of the DNA lesions generated by BLM. Specifically,
we are interested in how the lesions generated by BLM are recognized by DNA repair
enzymes and whether the difference in the efficiency of removing those lesions would
affect BLM's cytotoxicity among different tumor cell lines. In Chapter 5, we carried out
the first structural characterization of duplex DNA containing a 4'-oxidized abasic site
and compared its structure to the structure of duplex DNA containing a normal abasic site
in the same sequence context. In this chapter, in an effort to understand the influence of
the sequence context on the local conformation of a normal abasic site, we describe the
first systematic structural characterization of duplex DNA containing an abasic site (X)
with four different bases (A, G, T, or C) opposite the lesion in the d(5'-CCA AAG XAC
CGG G-3') sequence.
The normal abasic sites (also called apurinic/apyrimidinic sites, or Ap sites) are
common DNA lesions. Lindahl estimated that there is a constant level of 10,000 abasic
sites for a typical human cell(l). Most of the abasic sites are believed to result directly
from spontaneous depurination(l), or indirectly from deamination of cytosine to uracil,
which is then eliminated by uracil glycolylases(2). Abasic sites also result from
hydrolysis of oxidized or alkylated bases by lesion-specific glycosylases(3-5).
The abasic sites in DNA are chemically labile lesions. In solution, the abasic sites
exist as a mixture of ring-closed a and hemiacetals, ring-opened aldehyde, and
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aldehyde hydrate(6, 7). The major components of the mixture are ac and hemiacetals,
with the aldehyde constituting < 1% of the mixture(6, 7). However, the aldehyde form is
susceptible to base-catalyzed 3-elimination, which leads to a strand break(8). The half-
life of an abasic site in duplex DNA has been measured by our group and Sheppard's
group in 5 different sequence contexts and ranges from 200 to 900 h under physiological
conditions(pH 7.5, 150 mM NaCl at 37 °C)(9, 10).
The unrepaired abasic sites are mutagenic( 11). Studies on abasic sites as the template
for DNA replication suggest that several DNA polymerases (including Pol I and III from
E. coli, Pol ac from Drosophila, and T4 DNA polymerase) preferentially incorporate dA
opposite an abasic site(12-14). The selective incorporation of dA opposite an abasic site
is often referred to as the "A rule" (11). In addition, the abasic sites also cause frameshifts
in the replication product generated during translesion DNA synthesis catalyzed by Y-
family DNA polymerases(15-18).
In vivo, both the abasic sites and 4'-oxidized abasic sites are thought to be repaired
via the base excision repair pathway, which is initiated by apurinic/apyrimindic
endonuclease 1 (Apel) in humans(19, 20). Crystallographic studies from the Tainer
group on Apel complexed with duplex DNA containing an abasic site analog
(tetrahydofuran, or THF) have shed light on the structural features that might govern the
specific interactions between this protein and the abasic site lesions (Chapter 1)(21). The
unusual structural features for the THF-containing DNA in the DNA-enzyme complexes,
i.e., large bending of the DNA helical axis, extrahelical flipping of the abasic site (THF)
relative to the phosphodiester backbone, and penetration of protein side chains into the
regions adjacent to the abasic site, have been observed in several other structures of
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abasic site-protein complexes(22, 23). Whether the conformation of the abasic site in
solution is inherently perturbed and recognized by the repair enzymes or whether the
repair enzymes sense flexibility and alter DNA structures in the region of the lesion
remains unclear.
Solution structural studies by 2D NMR methods and molecular modeling on
oligonucleotides containing site-specifically incorporated abasic sites suggest a different
conformation of DNA in solution relative to those of proton-bound in the crystal
structure. Recent studies from our group on d(5'-CCAAAGXACTGGG-3', X denotes the
abasic site) indicated that the deoxyribose moiety was partially extrahelical and that the
overall structure was B-form without significant perturbation(24). Studies of several
different sequences containing the abasic site (X) (5'-GAXAC-3', 5'-AGXCA-3', and 5'-
TTXTT-3') from the Bolton group suggested that the local conformation around the
abasic site is influenced by the identity of the flanking bases and the base opposite the
abasic site(25-27). Because the opposite and flanking bases are proposed to participate in
the interaction with repair enzymes(21-23), elucidating their roles in determining the
local conformation of the abasic site is essential to understanding the recognition of
abasic sites by the Ap endonucleases. However, no systematic efforts have been
undertaken to investigate the modulation of the abasic site conformation by these
adjacent bases.
In the previous chapter, the solution structure of a duplex DNA with an abasic site in
the sequence of 5'-CCA AAG XAC CGG G-3' with an A opposite the abasic site was
investigated in detail as a comparison to the structure of a 4'-oxidized abasic site in the
same sequence context. In this chapter, duplex DNAs containing a normal abasic site
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with the three other bases (G, C, or T, Figure 6.1) opposite the abasic site have been
synthesized and characterized by 2D NMR spectroscopy in the same sequence context.
Molecular modeling and molecular dynamics calculations have been applied to study the
influence of this base on the local conformation of the lesioned DNA. The results,
together with the results from Chapter 5, indicate that all four pieces of oligonucleotides
adopt overall B-form conformation. The bases opposite the abasic site are all intrahelical.
The conformation around the abasic site is more perturbed when the base opposite the
lesion is a pyrimidine (C or T). In these cases, the neighboring base pairs (G6-C21 and
A8-T 19) are closer to each other than those in B-form DNA. Molecular dynamics
simulations reveal that the transient H-bond interactions between the pyrimidine (C20 or
T20) opposite the abasic site and the base 3' to the abasic site might play a role in
perturbing the local conformation. These results provide the first structural insight into
the dynamics of abasic sites that are intrinsically modulated by the bases adjacent to the
abasic site. The long-range goal of these structural studies is to understand how the
conformation of the abasic site in duplex DNA ultimately governs its recognition and the
rate of repair by Apel and other Ap endonucleases.
6.2 Experimental Section
Materials The oligonucleotides were synthesized on a 10 tmol scale by Invitrogen Inc.
E. coli uracil-DNA glycosylase (UDG) was purified from expression plasmid pET21a-
UDG kindly supplied by Dr. James Stivers, Johns Hopkins University, as previously
described. All other chemicals were purchased from Sigma-Aldrich Co.
Preparation of NMR samples The single-stranded oligonucleotide containing an abasic
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site, d(CCA AAG XAC CGG G) (1), (X denotes the abasic site), was synthesized by
treating d(CCA AAG UAC CGG G) with UDG as described in Chapter 5. Compound 1
was annealed in a 1:1 ratio with different templates (2, 3, or 4, Figure 6.1) to generate
duplex DNA containing an abasic site with four bases opposite the lesion (referred to as
Ab/G, Ab/C, Ab/T, and Ab/A, Figure 6.1) following the same procedure to prepare Ab/A
in Chapter 5. The final NMR samples contained Ab/G (2.7 mM), Ab/C (2.5 mM), or
Ab/T (2.7 mM) in 325 ~tL of 10 mM sodium phosphate, 0.2 mM EDTA, pH 6.5 in D2 0
or 10% D20/90% H2O (v/v).
1 4 6 8 11 13
1 5'- CCAAAGXACCGGG -3'
2 3'- GGTTTCGTGGCCC -5'
26 23 2120 19 16 14
Ab/G
1 4 6 8 11 13
1 5- CCAAAGXACCGGG -3'
3 3'-GGTTTCCTGGCCC -5'
26 23 2120 19 16 14
Ab/C
1 4 6 8 11 13
1 5- CCAAAGXACCGGG -3'
4 3'- GGTTTCTTGGCCC -5'
26 23 212019 16 14
Ab/T
1 4 6 8 11 13
5'- CCAAAGXACCGGG -3'
3'- GGTTTCATGGCCC -5'
26 23 2120 19 16 14
Ab/A
Figure 6.1 Sequences of the duplex DNA constructs containing a single abasic site (X)
with four different base (in bold). The structure of Ab/A is investigated in Chapter 5.
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NMR experiments The NMR experiments were performed on a custom-built 591MHz
spectrometer at the Francis Bitter Magnet Laboratory. The raw data were transferred to a
Silicon Graphic workstation and were processed using Felix 2001 (Accelrys Inc.). Proton
chemical shifts were referenced to an internal standard, sodium 3-(trimethylsilyl)-1-
propanesulfonate (TSP) at 0.00 ppm. NOESY (100 ms, 200 ms, and 400 mixing times),
TOCSY (60 ms and 110 ms mixing times), and E-COSY were recorded at 25 °C in D 20.
For NOESY and TOCSY experiments, datasets of 4096 (t2) x 512 (tl) complex points
were acquired with the spectral width of 7022.5 Hz in both dimensions and 32 scans per
tl increment. For the E-COSY experiment, datasets of 4096 (t2) x 1028 (tl) complex
points were acquired with 48 scans per tl increment. A pre-saturation pulse (2 s) was
applied during the recycle delay period to suppress solvent signals in all experiments
carried out in D2 0. Watergate-NOESY experiments (200 ms and 400 ms mixing times)
were carried out in 90% H 2 0/10% D20 at 4 °C. Datasets of 4096 (t2) x 512 (tl) complex
points were acquired with spectral widths of 13020.8 Hz in both dimensions and 32 scans
per t increment. For all the datasets, t dimensions were linear-predicted to 4096 points
and the data were processed with an exponential window function.
'H- 31P HSQC and H3'-selective PH-COSY experiments were performed on the 591
MHz spectrometer at 25 C in D 2 0. 'H-31P HSQC data were acquired with a spectrum
width of 6009.6 Hz in the H dimension and 2000 Hz in the 3 1p dimension (4096 x 128
complex points). H3'-selective PHCOSY experiments with 6009.6 Hz in 'H dimension
and 500 Hz in the 3 1p dimension (4096 x 256 complex points) were performed to measure
coupling constants of the DNA backbone (H3'-C3'-O-P). The H3' protons are specifically
excited by using a band-selective 180° pulse with an EBURP shape(28, 29). In the final
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datasets, the 3 1 p dimension was linear-predicted to 1024 points. The 3 1 p chemical shifts
were referenced to an external trimethyphosphate standard (0.00 ppm).
NMR Structure Determination and Refinement Distance restraints were derived from the
volumes of the cross peaks in NOESY spectra (200 ms mixing time). The peak volumes
were calculated with the peak picking protocol in the Felix 2000 software package.
Volumes of cross peaks between H2' and H2" (1.772 A) or between H5 and H6 (2.460
A) of cytosine were used to calibrate the proton-proton distances. The cross peak
intensities were classified as weak, medium, or strong with the distance restraints of 1.5-
3.0, 2.0-5.0, or 3.0-6.0 A respectively. Alternatively, a more rigorous approach of
iterative relaxation matrix analysis was applied to estimate the distance restraints using
the program MARDIGRAS(30, 31). MARDIGRAS calculations were carried out on the
NOESY spectra with a correlation time of 2.0 ns. For each NOESY cross peak, an upper
and a lower distance restraint was calculated. The final distance restraints derived from
MARDIGRAS calculation agreed well with the manual classification as described above.
Dihedral angle restraints of the deoxyribose moieties were derived from the coupling
constants measured in E-COSY experiments. Except for the abasic site, the coupling
constants of H1'-H2' and H1'-H2" were consistent with a Southern (C2'-endo)
conformation. The summaries of NMR restraints for Ab/G, Ab/C, and Ab/T are presented
in Table 6.1.
All structural calculations were performed on an SGI Altix 3700 LINUX server with
128 Intel Itanium 1.3 GHz processors at the Scripps Research Institute (TSRI) using the
SANDER module of AMBER 8.0(32). The starting model structures were built using the
Biopolymer module of Insight 2000 (Accelrys Inc.). Three starting structures were
239
Table 6.1 Summary of root-mean-square deviation (RMSD), NMR restraints and NMR
violations of the final 10 structures of Ab/G, Ab/C, and Ab/T.
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Ab/G Ab/C Ab/T
ac 13 
Pairwise RMSD(A)
Starting structures 4.54 4.54 4.55 4.55 4.55 4.55
Final 10 structures 1.55 1.45 1.53 1.41 1.62 1.73
Number of NMR restraints
NOE 455 455 478 479 452 453
Dihedral angle 58 58 63 63 62 61
Violation of Restraints
NOE violation (A) 0.071 0.107 0.112 0.089 0.092 0.110
Dihedral angle violation (0) 2.27 2.31 2.39 2.38 2.36 2.38
constructed, including an A-form, a B-form and a third form with arbitrary helical
parameters. The root-mean square deviation (RMSD) for the three structures is 4.5 A.
A Generalized-Born implicit solvent model was applied to simulate the solvent dielectric
constant. The initial model structures were energy minimized by 500 steps of conjugated
gradient minimization followed by 500 steps of steepest descent minimization to remove
high energy interactions introduced during the manual model building. The simulated
annealing was carried out by heating the structure from 300 K to 900 K in 5 ps followed
by cooling back to 300K over the next 15 ps. During the cooling process, weak
temperature coupling (slow cooling) was applied for the first 13 ps followed by strong
temperature coupling (rapid cooling) for the last 2 ps(33). NMR restraints were enforced
during the annealing process with an increasing force constant from 5 to 50 kcal/mol over
the first 3 ps and was maintained at 50 kcal/mol for the rest of the calculation(33). The
annealed structure was then subjected to a 100-ps constant temperature (300 K)
molecular dynamics with NMR restraints. Ten structures for each starting structure (A-,
B-, and the third form) were calculated by sampling conformations during the last 10 ps
of the molecular dynamics at a -ps interval. The resulting 30 structures have an averaged
RMSD of <2.0 A, which indicates a structural convergence after refinement. Ten final
structures were chosen from the 30 structures based on the fewest NMR violations to
represent the ensemble of the averaged structure. The statistical analysis of the final ten
structures is summarized in Table 6.1.
Molecular Dynamics Simulations with an Explicit Solvent Model The molecular
dynamics simulations were performed at a constant temperature (300 K) using the
software AMBER 8.0 following the protocol by Dupradeau et al.(34). The averaged
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structures were first solvated using the TIP3P solvent model with approximately 6, 000
water molecules in an octahedral solvent box with a thickness of 10 A. Twenty four
sodium ions were also included in the calculations to neutralize the system. The
molecular dynamics calculations were carried out on a 3-ns time scale. The conformation
was sampled every 1 ps and was analyzed by the PTRAJ module in Amber 8.0(32).
6.3 Results
Chemical shift Assignments of non-exchangeable protons Standard TOCSY (60 and 110
mixing time) and NOESY (100, 200, and 400 ms mixing time) experiments were
performed to assign non-exchangeable protons of DNA(35). The proton chemical shifts
associated with the deoxyriboses were assigned using TOCSY experiments. The NOE
connectivities between base protons (H6 of pyrimidines, H8 of purines) and deoxyribose
protons (HI', H2'/H2", H3', H4', and most of H5') were established by analyzing the
NOESY spectra (200 ms mixing time) to confirm the assignments. NOE connectivities
between H5 and H6 protons of cytosines and between methyl and H6 protons of
thymidines were also used to assist the assignments of NOE signals in overlapping
regions.
For Ab/G, the NOE connectivities in the base-HI' region are straightforward due to
dispersion of signals (shown in Figure 6.2 for Ab/G). On the strand of Ab/G containing
the abasic site, the NOE connectivity is disrupted between G6 and A8 as indicated by x
(Figure 6.2), consistent with the presence of the abasic site. NOE connectivities are
observed on the opposite strand to the abasic site between T19 and C21, suggesting that
the base opposite to the abasic site (G20) adopts an intrahelical conformation as in
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regular B-form DNA. Similar results were obtained for Ab/A (Figure 5.4, Chapter 5).
For Ab/C, the NOE connectivities between the H 1' protons and the base protons are
shown in Figure 6.3. Surprisingly, weak NOE interactions are detected between G6 HI'
and A8 H8 (the dashed box in Figure 6.3), in contrast to the absence of NOE
connectivities for Ab/G and Ab/A. The base-Hi' NOE connectivities for the residues on
the strand opposite the abasic site (C20 to T24) were difficult to assign due to
overlapping signals. To confirm the base-HI' connectivities for these residues, the
NOESY spectrum shown in Figure 6.4A was used. This region shows the connectivities
between the base proton and the methyl protons of thymidines. The chemical shift of the
base proton (H6) of C21 was assigned by its connectivity with T22 methyl protons
(Figure 6.4A). In addition, the TOCSY spectrum showing the through-bond
connectivities between H5 and H6 of cytosines is presented in Figure 6.4B to confirm the
assignments of base protons associated cytosines.
For Ab/T, the base-HI' NOE connectivities are shown in Figure 6.5. Weak NOE
interactions were detected between G6 HI' and A8 H8 (indicated by the arrow in Figure
6.3), similar to those observed for Ab/C. The base-HI' NOE connectivities for the
residues on the strand opposite the abasic site (G18 to T24) were more difficult to
establish due to the overlapping signals associated with T19, T20, T22, T23, and T24.
For these residues, the NOE connectivities are also analyzed in the region between the
base proton and the methyl protons of thymidines (Figure 6.6, solid lines). In this region,
the NOE connectivities were readily established from G18 to T20 and from C21 to T24
via the well-resolved signals of the methyl protons of thymidines.
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1 4 6 8
5'- CCAAAGXA
3'- GGTTTCGT
26 23 21 2019
Ab/G
11 13
CCGGG -3'
GGCCC -5'
16 14
8.5 8.3 8.1 7.9 7.7 7.5 7.3 7.1
Hl (ppm)
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G25 G . T24
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Hl (ppm)
7.5 7.3 7.1
Figure 6.2 The NOESY spectrum (200 ms mixing time) of Ab/G showing the NOE
connectivities between base (H8/H6) protons and HI'. The cross peak between A8H8 and
C9H5 is indicated by an arrow. "x" denotes disruption of the connectivity between G6
and A8 by the abasic site.
244
5.0
5.2
5.4
5.6
i -
A8H8-C9H5
C2 C
C9
0
A 5.8
6.0
6.2
6.4
5.0
5.2
5.4
5.6
_
0.
0.
5.8
6.0
6.2
6.4
9 t
t
!
1 4 6 8 11 13
5'- CCAAAGXACCGGG -3'
3'- GGTTTCCTGGCCC -5'
26 23 212019 16 14
Ab/C
8.3 8.1 7.9 7.7 7.5 7.3 7.1
HI (ppm)
a 1
e6: .I GIA
O
.- ' -* G25
A3 5.^ 
C21 
(14 °C1
* G26
e
0
f16
24
1'
~~I~~~T9m)-4
T22 T23 p
7.5 7.3 7.1
Figure 6.3 The NOESY spectrum (200 ms mixing time) of Ab/C showing the NOE
connectivity between base (H8/H6) protons and HI'. Two cross peaks (of c and I
anomers) between A8H8 and G6H1' (in the dashed box) are shown at a lower contour
level. The cross peaks between A8H8 and C9H5 are also indicated by arrows.
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Figure 6.4 Chemical shift assignments of base protons of C20, C21, T22, T23, and T24
for Ab/C. A: The NOESY (200 ms mixing time) spectrum showing the connectivities
associated with T methyl protons (solid lines). B: The TOCSY (60 ms mixing time)
spectrum showing the cross peaks between H5 and H6 protons of C. The dashed lines
indicated the chemical shift assignments of C21 (associated with the c and 3 anomers of
the abasic site), which are consistent with the observed connectivities with T22 methyl
protons.
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Figure 6.5 The NOESY spectrum (200 ms mixing time) of Ab/T showing the NOE
connectivity between base (H8/H6) protons and HI' protons. The cross peaks between
A8H8 and G6H1' and between A8H8 and C9H5 are indicated by the arrow and the label.
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Figure 6.6 The NOESY (200 ms mixing time) spectrum showing the connectivities
associated with T methyl protons (solid lines). The NOE interactions involving the T
methyl protons confirm the chemical shift assignments of base protons of G 18-T20 and
C21-T24.
Chemical shift Assignments of exchangeable protons The exchangeable protons (imino
protons of guanines and amino protons of cytosines) of each DNA with an abasic site are
indicative of Watson-Crick base pair interactions and global conformations. These
exchangeable protons were assigned by Watergate-NOESY experiments at 4 °C in 10%
D20/H 20 (v/v). Figure 6.7 (A-D) shows the imino proton region (12-15 ppm) with the
overlaid D spectrum of each oligonucleotide. This region shows the cross peaks of T-
imino to A-H2 protons and G-imino to C-amino protons. For Ab/A, 8 out of total 12
imino protons were detected by the Watergate-NOESY experiment (Figure 6.7A). The
imino protons associated with terminal base pairs (C1-G26 and G13-C14) and base pairs
adjacent to the abasic site (G6-C21 and A8-T19) could not be detected in either D or 2D
spectra. The absence of these imino proton signals suggests weak base pair interactions
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G18
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and fast exchange with solvent.
For Ab/G, besides some 8 imino signals detected in Ab/A, a weak signal is detected
in the D spectrum(Figure 6.7B, indicated by a red arrow). This signal is assigned as the
T19 imino protons based on a weak cross peak with the A8H2 proton. For Ab/C, a
similar weak, broad feature is observed, which might also be associated with T19
(indicated by the red arrow in Figure 6.7 C). Since there was no detectable cross peak
associated with this signal due to its low intensity, the assignment of this signal to T19 is
tentative.
For Ab/T, in addition to the 8 imino proton signals that were detected in other
constructs, a weak signal appears as a doublet upfield from the imino protons of guanines
(red arrow, Figure 6.7 D). This signal has been assigned to the imino protons of G6 based
on their cross peaks with the amino protons of C21 (solid red line, Figure 6.7 D). The
doublet feature is associated with the two anomeric states of the abasic site in Ab/T (cc
and , see the discussion below). Another interesting feature observed for the imino
protons in Ab/T is the signal associated with G18 (blue lines in Figure 6.7 D). This signal
is the downfield-shifted compared to those in other three constructs (blue lines in Figure
6.7 A-C). The detection of the G6 imino proton and the downfield-shifted G18 imino
protons (G6 and G18 residues are directly adjacent to or near the abasic site in Ab/T)
suggest that the base-pair interactions around the abasic site in Ab/T are different from
those in other constructs.
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Figure 6.7 Watergate-NOESY spectra (200 ms mixing time) of the four duplex DNAs
containing an abasic siteshowing the cross peaks involving T-imino to A-H2 and G-
imino to C-amino protons. The 1D spectra containing the imino proton signals are
overlaid on the top of the 2D spectra. The NOE signals associated with the G 18 imino
proton are indicated by the blue solid line.The NOE signals associated with the G6 imino
proton in D (Abrr) are indicated by the red solid line.
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In contrast to the imino protons, amino protons of each cytosine (including the amino
protons of terminal C1 and C14, as well as C21 adjacent to the abasic site) have been
assigned in the base-HI' region where the amino protons show strong cross peaks with
both C-H5 and C-H6. An example of the strategy to assign the chemical shifts of the
cytosine amino protons is shown in Figure 6.8 for Ab/G. The NOE connectivities
between each C-H5 proton and C-H6/ C-amino protons are indicated by red solid lines.
Strong cross peaks between the two amino protons are indicated by red dashed lines. One
of the two amino protons is shifted downfield relative to the other due to the H-bonding
interaction with the G-imino proton. The intensity of cross peaks involving the amino
protons at C21 was much weaker than other C-amino protons (Figure 6.8, Cross peak H
and its connected signals), suggesting that the H-bonding interactions of this G6-C21
base pair, which is 3' to the abasic site, are weaker than other base pairs. The same
strategy has been used to assign the exchangeable amino protons of cytosines in the other
constructs. The chemical shift assignments of both non-exchangeable and exchangeable
protons are summarized in Table 6.2 (Ab/G), Table 6.3 (Ab/C), Table 6.4 (Ab/T), and
Table 5.4 in Chapter 5 (Ab/A).
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Figure 6.8 The Watergate-NOESY spectrum (200 ms mixing time) of Ab/G as an
example to illustrate the strategy to assign the chemical shifts of 2 amino protons of C.
The NOE connectivities between C-H6 protons and C-H5/C-amino (H4I/H42) protons
are indicated by the solid red lines. The NOE connectivities between the two amino
protons of C are indicated by the dashed red lines. Cross peaks between the two amino
protons of C are assigned as A (CI5), B (CI6), C (C2), D (CIO), E (C9), F (CI), G
(CI4), and H (C2l).
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Table 6.2 Proton chemical shift assignments of Ab/G.
H8/H6 Me/H5 H ' H2' H2" H3' H4' H5'/" -NH2, -NH,
3.740/Cl 7.766 5.984 5.989 2.067 2.507 4.680 n.d'. 3740/ 8.018/7.1003.774
C2 7.553 5.748 5.348 2.036 2.309 4.823 4.087 4.022 8.749/6.982
A3 8.253 5.781 2.760 2.844 5.044 4.368 4117/4.004
A4 8.106 5.801 2.600 2.785 5.044 4.412 4.208
A5 7.959 5.963 2.516 2.782 4.992 4.399 4.208
G6 7.751 6.172 2.380 2.672 4.910 4.185 4.136/4.134
Ab-ca 5.222 2.113 1.850 4.632
Ab- 5.275 1.871 2.140 4.678
A8 8.326 6.288 2.751 2.931 4.975 4.438 n.d.
C9 7.329 5.292 5.854 2.046 2.392 4.810 4.128 n.d. 8.147/6.661
CO10 7.379 5.545 5.563 1.893 2.270 4.819 4.074 n.d. 8.615/6.874
Gl1 7.843 5.449 2.667 2.703 4.958 4.308 4.065/ 13.244
3.956
G12 7.742 5.791 2.600 2.742 4.992 4.312 4.156/ 13.229
4.117
G13 7.777 6.143 2.506 2.356 4.650 4.386 4.230/4.126
C14 7.820 5.999 6.014 2.164 2.563 4.689 nd. 3822/ 8.016/7.134
3.774
C15 7.650 5.712 6.009 2.203 2.470 4.867 4.212 4.078 8.498/6.934
C16 7.443 5.672 5.596 2.043 2.383 4.854 n.d. 4.126/ 8.689/6.992
4.091
G17 7.866 5.677 2.703 2.747 5.010 4.364 4.121 13.138
G18 7.688 5.928 2.491 2.696 4.914 4.373 4.204 12.866
T19 7.147 1.418 5.951 2.046 2.442 4.828 4.204 4.173/
4.126
G20 7.733 5.938 2.498 2.702 4.835 4.210 n.d.
C21 7.553 5.357 5.990 2.185 2.506 4.770 4.272 412 7.809/6.744
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 4 . 72 78 0/.44.128
T22 7.524 1.601 6.131 2.167 2.630 4.914 4.212 4.130/ 14.197
______~~~~~~4.1 14.1 174.117
T23 7.524 1.720 6.131 2.167 2.633 4.914 4.212 4.130/ 14.1184.1 4.117 8 _ _ __ _ _4.117
T24 7.354 1.764 5.730 1.968 2.309 4.880 4.212 4121/ 14.127
4.091
G25 7.880 5.685 2.693 2.737 4.992 4.368 4.108/ 13.004
4.078
G26 7.820 6.158 2.523 2.363 4.654 4.373 4217/1 1 1 i I I____ not  __ _ de4.143 _in g l
(an.d., not determined due to overlapping signals).
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Table 6.3 Proton chemical shift assignments of Ab/C.
H8/H6 Me/H5 HI' H2' H2" H3' H4' H5'/" -NH2, -NH, orH2
3.762/Cl 1 7.815 5.999 6.003 n.da. n.d. 4.681 n.d. 3.762/ 7.099/7.9833.778
4.092/C2 7.556 5.756 5.371 2.041 2.316 4.832 4.340 4.092/ 6.986/8.7324.018
A3 8.248 5.808 2.757 2.837 5.045 4.368 4.112/ 7.3494.013
A4 8.078 2.557 2.744 5.014 4.378 4.196
A5-a 7.892 5.851 2.350 2.601 4.956 4.333 4.2044333 4.204
A5-3 7.875 5.881 n.d. 2.645 4.954
G6-t 7.504 5.689 .d. n.d. 4.979 4.502 4.129
n~. n.d. 4502 4.129
G6-13 7.557 5.704 4.983
Ab-a 5.468 2.221 1.950 4.515
.................................................. n.d. n.d.-........Ab-_ 5.472 2.030 2.1122 4.439
4.105/A8-ct 8.146 6.219 2.792 2.887 4.929 4.494 4.14.138
4.142/A8-1 8.229 6.264 2.829 2.915 4.894 4.454 4.1804.180
C9-o( 7.374 5.872 2.036 2.394 4.793 n.d. n.d. 6.660/8.114
C9-1 7.345 6.660/8.155
CO10 7.412 5.553 5.510 1.931 2.276 4.805 n.d. 4.021 6.904/8.642
4.041/G Il1 7.827 5.488 2.644 2.677 4.962 4.330 4.4/ 13.2633.929
4.130/G12 7.738 5.772 2.592 2.742 4.987 4.380 4.1 13.2334.198
G13 7.771 6.139 2.506 2.361 4.648 4.380 4.203/4.127
3.773/C14 7.813 6.000 6.010 n.d. n.d. 4.688 4.213 3. 7.132/7.9753.811
C 15 7.643 5.711 6.003 n.d. n.d. 4.869 n.d. 4.061 6.934/8.481
4.084/C16 7.430 5.666 5.611 2.033 2.384 4.850 n.d. 4084/ 6.986/8.6464.117
G17 7.858 5.666 n.d. n.d. 4.994 n.d. n.d. 13.138
G18-Ca 7.655 5.915 2.474 2.632 4.916 4.368 4.198/ 12.8507.655 4.916 4.368 12850G 18-13 5.942 2.514 2.659 4.136
4099/
T19-a 7.223 5.963 2.269 2.319 4.892 4.370 4.
4.145
T19-3 7.279 6.033 2.269 2.356 4.889 4.307 4.102/
4.183
C20-a 7.757 5.807C20-aC 7.757 5.807 6.172 2.271 2.516 n.d. n.d. n.d.
C20-1 7.779 5.835
C21-a 7.893 5.949 6.023 2.068 2.522 4.741 n.d. n.d.
C21-_ 7.832 5.904
T22-a 7.594 1.723 6. 2.273 2.590 4.901 4.254 4.178/ 14093
T22-3 7.634 1.743 6.118 4.289 4.145
T23-at 7.521 6078 4173/T23-a 7521 1.744 6.078 2.138 2.560 4.895 4.264 41 14.097
T23-13 7.536 6,110 4.185
T24 7.357 1.760 5.721 1.971 2.299 4.861 n.d. 4.184 14.110
G25 7.863 5.679 2.682 2.734 4.977 4.355 4.206 12.996
4.141/G26 7.813 6.151 2.506 2.361 4.647 4.211 4.149
_____n.d., not determined due to overlapping signals).049(a n.d., not determined due to overlapping signals).
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Table 6.4 Proton chemical shift assignments of Ab/T.
H8/H6 Me/H5 HI' H2' H2" H3' H4' H5'/" -NH2, -NH, orH2
3.748/
CI 7.766 5.982 5.982 2.072 2.220 4.680 4.118 3.748 7.092/7.9583.778
C2 7.556 5.747 5.350 2.040 2.317 4.831 n.d. 4.086 6.974/8.728
4.121/
A3 8.252 5.789 2.761 2.845 5.048 4.367 4.4.000
A4 8.112 5.755 2.597 2.767 5.034 4.386 4.195
A5 7.923 5.896 2.433 2.716 4.997 4.361 4.188
G6 7.556 5.903 2.312 2.285 n.d. n.d. n.d. 12.396/12.453
Ab-ca 5.583 2.489 2.051 4.590
Ab- _ 5.745 2.471 2.048 4.428
4.186/
A8-cc 7.787 6.063 446 416A8-a 7.787 6.063 2.763 2.879 4.720 4.416 4.132
A8-3 7.811 6.064 4.261 4.149
4.093/
C9 7.352 5.199 5.681 2.059 2.375 4.704 4.169 4.0 6.622/7.9544.026
4.128/
C10 7.430 5.559 5.621 1.898 2.296 4.806 4.213 4.128/ 6.919/8.5834.100
G Il1 7.830 5.503 2.627 2.681 4.949 4.292 4.153 13.239
G12 7.734 5.788 2.588 2.737 4.983 4.382 4.290 13.231
G13 7.768 6.152 2.501 2.361 4.650 4.535 n.d.
3.810/
C14 7.821 6.000 5.991 2.056 2.165 4.695 4.151 3810/ 7.147/7.9993.834
C15 7.646 5.708 6.019 2.211 2.484 4.871 4.213 4.072 6.971/8.510
4.123/
C16 7.452 5.677 5.600 2.046 2.386 4.851 n.d. 4.123/ 7.023/8.6934.098
4.118/
G17 7.864 5.749 2.700 2.781 5.005 4.373 4. 13.1284.047
G18-cL 7.710G18-a 7.710 5.989 2.546 2.753 4.970 4.392 4.211 13.090
G18-f 7.706
T19-a 7.525 1.654 6.206 4.348 4.219
2.339 2.503 4.904 4.199/
T19-P 7.500 1.618 6.184 4.341 4.14.132
T20-a 7.563 1.538 5.996 2.072 2.525 4.813 n.d. n.d
T20-3 7.547 1.558 5.988
4.181/ 6.971/8.030
C21 7.670 5.707 6.097 2.273 2.577 4.845 4.260 4.181/ 6.986/8.016
............................ 
~~~~~~~4.146 6.986/8.016
T22 7.568 1.678 6.016 2.286 2.623 4.926 4.271 4.158 14.150
4.195/
T23 7.516 1.736 6.122 2.145 2.576 4.901 4.275 4.14.1464.146
4.190/T24 7.353 1.764 6.107 1.968 2.298 4.862 4.410 4.19 14.1354.179
4.109/G25 7.874 5.867 2.678 2.714 4.982 4.359 4.0 12.9984.047
G26 7.817 6.143 2.519 2.357 4.644 
(a n.d., not determined due to overlapping signals).
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Chemical shift assignments of the protons associated with the abasic site deoxyribose
Assignments of the protons associated with the abasic-site deoxyribose are key to
distinguishing the oc and anomers and to identifying the NOE interactions between the
abasic site and neighboring bases. The H ', H2'/H2", and H3' protons associated with the
abasic site deoxyribose were assigned using the 60 ms TOCSY spectra (Figure 6.9 and
for Ab/A, see Chapter 5, Figure 5.6). In all of the oligonucleotides, the chemical shifts of
the protons associated with the abasic site deoxyribose are shifted to some extent upfield
(HI', 5.0-5.5 ppm; H2'/2', 1.8/2.0 ppm; H3', 4.5-4.6 ppm) from the generic deoxyribose
protons (HI', 5.3-6.5 ppm; H2'/2', 2.0-3.0 ppm; H3', 4.7-5.0 ppm). The base opposite
the abasic site modulates the chemical shift of the HI'. When it is a purine, the chemical
shift of HI' is between 5.2-5.3 ppm (Figure 6.9 A). When it is a pyrimidine, the chemical
shift of HI' is between 5.5 and 5.6 ppm in the downfield-shifted region of the chemical
shifts of most HI' deoxyribose protons (Figure 6.9 B and C). The H4' and H5'/5" protons
could not be assigned due to spectral crowding in those regions.
The sugar protons at each abasic site exist as two sets of signals (Figure 6.9, solid red
lines), consistent with the ac and anomeric forms. The assignment of each anomer was
achieved using NOESY experiments (200 ms mixing time) based on the relative
intensities of the NOE signals between HI' and H2'/2". For the ac anomer, the HI' is
closer to H2', producing a more intense cross peak than to H2". The intensity pattern is
reversed for the anomer. The NOESY spectra containing the abasic site proton regions
are shown in Figure 6.10 (Ab/G), Figure 6.11 (Ab/C) and Figure 6.12 (Ab/T) with the
connectivity of H2' and H2" indicated by solid red lines. The ratio of o:3 in each case is
approximately 60:40 based on relative signal intensities associated with each anomer.
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Figure 6.9 Chemical shift assignments of protons associated with the abasic site
deoxyribose by TOCSY experiments (60 ms mixing time). For each oligonucleotide, the
through-bond connectivities between HI' and H2'/2" and between H3' and H2'/2" are
indicated by the solid red lines. The dashed red lines indicate the connectivities between
HI' and H3' through the same H2'/2" proton.
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Figure 6.10 The NOESY spectrum (200 ms mixing time) of Ab/G showing the NOE
connectivities between abase protons (HI' or H3' to H2'/H2"). Chemical shifts of the
abasic protons are labeled.
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Figure 6.11 The NOESY spectrum (200ms mixing time) of Able showing the NOE
connectivity between abase protons (H l' or H3' to H2' 1H2"). Chemical shifts of the
abasic protons are labeled.
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Figure 6.12 The NOESY spectrum (200 ms mixing time) of Abff showing the NOE
connectivity between abase protons (HI' or H3' to H2'1H2"). Chemical shifts of the
abasic protons are labeled.
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Sugar conformations To obtain insight into the sugar pucker of DNA, the coupling
constants of the deoxyribose protons have been measured using E-COSY experiments.
For all the residues in each duplex (except the abasic site), the values of JHI',H2 ' are
between 8 and 10 Hz and JHl', H2" are between 5 and 6.5 Hz. This range of coupling
constants is characteristic for a 2'-endo sugar pucker (S-type) for B-form DNA. The
coupling constants have also been measured for the abasic site in Ab/C and Ab/A (Figure
6.13). The observed coupling constants are consistent with a near-N-type (01'-endo)
conformation for cc anomer and a near-S-type (Cl'-exo) conformation for anomer for
both Ab/A and Ab/C. For Ab/G and Ab/T, coupling constant information at the abasic
site was not available due to the low cross peak intensities. Therefore, the sugar
conformations were not restrained during the modeling in Ab/G or Ab/T.
Phosphodiester backbone conformations In order to characterize the conformation of the
phosphodiester backbone, the dihedral angles of H3'-C3'-03'-P have been determined by
measuring the JH3', P coupling constants using H3'-selective 3IP-'H COSY experiments.
Due to the small dispersion of H3' and 3 1p chemical shifts, not all cross peaks were well
resolved. For Ab/G and Ab/A, all 31 p chemical shifts were between -3.8 and -5.0 ppm and
all the JH3'-P values were within 6-8 Hz, consistent with those expected for a generic B-
form DNA with regular backbone conformation.
For Ab/C, the majority of the 31p chemical shifts were between -3.8 and -5.0 ppm and
the JH 3 '-P values were within 6-8 Hz, consistent with B-form DNA. In addition, three 31p
signals were shifted downfield between -3. lppm and -3.4 ppm (cross peak C, D, and E in
Figure 6.14). These signals were assigned to be associated with the bases adjacent to the
abasic sites (G6, A8, and T19) based on the proton chemical shifts (H3' and H4') with
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these signals in 31p_1H HSQC experiments. Although the coupling constants associated
with these peaks were within the normal range (6-8 Hz), the perturbed 31p chemical shifts
suggest that the backbone conformations at these sitesare different from B-form DNA.
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Figure 6.13 Coupling constants between HI' and H2' IH2" measured by E-COSY
experiments for the abasic sites.A, AblA; B, Ab/C. The chemical shiftassignments of
these abasic protons are also shown. Due to overlapping signals,the coupling constant
between HI' and H2" for the a anomer in Ab/C cannot be accurately determined.
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Figure 6.14 H3' -selective PH-COSY experiment to measure the backbone H3' -C3' -03'-P
coupling constants of Ab/C. The phase-sensitive cross peaks are assigned as A: Ab7-a,
B, Ab7-~, C: A8, D: T19, and E: G6.
For Abrr, most of the 31p chemical shifts were between -3.8 and -5.0 ppm and the JH3,_
p values were within 6-8 Hz, consistent with B-form DNA. In addition, two 31p signals
are shifted downfield between -3.2ppm and -3.5 ppm (cross peak C and D in Figure
6.15). These two signals are assigned to be associated with G6 and T19 that are adjacent
to the abasic sites based on the proton chemical shifts (H3' and H4') with these signals in
31p_1H HSQC experiments. The coupling constants associated with these two 31p signals
are within the normal range (6-8 Hz). As discussed above for Ab/C, the perturbed 31p ,
chemical shifts suggest that the backbone conformations at those sites are different from
B-form DNA.
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Figure 6.15 H3' -selective PH-COSY experiment to measure the backbone H3' -C3' -03'-P
coupling constants of Abrr. The phase-sensitive cross peaks are assigned as A: Ab7 -a,
B, Ab7-f}, C: G6, D: T19.
The Karplus equation CJ(HCOP) = 15.3 cos2<p- 6.1 cos<p+1.6) was used to derive
dihedral angle constraints for H3' -C3' -03' -P from the experimentally determined
coupling constants (JID,_p). As noted above, the 31p chemical shifts and JH3,'p associated
with most residues in all the oligonucleotides are within the normal envelop expected for
B-form DNA. Therefore, the H3' -C3' -03' -P dihedral angles for these residues were
constrained to be ~0:t: 25° as in B-form DNA. For G6, AS and T19 in Ab/C and G6
and T19 in Ab/I', the unusually downfield shifted 31p chemical shifts may be indicative of
possibly perturbed dihedral angles. For these residues in Ab/C and Abff, all four
possible solutions to the Karplus equation (:t 40° and :t115°) were tested in separate
structural calculations. Only the solution that consistently gave the lowest energy was
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used in the final structural calculations. The final H3'-C3'-O3'-P dihedral angle
constraints for Ab/C were set to 40° + 25° (G6), -40° + 25° (A8), and -40° ±+ 25° (T19);
for Ab/T, the H3'-C3'-03'-P dihedral angle constraints were set to 40° + 25° (G6) and -
40° ±+ 25° (T19).
NOE interactions involving the protons associated with the abasic site and adjacent
bases A number of NOE interactions associated with the abasic sites and neighboring
bases have been identified and are summarized in Table 6.5. These NOE interactions,
along with the coupling constants, are essential in defining the conformation of the abasic
site. The NOE interactions for Ab/A were presented in Chapter 5. For each anomer of
Ab/G, three weak NOE interactions were observed between the sugar protons (H2'/H2",
and H3') of the abasic site and the base proton (H8) of A8 that is 3' to the abasic site. For
Ab/C, medium NOE interactions were observed between A8H8 and H3' of the abasic
site, as well as weak NOE interactions between A8H8 and H2'/H2" of the abasic site. For
Ab/T, medium NOE interactions were observed between A8H8 and H3' of the abasic site
for each anomer and a weak NOE interaction between A8H8 and H2' of the abasic site in
the c anomer.
Based on previous studies(24) and the results in Chapter 5 for Ab/A, a partial
extrahelical conformation of the abasic site is usually indicated by this unique NOE
pattern: medium NOE interactions between the H3' proton of the abasic site and A8-H8
and weak NOE interactions between the H2'/2" protons and A8-H8. The NOE pattern for
Ab/C and Ab/T therefore predicts that the abasic site deoxyribose in these two constructs
most likely adopts a partial extrahelical conformation.
For Ab/C and Ab/T, several unusual NOE interactions in the abasic site region were
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also observed between G6 and A8, the two bases adjacent to the abasic site. For Ab/C, a
weak NOE signal was observed between A8-H8 and G6-HI' for both anomers (indicated
by the dashed box in Figure 6.3). In addition, a weak NOE signal between A8-H8 and
G6-H2" was also observed. These NOE interactions suggest that A8 and G6 are in close
proximity in this construct relative to those in B-form DNA. These NOE interactions,
together with the downfield-shifted 3 1 p signals associated with the G6 and A8 residues,
indicate that the abasic site region of Ab/C adopts a different conformation from that of
Ab/A and Ab/G.
Table 6.5 Summary of the NOE interactions between protons around the abasic sites.
Ab/A(cc) Ab/A (l) Ab/G () Ab/G(P)
A8H8-AbH3' m A8H8-AbH3' m A8H8-AbH3' w A8H8-AbH3' w
A8H8-AbH2' w A8H8-AbH2' w A8H8-AbH2' w A8H8-AbH2' w
A8H8-AbH2" w A8H8-AbH2" w A8H8-AbH2" w A8H8-AbH2" w
Ab/T (oc) Ab/T () Ab/C (oc) Ab/C(P)
A8H8-AbH3' m A8H8-AbH3' m A8H8-AbH3' m A8H8-AbH3' m
A8H8-AbH2' wv A8H8-AbH2' w
A8H8-AbH2" w A8H8-AbH2" w
A8H8-G6H1' w A8H8-G6H1' w A8H8-G6H1' w A8H8-G6H1' w
A8H8-G6H2" w A8H8-G6H2" w
G6H4'-AbH2' w
G6H4'-AbH2" w
For Ab/T, a weak NOE signal was observed between A8-H8 and G6-H1' for each
anomer (arrow in Figure 6.4), similar to the observation for Ab/C. This NOE interaction
suggests that A8 and G6 in Ab/T are also in closer proximity compared to those in B-
form DNA. No NOE signals were observed between A8H8 and G6-H2", suggesting
subtle structural differences between Ab/C and Ab/T in the abasic site region.
266
Averaged structures of Ab/G, Ab/C, and Ab/T Ten structures of the a and 3 anomers of
Ab/G. Ab/C, and Ab/T (also Ab/A in Chapter 5) were calculated from 3 starting
structures using the experimentally determined distance and dihedral angle constraints.
None of the ten structures contained NOE violations > 0.5 A or dihedral angle violations
> 5° . The RMSD's of the final ten structures are between 1.5 and 1.7 A (Table 6.1). An
overlay of the ten structures for each construct is shown in Figure 6.16. The results reveal
that the overall structures are B-form with the bases (colored in blue) opposite the abasic
site stacked intrahelically between flanking base pairs. Compared to the base opposite to
the lesion, different conformations are observed for the abasic site deoxyribose (colored
in red, Figure 6.16) and bases adjacent to it (G6 and A8). The discussion below will focus
on the abasic site conformation in the averaged structure of each construct (shown in
Figure 6.17-6.19).
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A (aanomer)
Ab/A
B (~anomer)
Ab/A
Ab/G
Ab/G
Ab/C
Ab/C
Ab/f
Ab/f
Figure 6.16 The overlay often final structures of Ab/A, Ab/G, Able, and AblT. The
abasic site is colored in red and the base opposite the lesion is colored in blue. A,
Structures with the a anomer at the abasic site; B, Structures with the ~ anomer at the
abasic site.
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A (a anomer)
B (~anomer)
Figure 6.17 A stereo view of the conformation of the abasic site region in the averaged
structure of Ab/G. A, a anomer; B, ~ anomer. In B, only the abasic site and the opposite
bases are colored for clarity.
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A (a anomer)
B (~anomer)
Figure 6.18 A stereo view of the conformation of the abasic site region in the averaged
structure of Able. A, a anomer; B, ~ anomer. The abasic site deoxyribose and the base
opposite the lesion are colored.
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A (a anomer)
B (~anomer)
Figure 6.19 The stereo view of the conformation of the abasic site region in the averaged
structure of Abrr. A, a anomer; B, ~ anomer. The abasic site deoxyribose and the base
opposite the lesion are colored.
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Abasic site conformation The averaged structures of Ab/G (Figure 6.17) show that in the
cc anomer, the abasic site adopts an intrahelical conformation and in the 3 anomer, the
abasic site is partially extrahelical. The NOE interactions associated with the abasic site
protons in Ab/G are weak (Table 6.5) and accommodate a variety of conformations. In
the final ten structures for the cc anomer, two of them show that the 1'-OH group is within
the H-bonding distance from the imino group of the opposite G20. However, no imino
proton signals were detected for G20, implying that the H-bonding interaction, if exists,
is transient. The partially extrahelical conformation for the Ab/G anomer is very similar
to that of Ab/A determined in Chapter 5.
Figure 6.18 and 6.19 show the abasic site conformations of Ab/C and Ab/T. In all
structures, the abasic site is extrahelical. In addition, the backbone conformation around
the abasic site is perturbed so that G6 and A8 are closer to each other than in a normal B-
form DNA. These results are consistent with and defined by the NOE interactions
between the base proton of A8 and several sugar protons of G6 in both Ab/C and Ab/T
(Table 6.5).
Molecular dynamics simulations of abasic site-containing duplex DNA Molecular
dynamics simulations were carried out to characterize the conformational flexibility in
the abasic site region of all constructs. For Ab/G, the conformational flexibility is
dominated by the motion of the abasic site moiety. Figure 6.20 shows an overlay of 10
snapshots representing 20 ps of molecular dynamics simulations for the c and anomer
of Ab/G. The results indicate that the abasic site deoxyribose adopts a range of
conformations from intrahelical to extrahelical (Figure 6.20 A and B). The extrahelical
motion of the abasic site deoxyribose occurs without significant distortion of
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conformations of adjacent residues, which is illustrated by the snapshot of the a anomer
of Ab/G with an extrahelical abasic site (Figure 6.20 C). A similar extrahelical motion of
the abasic site has also been observed with Ab/A during the simulation (Chapter 5).
A
C
B
Figure 6.20 Molecular dynamics simulation of Ab/G showing the conformational
flexibility at the abasic site. A, (a anomer) An overlay of ten snapshots representing 20
ps molecular dynamics simulations to show the conformational flexibility of the abasic
site (colored in CPK); B, (~ anomer) An overlay of ten snapshots representing 20 ps
molecular dynamics simulations to show the conformational flexibility of the abasic site
(colored in CPK). C: A stereo view of one of the ten snapshots in A (a anomer) showing
the extrahelical conformation of the abasic site (Ab).
273
The molecular dynamics simulations of Ab/C reveal that the abasic site deoxyribose
remains partially extrahelical without significant conformational change. The flexibility
of the abasic site region is largely reflected by the motion associated with A8, 3' to the
abasic site. Figure 6.21A shows that A8 (in stick) adopts a range of conformations
(indicated by the double-headed arrows) that are capable of forming H-bonding
interactions with both T 19 (its expected base-pair partner) and C20 (the base opposite the
abasic site). Figure 6.21 B shows the snapshot with the transient H-bonding interaction
between A8 and C20 (viewed from the top along the helical axis). Quantitative analysis
of the distance (red trace, Figure 6.22) and angle (blue trace, Figure 6.22) between the H-
bond donor of C20 and the accepter of A8 during simulation suggests that the optimal H-
bond interaction occurs every -15 ps between C20 and A8 during the simulation (black,
triangular dot, Figure 6.22).
The molecular dynamics simulations of Ab/T reveal that the abasic site deoxyribose
remains partially extrahelical, similar to Ab/C. The flexibility of the abasic site region of
Ab/T is also dominated by the motion associated with A8 3' to the abasic site. Figure
6.23A shows that A8 (in stick) adopts a range of conformations (indicated by the double-
headed arrows) that are capable of forming H-bonding interactions with both T19 (its
expected base-pair partner) and T20 (the base opposite the abasic site). Figure 6.23 B
shows the snapshot with the transient H-bonding interaction between A8 and T20
(viewed from the top along the helical axis). Quantitative analysis suggests that the
optimal H-bond interaction occurs every 8 ps between T20 and A8, more frequent than
that in Ab/C (Figure 6.24). This observation can be explained by the stronger interaction
(2 H-bonds) between T20 and A8 than that in Ab/C (1 H-bond between C20 and A8).
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AB
1 4 6 8 11 13
5'- CCAAAGXACCGGG -3'
3'- GGTTTCCTGGCCC -5'
26 23 212019 16 14
Figure 6.21 Molecular dynamics of Able (a anomer) suggesting transient H-bonding
interactions between C20 and A8 formation. A, a stereo view of a snapshot of the
conformation at the abasic site. For the conformation of AS (in stick), 5 snapshots
representing lOps molecular dynamics simulations are overlaid to show the
conformational flexibility of AS (indicated by the double-headed arrow). B, a snapshot
of the conformation showing the transient H-bonding interactions (red dashed line)
between AS and C20. The conformation ofT19, the expected base-pair partner of AS, is
also shown.
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Figure 6.22 Quantitative analysis of the transient H-bond formation between A8 and
C20 in Ab/C in molecular dynamics simulation. Red trace, the distance between the
proposed H-bond donor (C20 amino-N) and the accepter (A8-Nl); blue trace, the angle
of donor-H-accepter. The black triangle indicates the optimum H-bonding interaction (the
distance < 3 A and the angle> 160°).
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AB
1 4 6 8 11 13
5'- CCAAAGXACCGGG -3'
3'- GGTTTCTTGGCCC -5'
26 23 212019 16 14
Figure 6.23 Molecular dynamics of Ab/f (a anomer) suggesting transient H-bonding
interactions between 1'20 and A8. A, a stereo view of a snapshot of the conformation at
the abasic site. For the conformation of A8 (in stick), 5 snapshots representing 10 ps
molecular dynamics simulations are overlaid to show the conformational flexibility of A8
(indicated by the double-headed arrow). Bt a snapshot of the conformation showing the
transient H-bonding interactions (red dashed lines) between A8 and 1'20. The
conformation ofT19t the expected base-pair partner of A8, is also shown.
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Figure 6.24 Quantitative analysis of the transient H-bond formation between A8 and
TIO in Abff in molecular dynamics simulation. Red trace, the distance between the
proposed H-bond donor (T2O imino-N) and the accepter (A8-N1); blue trace, the angle of
donor-H-accepter. The black triangle indicates the optimum H-bonding interaction (the
distance < 3 A and the angle> 160°).
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6.4 Discussion
Very few studies have been reported on the influence of the sequence context on the
structure and conformational flexibility of the abasic site lesion. Most studies have been
focused on abasic site analogs(36-38). The Bolton group has reported structural modeling
of duplex DNA containing normal abasic sites using 2D NOE spectroscopy(25-27, 39).
The discussion will be focused on the results that give insight into the role of the base
opposite the abasic site in the structure of the lesion. The structures of the abasic site (X)
in the sequence of 5'-GAXAC-3' with A or C opposite the lesion have been
investigated(25, 26). For both oligonucleotides, the molecule adopts an overall B-form
DNA conformation with the base opposite the lesion stacking intrahelically between
adjacent base pairs. For the abasic site with A opposite the lesion, a nearly equal
population of ca and 3 anomers were observed with slightly more a anomer. However,
conflicting results were reported for the structural modeling of this construct. In one
study, Goljer et al. showed that for the cc anomer, the abasic site deoxyribose was
extrahelical and for the 1i anomer, the abasic site was intrahelical(26). In a later study of
the abasic site with A opposite the lesion in the exact same sequence, Beger et al. showed
that that the abasic site deoxyribose in both anomers were intrahelical(25). Because no
NOE interactions were observed between the abasic site protons and adjacent bases, the
significance of the conformation of the abasic sites in the modeled structure is unclear.
The structure of the abasic site with C opposite the lesion was also examined by
Beger et al. in the same sequence context (5'-GAXAC-3') in an effort to understand the
influence of the base opposite to the abasic site(25). Their modeling suggested that the
overall structure is B-form with the abasic site and C opposite the lesion adopting an
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intrahelical conformation. Unlike the abasic site with A opposite the lesion, Beger et al.
observed two downfield-shifted 3 1p signals that were assigned to the residues adjacent to
the abasic site(25). This observation suggested that the backbone conformation was
perturbed from generic B-form DNA in the abasic site with C opposite the lesion.
However, no dihedral angle constraints were derived for the structural calculation. More
interestingly, their results suggested that there was only one anomer for the abasic site
with C opposite the lesion. Based on the relative NOE intensities associated with abasic
site protons, this species was assigned as the 3 anomer. The absence of the anomer in
this sequence is inconsistent with their previous studies that showed a mixture of cc and 3
anomers for the this site with four different bases opposite this lesion using a duplex
DNA containing a l'-[' 3C] labeled abasic site(6).
In summary, the modeling studies from the Bolton group described above suggested
that the base opposite the abasic site could influence the conformation of the abasic site.
However, their studies suffered from the lack of NOE interactions between the abasic site
and the adjacent bases. Furthermore, in one study, the H5 proton of C 3' to the abasic site
was mistakenly assigned as the Hi' proton of the abasic site(25), which compromised
their assignments of the anomeric state of the abasic site. Because of these limitations, the
relevance of the structure modeling from these studies remains uncertain.
Compared to the previous studies, our studies on duplex DNA containing the abasic
site with all four bases opposite the lesion have provided the first glimpse of such
structures in the 5'-GXAC-3' sequence context. Similar to previous studies(24-27, 39),
the structural modeling based on distance and dihedral angle constraints from 2D NMR
analysis suggests that the DNA is overall B-form for all lesions. Furthermore, in all cases,
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the bases opposite the lesion are all intrahelical. The chemical shifts of the abasic site
protons (HI', H2', H2", and H3') were assigned for all lesions and in all cases, a mixture
of cc and anomers were observed. The conformation of the abasic site was calculated
based on the NOE interactions with adjacent bases and dihedral angles associated with
the abasic site.
For the abasic site with A opposite the lesion, studies suggest that the abasic site
deoxyribose for both anomers are partially extrahelical (Chapter 5). The extrahelical
conformation is consistent with the observed NOE interaction pattern between the abasic
site protons (HI' and H2'/2") and the base proton 3' to the lesion (Figure 5.14, Chapter
5). This result is also consistent with the previous study from our group on the abasic site
in a very similar sequence context (5'-CCAAAGXACTGGG-3'/3'-GGTTTCATGACCC-
5')(24). For the corresponding lesion with G opposite the abasic site, weak NOE
interactions were also observed between the abasic site protons (HI' and H2'/2") and the
base proton 3' to the lesion. These weak interactions are not sufficient to define a unique
conformation for the abasic site deoxyribose. Molecular modeling suggests that the
abasic site in the anomer is intrahelical and that the 1'-OH group of the abasic site has
the tendency to form H-bonding interaction with the imino group of G opposite the
lesion. The abasic site in the 1i anomer adopts an extrahelical conformation that is similar
to the abasic site with A opposite the lesion.
For the abasic site with pyrimidines (C or T) opposite the lesion, the deoxyriboses are
partially extrahelical with both c and 1i anomers. These results are defined by and
consistent with a medium NOE interaction between H3' of the abasic site and the base
proton 3' to the lesion. The most interesting structural feature for the abasic site with a
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pyrimidine opposite the lesion is the unusually close proximity between bases adjacent to
the abasic site (G6 and A8). This conformation is supported by NOE interactions between
these two bases and unusual backbone conformations determined by the coupling
constants of H3'-C3'-O3'-P.
At present, it is not clear whether this structural feature exists for abasic sites with
pyrimidines opposite the lesion in any sequence context. Previous NMR characterization
on an abasic site analog (THF, or F) in the 5'-CGTGFGTGC-3' sequence with either C or
T opposite the lesion also revealed NOE interactions between the two bases adjacent to
THF, similar to that observed in this study(37). Although those studies did not lead to
final refined structures, the NOE interaction patterns suggested that the two bases
adjacent to THF were closer to each other than those in B-form DNA. Further studies of
the abasic site in more sequence contexts are required to draw a more general conclusion
on the role of the pyrimidine opposite the abasic site in defining the conformation of the
lesion.
Molecular dynamics calculations have been carried out to simulate the
conformational flexibility of the abasic site region with four bases opposite the lesion.
For the abasic site with a purine opposite the lesion, the conformational change is largely
due to the extrahelical movement of the abasic site sugar. For the abasic site with a
pyrimidine opposite the lesion, the simulation revealed much smaller motion associated
with the abasic site deoxyribose. Instead, we observed transient H-bonding interactions
between A8 3' to the abasic site and the pyrimidine opposite the lesion. This transient H-
bonding interaction is not observed for the abasic site with a purine opposite the lesion.
We propose that this H-bonding interaction is due to the lack of the base stacking
282
interaction between the unpaired pyrimidine with adjacent 3' bases.
Examples of transient H-bonding interactions between an unpaired base and an
adjacent base normally paired with another base have been documented. Computer
modeling of an abasic site analog (THF, or F) with C opposite the THF in the 5'-TCFTA-
3' sequence without NMR restraints revealed a similar transient H-bonding interaction
between T 3' to THF and C opposite the lesion during simulation(40). Such transient H-
bonding interactions were not observed during the simulation of THF with G opposite the
lesion in the same sequence context(40).
Are the transient H-bonding interaction observed between the base 3' to the abasic
site (A8) and the pyrimidine (C20 or T20) opposite to the lesion biologically interesting?
Some insight has been provided by the structural studies of Y-family DNA polymerases.
The transient H-bonding interactions between the incoming nucleotide and bases adjacent
to the abasic sites have been proposed to be responsible for frameshift mutations in
translesion DNA replication by Y-family DNA polymerases(15-18). Several crystal
structures of Dpo4 (a Y-family DNA polymerase from S. solfataricus) have been solved
in a complex with a primer/THF-containing-template(41). In one structure, the incoming
nucleotide (dCTP, the would-be base opposite THF) formed base pair interactions with G
5' to THF, which would lead to a -1 frameshift. In the structure, the THF moiety was
flipped partially extrahelical to accommodate the structural requirement of the base pair
interaction between the incoming nucleotide and the base 5' to THF. Although such
conformation was observed in a complex with the DNA polymerase, our results suggest
that the inherent structural flexibility of the abasic site could cause the transient base pair
interaction even without DNA polymerases.
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Finally, we are interested in how the conformation of the abasic site governs its
recognition and ultimately, repair by DNA repair enzymes. The distinct conformations
modulated by the base opposite the lesion suggest that the interaction with repair
enzymes is sequence dependent. Takeuchi and Demple et al. have examined the effect of
the base opposite the abasic site on Ap endonuclease (E. coli endonulease IV and
exonuclease III) activity(42). They observed similar kcat and Km among different
sequences. Since it remains unclear which step is rate limiting during the catalysis by Ap
endonucleases, the steady-state kinetic constants may not be indicative of the interaction
between the enzyme and the substrate DNA containing abasic sites. Further pre-steady
state kinetic analysis on the repair of the abasic site in a large sequence space, combined
with structural analysis of DNA lesions, would lead to the mechanism of sequence-
dependent recognition of the abasic site lesions in vivo.
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